US20020144905A1 - Sample positioning and analysis system - Google Patents

Sample positioning and analysis system Download PDF

Info

Publication number
US20020144905A1
US20020144905A1 US09/957,116 US95711601A US2002144905A1 US 20020144905 A1 US20020144905 A1 US 20020144905A1 US 95711601 A US95711601 A US 95711601A US 2002144905 A1 US2002144905 A1 US 2002144905A1
Authority
US
United States
Prior art keywords
substrate
aperture
sample
measurement
vesicles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/957,116
Inventor
Christian Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytion SA
Original Assignee
Cytion SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB1998/001150 external-priority patent/WO1999031503A1/en
Application filed by Cytion SA filed Critical Cytion SA
Priority to US09/957,116 priority Critical patent/US20020144905A1/en
Priority to US10/093,680 priority patent/US7201836B2/en
Assigned to CYTION SA reassignment CYTION SA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SCHMIDT, CHRISTIAN
Priority to US10/229,863 priority patent/US7244349B2/en
Publication of US20020144905A1 publication Critical patent/US20020144905A1/en
Priority to US10/334,815 priority patent/US7387715B2/en
Priority to US11/535,064 priority patent/US20070209935A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/48707Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48728Investigating individual cells, e.g. by patch clamp, voltage clamp
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5088Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above confining liquids at a location by surface tension, e.g. virtual wells on plates, wires

Definitions

  • the invention relates to systems for positioning and/or analyzing samples. More particularly, the invention relates to systems for positioning and/or analyzing samples such as cells, vesicles, cellular organelles, and fragments, derivatives, and mixtures thereof, for electrical and/or optical analysis, especially relating to the presence and/or activity of ion channels.
  • binding assays are relatively inexpensive, and amenable to high throughput, they require labeled high-affinity ligands, and generally are limited to assays for ligands that can compete effectively for labeled ligand.
  • Fluorescent or fluorogenic reagents generally are compatible with high throughput assays, including the analysis of ion channels using fluorescent calcium indicators, and the evaluation of membrane potential effects with potential-sensitive dyes.
  • such reagents typically are not sensitive enough for single cell measurements, and generally can provide only indirect measurements of the membrane component of interest.
  • the patch clamp was introduced by Neher and Sakmann in the early 1980s as a powerful technique for the direct study of drug effects on single receptors. In recognition of the strength of the method, Neher and Sakmann were awarded the Nobel prize in 1991.
  • Classical patch-clamp methods often are used in conjunction with functional membrane receptor assays, including receptors coupled to G-proteins and ion channel-forming receptors.
  • iii This method is highly specific and extremely sensitive: it can, in principle, be used to measure the channel activity of individual receptor molecules. In doing so, glass micropipettes with an opening diameter of typically 1-0.1 ⁇ m are pressed on the surface of a biological cell.
  • the membrane surface that is covered by the micropipette is called a “patch.” If the contact between the glass electrode and the cell membrane surface is sufficiently electrically isolating, the ion flow over the membrane patch can be measured electrically with the aid of microelectrodes, one placed in the glass pipette and the other placed in the milieu opposite the membrane. iv A key advantage of this electrophysiological method is that it makes directly accessible the function of the corresponding channel-forming proteins or receptors coupled to channel-forming proteins via the measured electrical characteristics of the channel-forming proteins.
  • the invention provides systems for positioning and/or analyzing samples such as cells, vesicles, cellular organelles, and fragments, derivatives, and mixtures thereof, for electrical and/or optical analysis, especially relating to the presence and/or activity of ion channels.
  • FIG. 1 is a schematic view of a system for positioning and/or analyzing samples in accordance with aspects of the invention.
  • FIG. 2 is a cross-sectional side view of a substrate chip prepared from Si/SiO 2 in accordance with aspects of the invention.
  • FIG. 3 is a cross-sectional side view of a measurement system having planar electrodes in accordance with aspects of the invention.
  • FIG. 4 is a cross-sectional side view of a measurement system having point or wire electrodes in accordance with aspects of the invention.
  • FIG. 5 is a cross-sectional side view of a measurement system having open fluid compartments in accordance with aspects of the invention.
  • FIG. 6 is a top view of a measurement system having multiple measurement sites in accordance with aspects of the invention.
  • FIG. 7 is a cross-sectional side view of the measurement system of FIG. 6, taken generally along line 7-7 in FIG. 6.
  • FIG. 8 is a cross-sectional side view of a measurement system having optical measurement aids in accordance with aspects of the invention.
  • FIG. 9 is a partially cross-sectional partially schematic side view of a measurement system for combined electrical/optical detection.
  • FIG. 10 is a contour plot of the electric potential adjacent an aperture in a substrate in accordance with aspects of the invention, computed by finite element method (FEM) simulation.
  • FEM finite element method
  • FIG. 11 is a plot of current versus time showing a decrease in current upon addition of Ca 2+ to a final concentration of 4 mM following the docking of vesicles at a 7- ⁇ m aperture in the unmodified surface of a suitable substrate.
  • FIG. 12AB is a pair of plots of current versus time showing the time course of vesicle binding and the subsequent development of membranes with very high electrical insulation resistance for (A) a 4- ⁇ m aperture and (B) a 7- ⁇ m aperture in a poly-L-lysine-coated SiO 2 substrate.
  • FIG. 13 is a plot of current versus time showing the passage of individual vesicles through a 7- ⁇ m aperture, as reflected in fluctuations in the plot recorded at a constant clamp voltage, V c , of ⁇ 80 mV.
  • FIG. 15AB is a pair of plots of current versus time showing the changes in measured membrane resistance of a membrane produced on a Si/SiO 2 carrier chip after fusion with vesicles containing nAChR (nicotinic acetylcholine receptor).
  • FIG. 15A shows the membrane resistance during accidental receptor openings in the absence of ligands at 400 mM KCl and positive potentials.
  • FIG. 15B shows the membrane resistance 150 seconds after the addition of the nAChR agonist carbamylcholine (20 ⁇ m final concentration), where no receptor openings are observed due to desensitization of the receptors.
  • FIG. 16 is a plot of current versus time showing the time course of positioning, binding, and subsequent development of a tight electrical seal for a Jurkat cell.
  • FIG. 17 is a series of plots of current versus time showing the current flowing through the membrane of a Jurkat cell for the indicated positive and negative clamp voltages.
  • FIG. 18 is an analysis of the current flowing through the membrane of a Jurkat cell for a +60 mV clamp voltage showing (A) a representative plot of current versus time, and (B) a histogram showing the relative likelihood of the measured currents.
  • the invention provides systems such as single and multiaperture biochips for positioning and/or analyzing membrane-bound samples, such as cells, vesicles, cellular organelles, and/or portions thereof.
  • Positioning a sample generally comprises locating or placing the sample at a preselected position, within the system, typically for subsequent analysis.
  • Analyzing the sample generally comprises detecting a presence or activity within the sample, while it is positioned at the preselected position, typically relating at least in part to electrical properties of the sample.
  • FIG. 1 shows a representative system 30 for positioning and/or analyzing samples in accordance with aspects of the invention.
  • the system includes a substrate 32 , at least two fluid compartments 34 a,b, and at least two electrodes 36 a,b. (In some cases, for example, where only optical measurements are to be performed, the system may have only a single fluid compartment and no electrodes.)
  • the substrate comprises a separating wall of electrically isolating material, and may include an aperture and/or window 38 and an associated adhesion surface 40 adjacent the aperture to which samples 42 may be bind or be fixed using any suitable mechanism.
  • the fluid compartments generally comprise any region or volume adapted to support a fluid adjacent the aperture.
  • the electrodes generally comprise any mechanism for applying and/or measuring an electric potential and associated electric field across the aperture.
  • a first side of the substrate is used as a sample or measurement side, and a second side of the substrate is used as a reference side, although these roles may be interchangeable.
  • the measurement side is used to hold samples during positioning and/or analysis, and typically includes adhesion surface 40 , a measurement fluid compartment 34 a and a measurement electrode 36 a.
  • the reference side is used to complete the electric circuit, and typically includes a reference fluid compartment 34 b and a reference electrode 36 b.
  • the measurement electrode and the reference electrode independently may be set to any suitable voltage, including ground.
  • the system may include or be interfaced with one or more auxiliary systems, including (1) a sample handling system 44 for introducing, removing, and/or otherwise manipulating fluids and/or samples, (2) an analysis system 46 for analyzing samples, particularly by mechanisms other than direct electrical measurement, and/or (3) an incubation system for storing samples before and/or during assays, and/or (4) a cleaning system for cleaning substrates and/or other system components.
  • auxiliary systems including (1) a sample handling system 44 for introducing, removing, and/or otherwise manipulating fluids and/or samples, (2) an analysis system 46 for analyzing samples, particularly by mechanisms other than direct electrical measurement, and/or (3) an incubation system for storing samples before and/or during assays, and/or (4) a cleaning system for cleaning substrates and/or other system components.
  • the system may be used for a variety of applications. These applications may include automated and/or high-throughput patch-clamp analysis (e.g., for drug screening), portable biosensor analysis (e.g., for environmental analytes), and so on. These applications also may include the separation of cells or vesicles, the analysis of the sizes of cells or vesicles, the direct functional analysis of ionotropic membrane proteins, for example, in ligand binding studies, and/or the positioning of cells or vesicles for any suitable purpose, including purely optical investigations and/or microinjections, among others.
  • applications may include automated and/or high-throughput patch-clamp analysis (e.g., for drug screening), portable biosensor analysis (e.g., for environmental analytes), and so on. These applications also may include the separation of cells or vesicles, the analysis of the sizes of cells or vesicles, the direct functional analysis of ionotropic membrane proteins, for example, in ligand binding studies, and/or the positioning
  • a sample such as a cell or vesicle is introduced into the measurement compartment and then is directed toward the aperture, for example, using an electric force created by the two electrodes.
  • the sample contacts the adhesion surface, binds across the aperture, and forms an electrical seal with the aperture sufficient for performing an assay of interest.
  • the effects of an applied voltage created by the electrodes then may be studied, typically before and/or after exposure to a suitable assay condition The studies may be performed by measuring changes in electrical properties across the aperture, such as current, resistance, or the like, and/or by measuring other changes in the sample, such as ion levels or the like.
  • the assay condition generally comprises any change of condition, optionally including a change in environmental condition, such as sample temperature, but more typically including the addition of one or more reagents such as candidate drug compounds to the sample.
  • the reagent may be a chemical reagent, such as an acid, a base, a metal ion, an organic solvent, or other substance intended to effect a chemical change in the sample.
  • the reagent may have or be suspected to have a biological activity or type of interaction with a given biomolecule.
  • Selected assay components may include membrane-active substances, such as pore promoters, proteoliposomes, and/or membrane proteins.
  • Selected assay reagents also may include oligonucleotides, nucleic acid polymers, peptides, proteins, drugs, and other biologically active molecules.
  • the system may have one or more advantages over prior systems for measuring electrical properties of cells and vesicles.
  • First, the system is relatively simple, both in the production of electrically insulating patch membranes and in the associated measurements. Thus, the system, alone or in combination with modern microtechnological methods, is suitable for use in automated and/or “high throughput screening” (HTS) applications.
  • Second, the positioning and measuring capabilities of the system are well suited to the combination of electrical and optical measurements, through which, on these planar membranes, obtained by means of the positioning process according to the invention, new, important information concerning membrane channels and receptors may be obtained.
  • the substrate generally comprises any surface or set of surfaces capable of separating two fluid compartments.
  • the substrate typically includes an aperture that passes through the substrate to connect the two fluid compartments and at least one adhesion surface adjacent the aperture for binding a sample such as a cell or vesicle for analysis.
  • the substrate preferably is nonconductive (e.g., electrically insulating), thus reducing or eliminating electrical contact between the two fluid compartments, except through the aperture.
  • the substrate may be formed of any suitable material.
  • the substrate is nonconductive, inert (in the system), and no more than slightly modifiable chemically.
  • exemplary materials include silicon (including silicon (Si) and silicon derivatives, such as silicon oxide (SO 2 ; silica) and silicon oxinitride (SiO x N y )), glass, quartz, plastic, and so on.
  • the silicon-based substrates have several advantages. First, they are commercially available. Second, they are easily processed, for example, so that they may be provided with an aperture and/or window, as described below in Example 1. Third, they readily may be coated or otherwise partially or completely covered with insulating and/or adhesion-promoting materials.
  • Such surface layers include layers of quartz, glass, and solid and/or gelatinous polymers, among others.
  • Such surface layers also include plastomers and elastomers, such as polyimides, polymethylmethacrylates, polycarbonates, and silica gels (e.g. Sylgard).
  • Such surface layers also may be homogeneous or inhomogeneous, where, for example, in the latter case, they may be applied as droplets.
  • the substrate may include two or more pieces or components, for example, being constructed of a holder on which the material actually relevant to membrane positioning and membrane binding is fastened or into which this material is admitted, where this material for the positioning, or alternatively the binding, of the membranes has at least one aperture.
  • the substrate may be formed with any suitable geometry, subject to the above limitations. However, preferably, the substrate is at least substantially planar, and more preferably, the substrate is microscopically flat and molecularly relatively planar, particularly at the adhesion surface.
  • the aperture and window(s) are the portions of the substrate most immediately involved in the positioning and/or analysis of samples.
  • the aperture generally comprises any opening or other passage through the substrate.
  • This opening may include a hole, a gap, and/or a slit, among others, and may allow fluid contact between fluid compartments positioned at opposite sides of the aperture.
  • the aperture may be capable of forming an electrical seal with a sample such as a cell or vesicle that is sufficiently “tight” to use in a patch clamp experiment.
  • Exemplary seals (depending on sample type and condition) have included >10 k ⁇ , >100 k ⁇ , >1 M ⁇ , >10 M ⁇ , >100 M ⁇ , >1 G ⁇ , >10 G ⁇ , >100 G ⁇ , and even >1T ⁇ .
  • the aperture may be capable of focusing an electric field with sufficient strength to position a sample such as a cell or vesicle about the aperture.
  • the aperture may include a hole, a gap, and/or a slit, among others.
  • the aperture is characterized by a length L ap and a diameter d aperture
  • the length is determined by the thickness of the substrate adjacent the aperture, generally ranging between about 3 ⁇ m and about 1000 ⁇ m, and preferably ranging between about 100 nm and about 20 ⁇ m.
  • the diameter of the aperture, as measured immediately adjacent the binding surface, is influenced by a variety of different factors, which may urge toward either smaller or larger apertures. First, smaller apertures generally increase the quality of the electrical seal between the aperture and the sample, up to a limit.
  • the aperture should be smaller, preferably significantly smaller, than the size of the sample (i.e., d aperture ⁇ d cell , d vesicle ), but larger, preferably significantly larger, than the lipids and other molecules present in the sample.
  • smaller apertures generally increase the mechanical stability of the membrane across the aperture.
  • the force required to deflect a portion of membrane is inversely proportional to the square of the radius of the portion being deflected (i.e., proportional to the value of r M ⁇ 2 ; see, e.g., Example 12), so that the selection of small (e.g., d aperture ⁇ 5 ⁇ m) apertures may significantly increase membrane stability, particularly relative to the typical (e.g., d aperture >100 ⁇ m) apertures used in conventional black lipid membrane (BLM) systems.
  • smaller apertures generally increase the strength and focus of the electric field passing through the aperture, which is especially useful when positioning samples.
  • the diameter of the aperture generally is less than about 15 to 20 ⁇ m, usually is less than about 10 ⁇ m, preferably is less than about 7 ⁇ m, and more preferably is less than about 5 ⁇ m. In particular, sizes between about 0.3 ⁇ m and about 7 ⁇ m may yield an outstanding probability and quality of sealing.
  • the aperture preferably should have a diameter of no more than a few tens of percent, and more preferably no more than about 30 percent, of the sample diameter. Thus, for cellular samples, which typically have a diameter of greater than about 20 ⁇ m, the aperture preferably should have a diameter of no more than about 5-7 ⁇ m.
  • the window generally comprises a portion of the fluid compartment adjacent and providing access to the aperture.
  • the preferred size of the window is determined by factors analogous to those described above for determining the preferred size of the aperture.
  • the diameter of the window preferably is less than about 1000 ⁇ m, and more preferably is significantly smaller, being not more than about 100 ⁇ m.
  • Examples 1-7 below describe exemplary apertures and windows, including geometries and relationships with other components of the system.
  • the adhesion surface generally comprises any surface or set of surfaces adjacent the aperture to which samples such as cells and vesicles may bind for analysis.
  • the adhesion surface typically is at least substantially planar over an area exceeding that of the bound portion of the sample but in some cases may be at least slightly concave in the direction of the sample.
  • the adhesion surface may have an area of at least about 25 ⁇ M 2 for a cell that is about 5 ⁇ m in (bound) diameter, at least about 100 ⁇ m 2 for a cell that is about 10 ⁇ m in (bound) diameter, and so on.
  • Binding generally comprises any stable or semi-stable association between a sample and an adhesion surface that results in an electrical seal between the sample and one or more apertures that is sufficiently “tight” to allow the desired measurement. Binding may be mediated by any suitable mechanism, direct or indirect, including electrostatic interactions, covalent bonding, ionic bonding, hydrogen bonding, van der Waals interactions, and/or hydrophobic-hydrophilic v interactions, among others. In general, binding may be facilitated by the appropriate selection, treatment, and/or modification of the substrate, the sample, the measurement medium, or a suitable combination thereof.
  • binding may be facilitated by appropriate selection of the substrate.
  • preferred substrates typically include a relatively flat or gently contoured binding surface adjacent the aperture of interest, so that cells or vesicles may bind to form an acceptable seal with the aperture without unwanted or unnecessary deformation.
  • preferred substrates also typically include a modifiable binding surface, so that the surface may be treated as desired to promote binding.
  • Binding also may be facilitated by appropriate treatment of the substrate, as suggested above.
  • the surface may be treated or otherwise modified so that electrostatic or, in given cases, hydrophobic, van der Waals or covalent binding of vesicles or cells, or -the corresponding membranes or membrane fragments, is promoted.
  • the binding surface may be coated with an adhesion promoter, such as poly-L-lysine, poly-D-lysine, gelatin, collagen, laminin, fibronectin, proteoglycans, polyethylenimine, albumen, BIOMATRIX EHS (Nunc Nalge International), BIOBOND (Electron Microscopy Services, Inc.), and/or MATRIGEL (Becton-Dickinson), among others.
  • an adhesion promoter such as poly-L-lysine, poly-D-lysine, gelatin, collagen, laminin, fibronectin, proteoglycans, polyethylenimine, albumen, BIOMATRIX EHS (Nunc Nalge International), BIOBOND (Electron Microscopy Services, Inc.), and/or MATRIGEL (Becton-Dickinson), among others.
  • an adhesion promoter such as poly-L-lysine, poly-D-lysine, gelatin, collagen, la
  • the binding surface (especially a silicon binding surface) may be coated with an oxide or oxynitride layer.
  • the binding surface may be coated with largely hydrophobic compounds such as Tocopherol.
  • an electrically charged surface may be generated by modification, in particular, by means of polycations and/or silanes, for example, aminosilanes, or the substrate may have a coating or other surface layer with an electrically charged surface.
  • Microstructured silicon/silicon oxide or silicon/silicon nitride substrates are especially suitable for providing a good electrostatic attraction, after being coated with a substance lending the desired surface charge.
  • the substrate may be subjected to oxygen plasma cleaned and/or partially or completely hydrophylized before the modification of its surface and/or before its immediate use, in addition to or in lieu of the above modifications.
  • unwanted hydrophylization/modification of the hydrophobic surface can be avoided by using silicon nitride for the surface layer.
  • Binding also may be facilitated by appropriate selection and/or treatment of the sample itself.
  • the sample may include unsaturated lipids or other compositions that increase the fluidity of its membrane, potentially enhancing membrane flexibility during binding and seal formation.
  • the sample may include charged lipids or other compositions that increase the charge on the sample, potentially enhancing the ability of the sample to bind electrostatically to substrate surfaces bearing an opposite charge.
  • the vesicle might include negatively charged palmitoyl-oleoyl-phosphatidylglycerol (POPG).
  • POPG palmitoyl-oleoyl-phosphatidylglycerol
  • binding may be facilitated by interactions between specific binding pairs (SBPs), where one member of the pair is associated with the sample and the other member of the pair is associated with the substrate.
  • SBPs specific binding pairs
  • the interactions between members of a specific binding pair typically are noncovalent, and the interactions may be readily reversible or essentially irreversible.
  • An exemplary list of suitable specific binding pairs is shown in Table 1. TABLE 1 Representative Specific Binding Pairs First SBP Member Second SBP Member antigen antibody biotin avidin or streptavidin carbohydrate lectin or carbohydrate receptor DNA antisense DNA enzyme substrate enzyme histidine NTA (nitrilotriacetic acid) IgG protein A or protein G RNA antisense RNA
  • Binding also may be facilitated by appropriate selection and/or treatment of the measurement medium.
  • the medium may include binding mediators that participate in or otherwise promote interactions between the sample and substrate, for example, by forming cross-bridges between the sample and substrate and/or by counteracting the effects of binding inhibitors associated with the sample, substrate, or medium.
  • the binding mediators may act specifically, for example, by binding to specific groups or molecules on the sample or substrate.
  • biotin might act as a specific binding mediator by binding to and cross-linking avidin or streptavidin on the sample and substrate.
  • the binding mediators also may act less specifically, or nonspecifically, for example, by binding to classes or categories of groups or molecules on the sample or substrate.
  • Ca 2+ ions might act as a relatively nonspecific binding mediator by binding to and cross-linking negative charges on the sample and substrate.
  • Ca2+ ions are particularly appropriate for mediating the binding of cells or vesicles containing negative lipids and substrates containing negative surface charges, such as SiO 2 substrates.
  • samples such as cells or vesicles may be broken up, for example, by treatment with a hypotonic medium, such as pure water.
  • a hypotonic medium such as pure water.
  • the fluid compartments generally comprise any region or volume adapted to support a fluid adjacent the aperture.
  • the compartments may perform several functions, including covering the sample, providing a medium through which the cell may be moved during positioning, and/or providing a medium for establishing electrical contact between the electrodes, among others.
  • the compartments generally may have any suitable volumes, but they typically have volumes between about 0.1 to 40-100 ⁇ L. Thus, assays typically require only a limited amount of sample, facilitating the analysis of effects of precious compounds.
  • the fluid compartments may be closed or open.
  • a closed compartment comprises a compartment that is at least substantially bounded or delimited on all sides by a wall or other separating layer, exclusive of an input and/or output port.
  • an open compartment comprises a compartment that is not bounded on at least one side (i.e., over at least some solid angle) by a wall.
  • Closed compartments typically are physically confined, i.e., bounded by some combination of the substrate, an electrode, and one or more spacers, being established within voids and channels therein.
  • the spacers are used in many embodiments, particularly those involving planar electrodes, to establish and maintain the relative positions of the substrate and electrodes.
  • Such spacers typically are formed of an electrically isolating material, like the substrate.
  • the spacers may include channels disposed between the aperture and the electrode. These channels, typically filled with a conductive solution, can serve as a sample or reference chamber. It is beneficial if the reference chamber has such small dimensions that the reference buffer solution may be fixed therein by capillary forces, and/or forced therein by surface tension (e.g., at the fluid/air interface in an open compartment).
  • Open compartments typically are free standing, i.e., not bounded in at least one, typically lateral, direction. Instead, the fluid may be fixed between the substrate and electrode without other physical boundaries by capillary forces and/or surface tension.
  • Examples 2-7 below describe exemplary fluid compartments, including geometries, boundaries, and relationships with other components of the system.
  • the electrodes generally comprise any mechanism for creating and/or modulating an electric potential across an aperture, particularly for use in positioning and/or analyzing samples.
  • the electrodes may be formed of any material capable of inducing current flow through an aperture upon application of a physiological potential. Suitable electrodes include silver, gold, and/or platinum, among others. Preferred electrodes include silver/silver chloride (Ag/AgCl) and/or platinum (Pt) redox electrodes.
  • the electrodes may be formed with any suitable geometry and be disposed in any suitable arrangement, consistent with their performing their intended function(s).
  • Preferred electrodes have planar, cylindrical, or point geometries.
  • Preferred electrode arrangements are symmetrical, with similar electrodes positioned at similar distances and orientations from each aperture on each side. Symmetrical electrode arrangements generally will create symmetrical electric fields.
  • the electrodes are located opposite one another across a single aperture, with each electrode reaching into at least one compartment, or at least contacting a surface of it.
  • the electrodes customarily are located at a distance of about 0.5 to 3 mm, and usually about 0.5 to 1 mm, from the substrate, although they can be closer or farther in some embodiments.
  • the electrodes may be attached directly to a recording carrier, or to a cartridge in which this carrier is packaged, and/or to a holder that is not in direct contact to the substrate.
  • the electrodes should be capable of creating an electric potential sufficient to perform their function, for example, positioning and/or analyzing samples, without unduly disrupting the samples.
  • Preferred electric potentials give rise to electric field intensities of greater than about 100 V/m, particularly adjacent the aperture.
  • one electrode is referred to as a measurement electrode, p Examples 2-7 below, among others, describe exemplary electrodes, including geometries (e.g., planar, cylindrical, and point), materials (e.g., silver and/or platinum), and relationships with other components of the system.
  • the invention provides multiaperture systems for positioning and/or analyzing samples. These systems include two or more apertures, which may be disposed at the same and/or separate sites. Apertures disposed at the same site may be used to study single samples at two or more positions on the sample. In contrast, apertures disposed at separate sites may be used to study two or more samples, sequentially and/or simultaneously, at one or more positions on each sample.
  • the production of multiaperture systems generally is straightforward, especially using silicon substrates and Ag/AgCl electrodes, both of which are easily microstructurable.
  • multiaperture systems may be produced from a single continuous substrate having two or more apertures or by joining together two or more smaller substrates each having one or more apertures. The latter approach may be less expensive for substrates such as silicon with costs that increase faster than area.
  • Exemplary multiaperture systems employ a multiarray layout having a plurality of separate measurement sites.
  • each site includes at least one aperture and fluid and electrical contact with at least one fluid compartment and at least one electrode, respectively, on each side of the aperture.
  • the fluid compartments and electrodes on one side of the substrate generally are separated to allow independent recordings.
  • the fluid compartments and electrodes on the other side may be partially or totally combined, because these components typically function merely to provide a common electrical potential (e.g., ground).
  • the sample generally may be positioned on either the measurement or the reference side, although typically it is positioned on the measurement side so that each fluid compartment independently can contain the same or different types of samples.
  • several apertures may be used on one substrate, and the measurements may be performed over at least two apertures sequentially and/or in parallel and/or in such a manner that all or several electrodes on one side of the substrate have a common electrical potential, or, alternatively, are combined to form one electrode.
  • more than two electrodes and more than one aperture can be present in such a way that at least one electrode, for example, a reference electrode, serves the measurement via more than one aperture, or the measurement arrangement can have a substrate with more than one aperture and twice as many electrodes as apertures in such a way that one aperture always is located between two electrodes.
  • Measurement sites may be separated using any suitable mechanism, including hydrophilic/hydrophobic surface patterning, as described below, and/or dividing the carrier surface into small compartment wells (e.g., by laminating a thin polydimethylsiloxane (PDMS) layer containing small holes to the carrier surface adjacent the aperture).
  • PDMS polydimethylsiloxane
  • the multiaperture system generally may include any number of measurement sites, positioned in any suitable arrangement, with any suitable size or footprint, all consistent with forming electric fields within each site to position and/or analyze samples.
  • Preferred configurations may be selected based on utility and/or convenience.
  • preferred systems may include features selected from standard microplates, so that the system may be used with standard microplate equipment, including handlers, washers, and/or readers, among others. These features may include a rectangular frame, with a major dimension of about 125-130 mm, a minor dimension of about 80-90 mm, and a height of about 5-15 mm, although other dimensions are possible.
  • the frame may include a base configured to facilitate handling and/or stacking, and/or a notch configured to facilitate receiving a cover. These features also may include 96, 384, 864, 1536, 3456, or 9600 measurement sites, among others, positioned on a rectangular or hexagonal array. Three exemplary configurations that will fit as rectangular arrays within a microplate-sized frame are listed in the following table: Arrangement of Pitch (mm) Density (/mm 2 ) Number of Sites Sites Between Sites of Sites 96 8 ⁇ 12 9 1/81 384 16 ⁇ 24 4.5 4/81 1536 32 ⁇ 48 2.25 16/81
  • pitch is the center-to-center site-to-site spacing
  • density is the number of sites per unit area.
  • system components particularly components in the optical path in optical assays.
  • system components preferably are made of opaque black plastic to reduce background photoluminescence and/or “crosstalk,” where crosstalk is the transmission of light emitted in one site to adjacent sites where it may be detected.
  • system components preferably are made of opaque white plastic to increase reflection of emitted light out of the site by the white surfaces while still reducing crosstalk.
  • the positioning and measurement system of the present invention optionally may be coupled to or integrated with an analysis system for analyzing samples and sample components.
  • the analysis system generally comprises any mechanism for analyzing or otherwise characterizing samples, qualitatively or quantitatively, other than by direct electrical measurement as used by the positioning and measurement system.
  • the analysis system may require that the sample be separated from the measurement system and/or from other sample components, as described above. Alternatively, or in addition, the analysis system may allow the sample to be studied in situ, without such separation.
  • measurements made by the positioning and measurement system and measurements made by the analysis system may be performed simultaneously or sequentially, in any order or in any combination, in association with or independent of one another.
  • the analysis system may be based on any suitable analytical technique, including spectroscopic, hydrodynamic, and imaging methods, among others, particularly those adaptable to high-throughput analysis of multiple samples.
  • Preferred analysis systems are based on the optical analysis of samples, particularly luminescence-based optical analysis, but also absorption, scattering, circular dichroism, optical rotation, and imaging, among others.
  • luminescence analysis light transmitted from the sample is detected and analyzed, and properties of the detected light are used to infer properties of the sample, including the presence, size, shape, mobility, quantity, activity, and/or association state of selected components of the sample.
  • photoluminescence including fluorescence and phosphorescence, the emission of light from the sample is induced by illuminating the sample with appropriate excitation light.
  • the emission of light from the sample is induced by chemical reactions occurring within the sample.
  • the analysis may involve measuring various properties of the detected light, including its intensity, lifetime, polarization, quantum yield, and Stokes' shift, among others.
  • the analysis also may involve using one or more of these properties in techniques such as fluorescence intensity (FLINT), fluorescence polarization (FP), fluorescence resonance energy transfer (FRET), fluorescence lifetime (FLT), total internal reflection fluorescence (TIRF), fluorescence correlation spectroscopy (FCS), fluorescence recovery after photobleaching (FRAP), and fluorescence imaging, including confocal CCD observation, among others.
  • luminescence assays light typically is detected from a luminophore, i.e., a molecule or other species that emits luminescence.
  • the luminophore may be endogenous or exogenous.
  • the luminophore may be the material of interest in the assay but more commonly is simply a reporter that provides information about another material that is the true material of interest.
  • the luminophore may be an exogenous molecule that reports on (1) membrane potential, (2) the presence or concentration of a target metal, such as Ca 2+ , Mg 2+ , and Zn 2+ , (3) the presence or concentration of an inorganic ion, such as Na + , K + , and Cl ⁇ , (4) pH, (5) reactive oxygen species, including nitric oxide, (6) ion channels, including Ca 2+ channels, Na + channels, K + channels, and Cl ⁇ channels, (7) signal transduction, (8) cell viability, and (9) endocytosis and exocytosis, among others.
  • Suitable luminophores for reporting on this and other information are described in Richard P. Haugland, Handbook of Fluorescent Probes and Research Chemicals (6 th ed. 1996), which is incorporated herein by reference.
  • the optical analysis system typically will include a light source, a detector, and one or more optical relay structures for directing excitation light from the light source to the sample and for directing emission light from the sample to the detector.
  • the light source and excitation optical relay structure are optional during analysis utilizing chemiluminescence methods.
  • the optical analysis system may use epi- and/or trans-detection schemes, involving illuminating off of and/or through the sample, respectively.
  • optical analysis systems and components thereof, are described below under Examples and in the various patents, patent applications, and other materials listed above under Cross-References and incorporated herein by reference.
  • Preferred optical analysis systems are described in the following materials, which are incorporated herein by reference: U.S. Pat. No. 5,355,215, issued Oct. 11, 1994; U.S. Pat. No. 6,097,025, issued Aug. 1, 2000; U.S. Provisional Patent Application Serial No. 60/267,639, filed Feb. 10, 2001; and Joseph R. Lakowicz, Principles of Fluorescence Spectroscopy (2 nd ed. 1999).
  • the combined system is suitable for simultaneous and/or sequential electrical and optical (e.g., photoluminescence) measurements.
  • Suitable apparatus may include a planar, and vertically easily realizable, optically transparent structure, for example, with the use of planar pointed electrodes, or alternatively point electrodes disposed outside of the vertical lines going through the aperture.
  • planar pointed electrodes or alternatively point electrodes disposed outside of the vertical lines going through the aperture.
  • This allows not only fluorescence or electrical analysis of single cells (or membranes) but also the combined optical-electrical observation of cells (or membranes), particularly in response to exposure to externally applied substances, such as potential medical drugs.
  • This revolutionary approach allows significantly more efficient selection of new drugs and the elucidation of their molecular action.
  • Example 7 describes an exemplary analysis system. Additional examples are described in the various patents and patent applications listed above under Cross-References and incorporated herein by reference.
  • the positioning and measurement system optionally may be coupled to or integrated with a sample-handling system for adding, manipulating, exchanging, and/or removing samples and sample components, including cells and vesicles, sample media, and compounds and reagents, such as candidate modulators and/or other analytes.
  • the sample-handling system may add samples such as cells or vesicles to arbitrary compartments, convey liquid into and/or out of arbitrary compartments, and/or exchange samples and/or liquid between arbitrary compartments, among others.
  • the sample-handling system also may separate samples, or sample components, in particular using capillary electrophoresis (CE) and/or high-pressure liquid chromatography (HPLC), and serve the analysis of the separated substances, or it can be provided with means that serve the continuous or regular testing of the state of the liquid in the compartments as well as with means for retroactive regulation according to preset filling parameters. Because it is reasonable, according to the analysis strived for, to bring the membrane into contact with measurement solution on both sides, the addition of a substance to be investigated obviously can be done on the side customarily serving as the reference side.
  • the sample-handling system may be multiplexed to interact with several substrates and/or with a multiaperture substrate, among others.
  • the sample-handling system may be based on any suitable mechanism, including tubes, pumps, hydrostatic pressure differentials, electro-osmotic processes, piezo drop-on-demand processes, ink-jet processes, contact transfer processes, temperature-controlled processes, and/or mechanical displacement, among others.
  • fluids such as reference buffers may be introduced into a pasty gel, whereby an exchange of the liquid lying outside the gel is possible without changing the composition of the reference buffer stored in the gel.
  • Suitable gels include agarose and polyacrylamide.
  • Example 2 describes an exemplary sample handling system. Additional examples are described in the various patents and patent applications listed above under Cross-References and incorporated herein by reference, including U.S. patent application Ser. No. 09/777,343, filed Feb. 5, 2001; and U.S. Provisional Patent Application Serial No. 60/267,639, filed Feb. 10, 2001.
  • the sample generally comprises any species having a membrane or other surface capable of forming a seal with an aperture sufficient for performing electrical measurements such as patch clamp experiments.
  • the sample may include cells, vesicles, cellular organelles, membrane-bound viruses, and fragments, derivatives, and mixtures thereof.
  • Biological samples may include or be derived from (1) eukaryotic cells, i.e., cells with a nucleus, including cells from plants, animals, fungi, yeast, and protozoans, or enucleated derivatives thereof; (2) prokaryotic organisms, including bacteria and archaebacteria; (3) viruses; (4) organelles or extracts, such as nuclei, mitochondria, endosomes, the Golgi apparatus, peroxisomes, lysosomes, endoplasmic reticulum, chloroplasts, axons, and dendritic processes, among others; and (5) gametes, including eggs and sperm.
  • eukaryotic cells i.e., cells with a nucleus, including cells from plants, animals, fungi, yeast, and protozoans, or enucleated derivatives thereof
  • prokaryotic organisms including bacteria and archaebacteria
  • viruses (4) organelles or extracts, such as nuclei, mitochondria, endosome
  • These cells and other materials may be obtained from any suitable source, including cell cultures, patient samples, and tissues, among others. These cells also may be subjected to any suitable treatments to alter membrane properties, for example, to introduce a novel or modified ion channel, among others. These treatments may include genetic modification by any suitable method, including chemical treatment, irradiation, transfection, infection, and/or injection, among others.
  • Vesicles and other synthetic samples may include or be derived from (1) unilamellar vesicles, (2) multilamellar vesicles, (3) small vesicles (having diameters less than about 1000 nm), (4) large vesicles (having diameters greater than about 1000 nm), (5) monodisperse vesicles, and (6) polydisperse vesicles. These vesicles may be formed from any suitable lipid(s) and/or protein(s) using any suitable technique.
  • Exemplary lipids include DLPC, DMPC, DPPC, DSPC, DOPC, DMPE, DPPE, DOPE, DMPA, DPPA, DOPA, DMPG, DPPG, DOPG, DMPS, DPPS, and DOPS, among others.
  • sample positioning generally occurs in two sequential substeps: (1) a first (prepositioning) substep, in which the sample is introduced to the measurement compartment, and (2) a second (micropositioning) substep, in which the sample is brought into proximity or actual contact with the adhesion surface. These steps may be performed robotically, at least substantially without direct human involvement or intervention.
  • the prepositioning substep generally involves introducing the sample to the measurement compartment, preferably in a manner that facilitates subsequent binding of the sample to the adhesion surface.
  • the sample may be introduced generally above the adhesion surface (or associated aperture), so that it is directly between the electrodes, if they are symmetrically arranged, and so that gravity will tend to pull it straight down toward the aperture.
  • the sample may be introduced relatively close to the adhesion surface, and/or with an initial velocity toward the adhesion surface, among others.
  • the micropositioning step generally involves bringing the sample into proximity or actual contact with the adhesion surface, once the sample is in the measurement compartment.
  • samples may be micropositioned using any suitable force or other mechanism, including sedimentation (e.g., “1g-sedimentation” under the influence of gravity), electromagnetic forces (e.g., electrophoresis, electro-osmosis, and the like), optical forces (e.g., optical tweezers), fluid-mediated forces (e.g., pressure, vacuum, flow, diffusion, and the like), and/or manual forces.
  • the cells may be positioned by fluid flow from the sample compartment to the reference compartment by a hydrostatic pressure difference or by a difference in surface tension between the two compartments.
  • samples are micropositioned using electromagnetic forces, specifically, field focusing of an electric field created by applying a potential across the two electrodes.
  • this technique exploits the field focusing that occurs adjacent the aperture, creating an electric force that, at least adjacent the aperture, points in all positions toward the aperture, with a strength that increases with proximity to the aperture.
  • the measurement process provided by aspects of the invention allows in particular the measurement of ion channel flows in a reliable and reproducible manner, often with a high signal-to-noise ratio.
  • These abilities reflect the precise positioning and electrically tight binding of cells, vesicles, cellular organelles, and/or membranes of corresponding origin, at microstructured apertures in a planar substrate.
  • This electrically tight binding may be achieved at least in part by strong interactions between the surface of the substrate and the surface of the bound membrane, such as strong electrostatic attractions.
  • the current provides insight into membrane electrical properties, such as its conductivity, and therefore insight into the conformation state of the channel-forming protein (e.g., open (passing ions) or closed (blocking ions)).
  • the current may be used to analyze voltage dependencies, ligand binding events, and so on.
  • the ability of current measurements to yield meaningful data in a patch clamp or other electrophysiology experiment is dependent on ensuring that the measured current reflects ion flow through the sample (e.g., through ion channels in the membrane) and not through other components of the system.
  • the measured current includes no more than a ten or twenty percent contribution from unintended sources (e.g., that sources of noise lie under the signals to be measure by approximately the factor of five or ten).
  • the problem of leakage currents can be solved in a variety of ways. For example, enlarging the aperture and thereby the patch of membrane to be analyzed may reduce the contribution of leakage currents to the total signal, because the area of the membrane patch and so the intended signal will grow as the radius of the aperture squared, while the circumference of the membrane and so the leakage current will grow merely as the radius.
  • increasing the size of the membrane may lead to a loss in specificity, particularly in biological systems, because more channels and more types of channels will be in the membrane area analyzed. Then, in general, an unambiguous or completely artifact-free statement, for example, in the case of the addition of ligands, may no longer be possible.
  • Further (mechanical) stability may be derived from using capillary forces to fill and store the reference and/or measurement buffers.
  • unbounded or open fluid compartments may experience fewer disturbances (e.g., due to temperature differentials) of the membrane due to hydrostatic pressure than closed systems.
  • the measurement systems described here may be used for a variety of applications, some of which are described below in Example 16, including “perforated-patch,” “whole-cell,” and “inside-out” patch clamp techniques.
  • measurement systems of the planar type are particularly well suited, due to the short diffusion times associated therewith, to the use of “perforated-patch” techniques.
  • IX In these techniques, an electrical connection to the interior of the cells (cytosol) is achieved by permeabilization of the area of the membrane suspended across the aperture with pore-forming antibiotics.
  • An advantage of this technique is that it does not require washing out the cytosol with measurement buffer solution for simultaneous electrical access.
  • a pore former such as, for example, amphotericin B or nystatin can be added to the reference compartment, after a biological cell, or, under special circumstances, a vesicle (if its mechanical stability is sufficiently high) is bound to the upper side of the aperture. In doing so, the rate of perforation of the membrane patch over the aperture is significantly greater than in comparable standard patch-clamp techniques.
  • measurement systems of the planar type also are particularly well suited to the use of “whole-cell” techniques.
  • an electrical connection to the cytosol is achieved by destroying the membrane patch, for example, using a voltage pulse.
  • This destruction may facilitate the simple addition of larger proteins into the cytoplasm, via the reference solution, again because the planar layout of the measurement system allows significantly faster diffusion of large macromolecules into the cytosol or the interior of a vesicle than comparable standard whole-cell techniques.
  • the system facilitates the addition and/or exchange of various system components, including solutions and/or substances, as suggested above.
  • the measurement solution, the reference solution, or both solutions may be replaced by another solution.
  • a substance to be analyzed may be added to the solution on the measurement and/or reference side.
  • the substance may include a pore former that can be added to one or both compartments with the aim of increasing the electrical conductivity, or, alternatively, the permeability of the membrane with respect to certain ions.
  • the substance also may include detergent-solubilized proteins or proteoliposomes of arbitrary size, with the aim of fusing them to the membrane over the aperture and thereby making arbitrary membrane proteins contained therein accessible to electrical or optical measurements.
  • proteoliposomes The fusion of proteoliposomes is described in detail in U.S. patent application Ser. No. ______ , filed Sep. 14, 2001, titled EFFICIENT METHODS FOR THE ANALYSIS OF ION CHANNEL PROTEINS, and naming Christian Schmidt as inventor.
  • Examples 12-16 below describe exemplary results obtained from various electrical measurements on vesicle and cell-derived membranes.
  • This example illustrated in FIG. 2, describes an exemplary Si/SiO 2 chip substrate 50 for use in positioning and/or studying cells, vesicles, and the like, in accordance with aspects of the invention.
  • the substrate includes a body 52 , a surface layer 54 , a window 56 , and an aperture 58 .
  • the body comprises an at least substantially planar, commercially available silicon wafer.
  • the surface layer comprises a silicon oxide or silicon oxynitride layer formed adjacent one or more sides of the body.
  • the surface layer has a thickness of at least about 50 to 200 nm and provides at least one adhesion surface 60 a,b capable of binding cells, vesicles, and/or other samples.
  • the window and aperture comprise openings through the body and surface layer, respectively. These openings are at least substantially concentrically aligned, with dimensions sufficient to allow fluid contact between opposite sides of the substrate.
  • the substrate may be produced using any suitable method, including photolithography or, for apertures having diameters of less than about 1.5 ⁇ m, electron beam lithography. These methods may involve anisotropic etching of the silicon in a medium containing KOH, as well as reactive ion etching of the silica layer.
  • the substrate may include a body and/or a surface layer having a different geometry and/or formed of different materials.
  • the window may be absent, or the window and the aperture both may be openings in the body, particularly in embodiments lacking a surface layer.
  • This example illustrated in FIG. 3, describes an exemplary measurement system 70 having planar electrodes, in accordance with aspects of the invention.
  • the measurement system includes a substrate 72 , at least two fluid compartments 74 a,b, at least two redox electrodes 76 a,b, and optionally at least four spacers 78 a - d.
  • all of these components are at least substantially planar; however, in other embodiments, one or more of these components may have a different geometry.
  • samples may be introduced into either compartment, and measurements may be performed with the system in any orientation.
  • top fluid compartment 74 a and top electrode 76 a are referred to here as the measurement compartment and measurement electrode
  • the bottom fluid compartment 74 b and the bottom electrode 76 b are referred to as the reference compartment and the reference electrode.
  • the substrate is used to support cells, vesicles, and other samples for electrical analysis.
  • the substrate includes a body 80 , a window 82 , and an aperture 84 connecting the two fluid compartments.
  • the substrate further includes at least one adhesion surface 86 a,b positioned adjacent one or both ends of the aperture for binding cells, vesicles, and/or other samples.
  • An exemplary substrate is described in more detail in Example 1.
  • the fluid compartments are used to support fluids such as electrolyte solutions or growth media in apposition to the substrate and aperture.
  • the compartments are formed by apertures or voids in the substrate, spacers, and/or electrodes.
  • the measurement electrode is positioned at least substantially parallel to the surface of the substrate, preferably at a distance of up to about 1 mm from the surface of the substrate.
  • the measurement electrode further is positioned so that opening 88 is at least substantially concentrically positioned above aperture 84 .
  • Reference electrode 76 b comprises a 2-mm thick square silver plate (e.g., 20 ⁇ 20 mm 2 ), which preferably has a purity greater than about 99.98% silver.
  • the preferred silver/silver chloride (Ag/AgCI) reference electrode may be produced during manufacture of the system, for example, (1) by exposing the reference compartment to a molecular Cl 2 gas, typically while applying a potential to the electrode, or (2) by filling the reference compartment with 1 M HCl, and then chlorinating the exposed silver for 90 seconds under a 0.8-V potential.
  • the substrate is mounted, after its underside is wetted with buffer solution, over the reference compartment filled with reference buffer solution.
  • the reference electrode functions to support and maintain other components of the system.
  • the spacers may be used for several functions, including (1) separating the substrate and electrodes, (2) forming the fluid compartments, and (3) contributing to the structure of a feed opening 90 used to introduce samples to the sample compartment.
  • first and second spacers 78 a,b are positioned about the measurement electrode. These spacers include openings 92 a,b that may be aligned concentrically with opening 88 in the measurement electrode and aperture 84 in the substrate to form a “feed opening” for introducing samples into the system.
  • the feed opening may be of arbitrary form; typically, however, it is elliptical, in particular circular, with a preferred diameter of about 0.2 to 2 mm, and a more preferred diameter of about 0.5 to 1 mm, to facilitate its concentric alignment with the aperture.
  • a third spacer 78 c is positioned between the measurement electrode and the substrate to form an insulating barrier between these two elements.
  • This spacer preferably formed from silicone (e.g., Sylgard 184, Dow Coming, USA), includes a ring-like opening 92 c that again may be mounted concentrically about aperture 84 , for example, with a radius r of about 1 mm.
  • a fourth spacer 78 d is positioned between the reference electrode and the substrate to forming an insulating barrier between these two elements.
  • This spacer preferably formed as a 0.5 to 2 mm-thick silicon rubber seal (e.g., Sylgard), includes a channel or chamber 92 d having dimensions of about 1 mm in width and less than about 6 mm in length. The spacer may be imprinted and, if filled with buffer solution, produce contact between the aperture, or alternatively the membrane, and the reference electrode.
  • the measurement system may be configured or adapted to facilitate the addition, positioning, and/or analysis of samples.
  • the setup preferably has means on one or both sides of the substrate that make possible an addition of liquid, a storage of liquid, and, in given cases, an exchange of liquid, as well as the addition of cells, vesicles, or other cellular organelles, or parts of the same, between the substrate and the electrode(s).
  • a small (e.g., 5 to 10 ⁇ L) volume of measurement or vesicle solution e.g., a cell suspension
  • vesicle solution e.g., a cell suspension
  • the aperture preferably has a diameter such that, when a voltage differential exists over the chip, an inhomogeneous electrical field, mediated by the electrodes, is set up around the aperture. This field may increase in magnitude near the aperture, such that samples can be moved electrophoretically toward the aperture.
  • the substrate preferably includes at least one surface 94 a,b, on one or both sides of the aperture, that is attractive for biological membranes, permitting the molecule-specific and/or multivalent ion-mediated binding of cells, vesicles, membrane fragments, and/or cellular organelles.
  • the surface of the substrate further may be structured to create hydrophilic and hydrophobic areas, with the hydrophilic area preferably positioned around the aperture.
  • This example illustrated in FIG. 4, describes an exemplary measurement system 110 having point or wire electrodes, in accordance with aspects of the invention.
  • the measurement system includes a substrate 112 , two fluid compartments 114 a,b, and two point or wire electrodes 116 a,b.
  • the substrate and fluid compartments are used to support samples and fluids, respectively, as described above.
  • the substrate includes a body 118 , a window 120 , and an aperture 122 connecting the two fluid compartments.
  • the substrate further may be surface modified and/or fastened to a holder, including a glass or Teflon holder.
  • the electrodes are used to apply an electric potential and associated electric field across the aperture, also as described above.
  • the electrodes comprise the chlorinated end surfaces 124 a,b of two silver wires 126 a,b, or, alternatively, two silver electrodes, disposed above and below the substrate.
  • the electrodes preferably have diameters between about 0.1 and 2 mm and a relative separation of about 4 mm.
  • the electrodes may be provided with a protective outer layer 128 a,b that covers and protects the outside surface of the electrodes, except at the end surfaces.
  • the measurement system may be used for positioning and/or analyzing samples.
  • sample medium is added to both sides of the substrate, and held between the substrate and electrode by capillary forces.
  • cells or vesicles are added to an appropriate (e.g., modified) side of the substrate, and cell binding and/or membrane formation are pursued with the aid of a change in the electrical parameters.
  • the properties of ion channels or other membrane components are studied using suitable electrophysiology methods.
  • the addition or exchange of samples and/or sample media may be performed using a sample handling system, as described above, such as a pipette or tube mounted near the aperture.
  • FIG. 5 describes an exemplary measurement system 150 having open fluid compartments, in accordance with aspects of the invention.
  • the measurement system includes a substrate 152 , at least two fluid compartments 154 a,b, and at least two electrodes 156 a,b. These components perform at least substantially the same functions as their namesakes in Examples 2 and 3.
  • the substrate comprises an insulating silicon chip 158 .
  • the substrate may include a groove that is closed by a thin silicon nitride (Si 3 N 4 ) 160 /silicon oxide (SiO2) 162 diaphragm containing a small aperture 164 having a diameter that usually is less than about 20 ⁇ m.
  • the substrate further may include a surrounding insulating layer 166 , for example, thermally grown silicon oxide, to reduce system capacitance.
  • the surface of the substrate may be treated to promote the tight adhesion of cell or vesicle-associated lipid bilayers, for example, by (1) physisorption of poly-L-lysine (with a typical molecular weight greater than about 15,000 daltons), (2) chemical modification with 4-aminobutyl-dimethyl-methoxysilane, and/or (3) attachment of molecules that bind (specifically or nonspecifically) to the cell surface (e.g., lectins), among others.
  • the fluid compartments comprise open regions of the substrate surface adjacent the aperture to which fluid is confined.
  • fluid is confined by a combination of hydrophilic and hydrophobic interactions. Specifically, fluid is attracted to the region adjacent the aperture by hydrophilic interactions and excluded from regions away from the aperture by surrounding layers of hydrophobic material 168 a,b attached or bound to the surface. Consequently, the buffer compartments are delineated by the surface of the substrate on one side and by surface tension on the opposing side, creating dome-shaped compartments, as shown.
  • the electrodes comprise conductive elements such as Ag/AgCl for generating an electric potential across the aperture.
  • the electrodes which may be used for positioning and/or recording, are immersed in the fluid compartments.
  • the electrodes may be directly attached to the substrate (e.g., by sputtering or printing) or to a container that contains the substrate.
  • a first (measurement or recording) electrode is used to apply a measurement voltage
  • a second (reference) electrode is used to apply a ground.
  • the measurement system may be used for positioning and/or analyzing samples, at least substantially as described above.
  • samples upon application of a voltage between the two fluid compartments, mediated by the redox electrodes immersed in the two compartments, a strongly inhomogeneous field is created around the aperture that attracts cells, vesicles, and other charged objects towards the aperture.
  • these samples may be analyzed electrically and/or optically, among others.
  • FIGS. 6 and 7 describes an exemplary measurement system 190 having multiple measurement sites, in accordance with aspects of the invention.
  • the drawings show two alternative embodiments, separated by break lines, that include different carrier/electrode configurations.
  • the measurement system includes a plurality of measurement sites, each capable of positioning and/or analyzing a sample, as described above. More specifically, the measurement system includes a substrate 192 , a plurality of fluid compartments 194 a,b, and a plurality of electrodes 196 a,b. The measurement sites are formed from portions of the substrate and combinations (e.g., pairs) of fluid compartments and electrodes.
  • the substrate preferably comprises (1) a silicon body 198 , (2) a silicon nitride diaphragm 200 having a plurality of apertures 202 , at least one per measurement site, and (3) a hydrophobic and/or insulating surface coat 204 .
  • the fluid compartments preferably comprise (1) a plurality of measurement compartments 194 a, and (2) at least one reference compartment 194 b.
  • the electrodes preferably comprise (1) a plurality of measurement electrodes 196 a, at least one per aperture or measurement site, and (2) at least one reference (ground) electrode 196 b.
  • the measurement system further may include additional features, such as (1) a support or carrier plate 206 to simplify the design and/or to increase the reliability of the system, and/or (2) one or more reference fiducials 207 for reference and/or alignment purposes, as described below.
  • the substrate contains a patterned surface that physically separates the measurement compartments, allowing independent measurements.
  • the patterned surface may be created by the patterned attachment of hydrophilic materials at measurement sites and hydrophobic materials at intervening positions.
  • the measurement compartments may be accessed independently using a separate measurement electrode for each compartment, where each electrode is connected independently to one or more voltage sources, such as a voltage clamp circuit.
  • the substrate contains a reference compartment that can be separated but that preferably is unified to form a single compartment in contact with a single (usually ground) electrode.
  • the substrate includes a silicon chip containing grooves that are closed by a silicon nitride/silicon oxide diaphragm.
  • the diaphragm includes a small aperture having a diameter of less than about 20 ⁇ m.
  • the substrate otherwise may be surrounded by an insulating layer, for example, a thermally grown silicon oxide layer, to reduce the system capacitance.
  • the substrate generally comprises any structure adapted to provide two or more sites for positioning and/or analyzing samples electrically, as described above.
  • the substrate may be formed from any suitable material, including silicon, plastic, and/or glass.
  • the substrate generally may include any number of sample sites arranged in any suitable format, as described above. Preferred formats include 8 ⁇ 12 (96) rectangular arrays and 16 ⁇ 24 (384) rectangular arrays, with standard microplate footprints. Some embodiments may include additional sites, including additional rows or columns of sites. For example, in one such embodiment, the system includes an additional row of sites, configured as an 8 ⁇ 13 (104) rectangular array.
  • the fluid compartments generally comprise any region adapted to support fluid for bathing the sample and for providing electrical contact between the measurement and reference compartments.
  • the measurement compartments are used for positioning and/or analyzing samples. These compartments are defined by hydrophilic spots on the chip surface, surrounded by a hydrophobic surface coating, for localizing fluid.
  • the measurement compartments include an aperture positioned within the hydrophilic spot and a measurement electrode positioned for electrical contact with the associated measurement fluid.
  • the hydrophilic spot typically includes an at least substantially planar or concave adhesion surface, which may be selected and/or treated as described above to promote sample binding and/or membrane formation.
  • the reference compartments are used for completing the electric circuit, typically to electric ground. These “backside” compartments may be combined to form one or more large compartments (corresponding to two or more measurement compartments), since the separate compartments typically would contain the same buffer solution and each be connected to ground. In particular, a single large backside compartment and a single backside electrode are sufficient for spatial resolution of individual recordings, if the measurement compartments are addressed individually. In some embodiments, the backside electrode may be deposited directly on the recording chip or on an embedding cartridge.
  • the electrodes generally comprise any mechanism adapted to apply and/or measure an electric potential across the aperture, with each measurement site in contact with at least one measurement electrode and at least one reference electrode, as described above.
  • the composition of the electrodes is selected to allow current flow at physiological potentials.
  • Preferred electrodes include silver/silver chloride (Ag/AgCl) and/or platinum (Pt) redox electrodes for both the sample and reference compartments.
  • Particularly preferred electrodes include silver (Ag) as the electrode material, chlorinated within a chlorine (Cl 2 ) atmosphere.
  • the number of electrodes may vary.
  • the upper side of the substrate (associated with the measurement compartments) preferably includes enough separate electrodes independently to address each corresponding recording site, e.g., 8 ⁇ 13 electrodes on a 2.25 mm grid.
  • the lower side of the substrate (associated with the reference compartment) preferably includes a single electrode.
  • the electrodes may be insulated outside the measurement compartment.
  • Preferred insulation material preferably has a high electrical resistance and a low dielectric constant and loss.
  • Particularly preferred insulation material is produced from Teflon, silicon nitride (Si 3 N 4 ), and/or Sylgard by spin coating or chemical vapor deposition (CVD). These materials are sufficiently hydrophobic (even after short oxygen-plasma treatment) to confine the measurement and reference compartments. Moreover, these materials may include or be formed to include grooves or holes, potentially improving fluid support and/or reducing evaporation.
  • the electrodes at the various measurement sites may be connected electrically to corresponding contacts 208 for clean and/or easy access to appropriate electronic components, such as amplifiers, recording devices, and the like.
  • the contacts are positioned near the edge or border of the substrate, and a bonding wire 210 joins the electrodes and contacts, although more generally any mechanism capable of establishing an electrical connection may be employed.
  • the electrodes can be bonded to contacts placed on a plastic (e.g., polypropylene) carrier that embeds the entire recording chip.
  • the support element generally comprises any mechanism for independently and portably supporting the substrate and associated system components, potentially simplifying design and/or increasing reliability.
  • the support element may support the substrate at its edges and/or in its interior, with the interior support potentially reducing or preventing sagging and/or stress of the substrate.
  • the support element includes a carrier plate 206 and a spacer 212 sandwiched between the substrate and the carrier plate near the edges of the substrate.
  • the carrier plate may be formed from glass (e.g., PYREX) and/or any other suitable material.
  • the substrate, spacer, and carrier plate may be joined using any suitable mechanism, such as anodic bonding.
  • the separation between the substrate and the carrier plate i.e., the spacer thickness
  • the separation between the substrate and the carrier plate preferably is chosen to be less than about 1 mm, to allow filling of the backside (i.e., reference) compartment by capillary forces.
  • the reference fiducials generally comprise any feature or characteristic of the measurement system adapted to provide information that facilitates sample handling and/or analysis, for example, as described in U.S. Pat. No. 6,258,326, issued Jul. 10, 2001, which is incorporated herein by reference.
  • the reference fiducials may be used to encode information and/or to provide reference positions.
  • the reference fiducials may encode information relating to the identity of the manufacturer of the system and/or one or more properties of the system and/or the associated samples.
  • the reference fiducials may provide reference positions useful to correct for cross-system drift (due to dimensional irregularities in the system) and/or to align the system with ancillary devices, such as an electrical device for electrical analysis and/or an optical device for optical analysis.
  • the reference fiducials may encode information using any suitable mechanism, including electrical and/or optical mechanisms.
  • the reference fiducials may encode information electrically, based on the resistance, capacitance, and/or inductance, among others, of a particular portion or portions of the system.
  • the reference fiducials may encode information optically, based on the size, shape, position, color, absorptivity, reflectivity, and/or transmissivity of a particular portion or portions of the system.
  • the reference fiducials may be identified and read using any suitable mechanism, including the electrical device and/or optical device used in sample analysis.
  • This example illustrated in FIG. 8, describes an exemplary measurement system 230 having optical measurement aids, in accordance with aspects of the invention.
  • the measurement system includes a substrate 232 , a plurality of fluid compartments 234 a,b, a plurality of electrodes 236 a,b, and a carrier plate 238 , at least substantially as described above in Example 5.
  • the system further includes an optical measurement aid for use in conjunction with a suitable optical analysis system, as described above.
  • the optical measurement aid generally comprises any element or mechanism adapted to facilitate and/or enable optical analysis of samples such as cells or vesicles positioned on or near the substrate.
  • the optical measurement aid may comprise a modification of one or more of the elements listed above and/or a new element in addition to and/or in lieu of one or more of the elements listed above.
  • the optical measurement aid may comprise a support element that includes a short spacer and/or a thin, optically transparent carrier plate, as described above.
  • a short spacer and/or a thin carrier plate may shorten the optical path length between the optical device and sample, by reducing the separation between the substrate and carrier plate.
  • a thin carrier plate also may better match the optical requirements of the optical analysis system.
  • the thickness of the carrier plate may be selected to correspond to the thickness of a standard microscope cover slip, for example, 0.08 to 0.13 mm thick (No. 0), 0.13 to 0.17 mm thick (No. 1), 0.16 to 0.19 mm thick (No. 11 ⁇ 2), or 0.17 to 0.25 mm thick (No. 2), among others.
  • the carrier plate may be selected to improve overall optical transmission, for example, by using crystal-clear, pure water-white glass or super clarity, clear-white borosilicate glass.
  • the carrier plate may be selected to improve transmission of polarized light, for example, by using strain-free glass or fused silica.
  • the carrier plate may be selected to have uniform surface quality, exceptional flatness, and/or precise dimensions, among others.
  • the optical measurement aid also may comprise a carrier plate or other interface having an array of lenses 240 such as microlenses that correspond in number and spacing to the array of measurement sites.
  • These lenses may be formed from any suitable material (such as glass or plastic) using any suitable technique (such as etching or molding).
  • the lenses may be used for high-magnification and/or high numerical aperture analysis of samples, including the analysis of single cells positioned on single apertures.
  • the x-y resolution of the recording apertures and microlenses preferably is less than a few (e.g., about 1-4) ⁇ m, which may be facilitated using a high-precision bonding process.
  • the z resolution of these components preferably is less than a few (e.g., about 1-4) ⁇ m, which may be facilitated using lenses having high numerical apertures.
  • the lenses in the array generally may have any shape capable of collecting light from the sample and/or focusing light onto the sample.
  • the lenses may be plano-convex, meaning that they have a flat (plano) surface and an opposed outwardly bulging (convex) surface.
  • the plano-convex lenses may have two orientations. In the first orientation, exemplified by lens 240 , the convex surface 242 faces toward the sample site, and the planar surface 244 faces away from the sample site. In the second orientation, exemplified in FIG. 8 by lens 240 ′, the convex surface 242 ′ faces away from the sample site, and the planar surface 244 ′ faces toward the sample site.
  • the lens will collect light transmitted from the sample and direct the collected light toward a detector, such as an imaging detector (e.g., a charge-coupled device (CCD)) or a point detector (e.g., a photomultiplier tube (PMT)), among others.
  • a detector such as an imaging detector (e.g., a charge-coupled device (CCD)) or a point detector (e.g., a photomultiplier tube (PMT)), among others.
  • an imaging detector e.g., a charge-coupled device (CCD)
  • a point detector e.g., a photomultiplier tube (PMT)
  • the optical measurement aid also may include a window 246 in the substrate having a shape configured to match an optical sensed volume, including the frustoconical shape through which excitation light is directed onto the sample and/or from which emission light is detected from the sample, for example, as described in U.S. patent application Ser. No. 09/478,819, filed Jan. 5, 2000, which is incorporated herein by reference.
  • the matching may be used in optical analysis to increase sensitivity (for example, by avoiding detection from walls of the sample well) and/or to decrease sample volume, among others.
  • This example illustrated in FIG. 9, describes an exemplary measurement system 270 for combined electrical/optical detection, in accordance with aspects of the invention.
  • the combined measurement system includes an electrical analysis system 272 and an optical analysis system 274 .
  • the electrical analysis system generally comprises any system for performing electrical measurements such as patch clamp measurements on a sample such as a cell, vesicle, or biological organelle.
  • the electrical analysis system may include any suitable combination of apertures 275 , substrates 276 , fluid compartments 278 a,b, and electrodes (not visible in this view), among other elements, as described above. Exemplary systems are described above in Examples 2-6.
  • the optical analysis system generally comprises any system for detecting light transmitted from the sample, particularly photoluminescence and chemiluminescence light.
  • the optical analysis system may include a light source 280 , a detector 282 , and an optical relay structure 284 for transmitting excitation light from the light source to the sample and emission light from the sample to the detector.
  • the system further may include additional components for performing additional and/or duplicative functions, including (1) filters 286 positioned in the excitation and/or emission optical paths for altering the intensity, wavelength, and/or polarization of the excitation and emission light, respectively, (2) confocal optics elements 288 such as an aperture positioned in an image plane for reducing detection of out-of-focus light, and (3) a reference monitor 290 positioned to detect a portion of the excitation light for correcting for variations (e.g., fluctuations and/or inhomogeneities) in the excitation light.
  • filters 286 positioned in the excitation and/or emission optical paths for altering the intensity, wavelength, and/or polarization of the excitation and emission light, respectively
  • confocal optics elements 288 such as an aperture positioned in an image plane for reducing detection of out-of-focus light
  • a reference monitor 290 positioned to detect a portion of the excitation light for correcting for variations (e.g., fluctuations and/or inhomogeneities) in the ex
  • the light source generally comprises any mechanism for producing light suitable for use in an optical assay, such as a photoluminescence, scattering, and/or absorbance assay, among others.
  • Suitable light sources include lasers, arc lamps, incandescent lamps, fluorescent lamps, electroluminescent devices, laser diodes, and light-emitting diodes (LEDs), among others.
  • the light source may be capable of use in one or more illumination modes, including continuous and time-varying modes, among others.
  • the detector generally comprises any mechanism for detecting light transmitted from a sample in an optical assay. Suitable detectors include charge-coupled devices (CCDs), intensified charge-coupled devices (ICCDs), videcon tubes, photomultiplier tubes (PMTs), photodiodes, and avalanche photodiodes, among others.
  • CCDs charge-coupled devices
  • ICCDs intensified charge-coupled devices
  • PMTs photomultiplier tubes
  • the detector may be capable of use in one or more detection modes, including (a) imaging and point-reading modes, (b) discrete (e.g., photon-counting) and analog (e.g., current-integration) modes, and (c) steady-state and time-resolved modes, among others.
  • the optical relay structure generally comprises any mechanism for transmitting light between the light source, sample, and detector (or simply the sample and detector in a chemiluminescence assay). Suitable optical relay structures may include mirrors, lenses, and/or fiber optics, among others.
  • the optical relay structure includes a beamsplitter that generally transmits excitation light toward the sample and generally reflects emission light toward the detector.
  • FIG. 9 shows an exemplary embodiment of a combined electrical/optical measurement system, including components as described above.
  • a parallel read-out system is used for confocal-optical recordings, for example, using the chip substrate system of FIG. 8.
  • the chip substrate is placed in an appropriate light beam that is able to excite fluorescent probes of interest, and the sample membranes or cells are positioned at the individual apertures of the chip.
  • the samples are excited using one parallel light beam, for example, using a 45-degree mirrored beamsplitter.
  • the fluorescent light coming from the biological sample or any associated fluorescent probes is transmitted to an optional filter and confocal optics element to increase the signal-to-noise ratio before being projected onto the light sensitive chip of a CCD camera.
  • the confocal optics element reduces or eliminates out-of-focus light not originating from the sample.
  • the spatial resolution of the CCD chip allows detection of fluorescence from all apertures (and consequently all biological samples) simultaneously, if desired.
  • the system may be configured to allow top and/or bottom illumination and/or detection of the sample(s), permitting the following combinations: (1) top illumination and top detection, or (2) top illumination and bottom detection, or (3) bottom illumination and top detection, or (4) bottom illumination and bottom detection.
  • Same-side illumination and detection, (1) and (4), is referred to as “epi” and is preferred for photoluminescence and scattering assays.
  • Opposite-side illumination and detection, (2) and (3) is referred to as “trans” and is preferred for absorbance assays.
  • the system may be configured to allow illumination and/or detection at oblique angles.
  • illumination light may impinge on the bottom of a sample holder at an acute angle (e.g., about 45 degrees) relative to detection.
  • an oblique system may reduce the amount of excitation light reaching the detector.
  • Suitable systems, and components thereof, for top/bottom and/or oblique illumination are described in the following materials, which are incorporated herein by reference: U.S. Pat. No. 5,355,215, issued Oct. 11, 1994; U.S. Pat. No. 6,097,025, issued Aug. 1, 2000; and U.S. Provisional Patent Application Serial No. 60/267,639, filed Aug. Feb. 10, 2001.
  • This example describes exemplary methods for producing, sizing, and binding lipid vesicles.
  • DPPE-rhodamine dipalmitoyl phosphatidyl-ethanolamine-rhodamine
  • lipid vesicles After a 1-hour incubation under vacuum, to the flask is added either 10 mL H 2 O or 10 mL of a buffer solution having a concentration of less than 150 mM of KCl and/or less than 600 mM of sucrose or preferably of sorbitol. After a subsequent 16-hour incubation at 37° C., the resulting lipid vesicles appear as an almost transparent cloud. The lipid vesicles are aspirated and removed using a 1 mL pipette and stored at 4° C. until further use. Storage of the vesicle solution may be improved by the addition of sodium azide (NaN 3 ) to a concentration of 0.2% by weight. This vesicle preparation procedure yields mostly (>90%) unilamellar vesicles, with sizes up to 250 ⁇ m. However, some of the vesicles may contain additional smaller vesicles, which are not relevant for membrane formation.
  • NaN 3 sodium
  • the ability of the resulting vesicles to establish electrically tight seals against a surface aperture is enhanced by purification of the initial vesicle mixture to remove vesicles and lipid impurities that are smaller than about 10 ⁇ m in size. Without such purification, the binding of such smaller vesicles in the vicinity of the aperture may prevent electrically tight sealing of the aperture by large (e.g., larger than 10 ⁇ m) vesicles.
  • the vesicles may be sized by dialysis, for example, using a nylon mesh with a 20- ⁇ m pore size for at least about 20 hours.
  • the membrane fluidity of the resulting vesicles may be lowered, for example, by adjusting the lipid composition so that it includes a higher fraction of low-fluidity lipids and/or by lowering the temperature so that it is closer to the phase-transition temperature of the vesicles (e.g., less than or equal to about 4° C., or more preferably less than or equal to about 1° C., for some lipids).
  • the unilamellarity of the resulting vesicle membranes may be demonstrated and/or verified using any suitable analytical technique, such as microscopic analysis using a confocal microscope.
  • vesicles may be produced, sized, and bound using any suitable methods.
  • large unilamellar vesicles (giant unilamellar vesicles, GUVs) may be produced using the hydration method.
  • proteoliposomes may be produced using an appropriately modified hydration method.
  • xiii Additional vesicles may be produced using the methods described in U.S. patent application Ser. No. ______ , filed Sep. 14, 2001, titled EFFICIENT METHODS FOR THE ANALYSIS OF ION CHANNEL PROTEINS, and naming Christian Schmidt as inventor.
  • This example illustrated in FIG. 10, describes exemplary methods for electrophoretically positioning samples such as cells and lipid vesicles.
  • the positioning attainable using these methods may exceed that attainable using gravity sedimentation, in at least the following ways: (1) a decrease in the necessary number of vesicles or cells, (2) an increase in the total rate of membrane formation, and (3) an increase in the probability of a successful membrane setup or cell binding.
  • Vesicles and cells also may be prepositioned prior to electrophoretic positioning to improve performance, for example, by introducing the vesicles or cells to the sample so that they are initially positioned above the aperture.
  • FIG. 10 shows results of a finite element method (FEM) simulation of the electric potential distribution around a substrate in accordance with aspects of the invention.
  • the substrate includes a 4- ⁇ m aperture positioned between parallel electrodes.
  • the field distribution is shown as a series of equipotential lines (corresponding a cross-section through the three-dimensional equipotential surfaces), with a spacing of 4 mV, where the potential difference between the electrodes is 80 mV.
  • the field-line curve is distorted in this simulation from its normal circular form to an elliptical form to reflect leak currents in the edge region of the carrier chips.
  • E the spatial rate of change of the potential
  • the electric field is perpendicular to the equipotential surfaces at all positions, pointing in the direction of decreasing potential.
  • the electric field is stronger where the equipotential surfaces are closer together, and weaker where these surfaces are farther apart. Consequently, from FIG. 10, the electric field points toward the aperture (on one side of the aperture), with a strength that increases with proximity to the aperture.
  • Electrophoretic positioning methods generally may be used in any system capable of creating and focusing an electric field through an aperture.
  • the electrodes used to create the field are positioned relatively close together, for example, within about 5-10 mm, reducing the voltage required to create an acceptable electric field.
  • the measurement and reference electrodes are located, one above and one below the substrate, at a distance of about 0.2 to 3 mm, preferably about 0.5-2 mm, and more preferably about 0.5 to 1 mm.
  • the associated electrophoretic-driving force directs vesicles and cells, following the electric field, toward the aperture.
  • the electric field is strongly inhomogeneous, increasing sharply in magnitude with proximity to the aperture, vesicles and cells move automatically toward the aperture.
  • the fields are most effective near the aperture (e.g., within about 200 ⁇ m of the aperture), so that samples preferably are brought into this range by prepositioning or reach it convectively.
  • a hole for example, d ⁇ 1 mm may be located in the measurement electrode with respect to the aperture.
  • the offset voltage V offset between the electrodes may be corrected before each measurement. To do so, 5 ⁇ L of buffer solution is added directly to the aperture, and the measurement electrode is brought to within about 1 mm from the substrate surface. After a liquid meniscus forms between the surface of the substrate and the electrode, the offset voltage and the capacitance of the system are adjusted to compensate.
  • a 10- ⁇ L dispersion of lipid vesicles subsequently is added to the upper side of the measurement electrode, where the vesicles can sediment through the circular opening located in the measurement electrode.
  • V M ⁇ 50 to ⁇ 80 mV.
  • the focusing achieved measured in the number of vesicles passing through the aperture opening with unmodified surfaces, is a function of the size of the window (that is, the portion of the SiO 2 layer laid open by etching). Smaller SiO 2 windows (e.g., less than about 45 ⁇ 45 ⁇ m 2 ) clearly increase vesicle throughput.
  • a 3- ⁇ L dispersion of lipid vesicles subsequently is added to the measurement compartment near the aperture, where, in the case of a plane parallel electrode arrangement, the vesicles can sediment through the circular opening located in the measurement electrode.
  • Vesicles that come into the vicinity (e.g., less than about 200 ⁇ m) of the aperture experience a very high field intensity (generally but not necessarily between about 100 kV/m and several kV/m) and are accelerated according to the electric field curve directly to the aperture. After the vesicles bind to the substrate and form an electrically tight seal, they are analyzed electrically.
  • FIG. 11 shows a plot of current versus time after the docking or binding of vesicles to a 7- ⁇ m aperture in the unmodified surface of a suitable substrate.
  • the plot shows that the addition of Ca 2+ to a final concentration of 4 mM leads quickly to a tight electrical seal between the vesicle membrane and the substrate surface.
  • the addition of Ca 2+ causes a rapid, significant drop in current, indicating that the membrane has at least substantially blocked ion pathways through the aperture.
  • FIG. 12AB describes the binding and/or other interactions of vesicles as described above with polylysine-modified SiO 2 surfaces.
  • the binding between these vesicles and surfaces may be strong and rapid, manifesting itself in less than about 0.5 seconds after an appropriate proximity is reached.
  • the probability of successfully positioning a vesicle and subsequently forming an electrically tight membrane seal is strongly dependent on the size of the aperture, the size of the SiO 2 window, and the number, size, and size distribution of the vesicles in the vesicle solution. If substrates having aperture diameters less than about 2 ⁇ m and window sizes greater than about 40 ⁇ m are used in conjunction with suspensions of vesicles having a vesicle diameter greater than about 40 ⁇ m, the probability of binding and forming an electrically tight seal may exceed 90% (n>15, where n is the number of trials). In general, a decrease in the width of the aperture and an increase in the purity of the vesicle suspensions lead to greater reproducibility in the formation of tight aperture seals, both substrate to substrate and vesicle preparation to vesicle preparation.
  • Vesicles that bind to the surface subsequently may be drawn out to form substantially flat, defect-free membranes.
  • Fluorescence microscopy studies performed using vesicles labeled with both rhodamine (to label vesicle membranes) and carboxyfluorescein (to label vesicle interiors) show that vesicles flatten and may burst upon binding, forming unilamellar structures, since bound vesicles appear flat and red, suggesting that carboxyfluorescein has been released.
  • These studies were conducted using polylysine-coated glass and a confocal microscope (LSM 510, Zeiss Jena, Germany).
  • an adhesion promoter for example, polycations.
  • an aqueous solution of polycations e.g., 0.1% poly-1-lysine bromide, MW 100,000, Sigma
  • the covalent binding of peptide polycations preferably is done using previously activated hydroxyl groups of the quartz surface, for example by means of tosyl chloride (triphenylchloromethane).
  • the surface also may be modified by other compounds having cation characteristics in the desired pH range, such as, for example, 4-aminobutyl-dimethyl-methoxysilane. Finally, treating the substrates in O 2 plasma for several minutes before surface modification leads to more consistent surface characteristics.
  • FIG. 12AB shows the time course of vesicle binding and the subsequent development of membranes with very high electrical insulation resistance for a 4- ⁇ m aperture (FIG. 12A) and a 7- ⁇ m aperture (FIG. 12B) in a poly-L-lysine-coated SiO 2 substrate.
  • the measurements were performed in the presence of 10 ⁇ M KCl, using a clamp voltage of ⁇ 80 mV.
  • This example describes electrical factors relating to preferred aperture sizes, including characteristic electrical properties.
  • is the effective noise flow
  • r is the radius
  • f is the frequency
  • k is the Boltzmann constant
  • R is the resistance
  • T is the temperature.
  • r M / ⁇ square root ⁇ square root over (R spec ) ⁇ should be very small.
  • the minimization of this product can be pursued according to the invention in two ways: (1) by minimizing the membrane radius r M , and/or (2) by the electrically tight sealing of the membranes used.
  • This example describes the effects of vesicle fusion on electrical parameters of the measurement system, as described above.
  • the resistance across the sample substrate changed significantly following vesicle fusion.
  • the resistance is up to 1 M ⁇ (usually ⁇ 450 k ⁇ ) in 85 mM KCl, and similarly usually up to 1 M ⁇ in 1 mM KCl, depending in both cases on the size of the aperture. Greater resistances are interpreted as artifacts, possibly reflecting, for example, the inclusion of air bubbles under the aperture opening.
  • the resistance is greater than about 6.4 G ⁇ in 85 mM KCl, greater than about 10 G ⁇ in 10 mM KCl, and greater than about 40 G ⁇ in 1 mM KCl, corresponding to four order-of-magnitude increases in resistance.
  • This example illustrated in FIG. 13, describes the passage of vesicles through apertures in the substrate.
  • the composition of the vesicles with respect to size can be determined for a given vesicle solution.
  • the method of the invention therefore possesses utility for analyzing size distributions in selected populations of vesicles and cells.
  • FIGS. 14 and 15AB describes observation of electrical activity of alamethicin pores and nicotinic acetylcholine receptors (nAChR) in fused vesicles. These observations confirm the biological utility of the invention.
  • nAChR nicotinic acetylcholine receptors
  • FIG. 14 shows a plot of current versus time for membranes containing alamethicin.
  • a membrane is formed over an aperture in 85 mM KCl.
  • alamethicin is added to the measurement compartment, to a final concentration of 0.1 ⁇ g/mL.
  • xvii Finally, a potential is applied, and a plot of current versus time is generated. The amplitude and dwell times of the current fluctuations observed in this plot, corresponding to 600 pS conductivities of the alamethicin pores, prove the functionality and high sensitivity of the system.
  • FIG. 15AB shows an analogous plot of current versus time for membranes containing the membrane protein nAChR.
  • a membrane is formed as above.
  • nAChR is introduced into the membrane via Ca 2+ -mediated fusion.
  • nAChR is purified from an appropriate source, and then reconstituted into small unilamellar vesicles.
  • these vesicles are added to the measurement compartment, and then fused to the membrane by increasing the Ca 2+ concentration of the sample chamber to greater than about 1 mM. In given cases, the fusion is supported by the subsequent temporary setup of an osmotic gradient.
  • FIGS. 16 - 18 AB This example, illustrated in FIGS. 16 - 18 AB, describes use of the above-described systems in the study of cells.
  • the methods of the invention are generally applicable to the investigation and analysis of cells.
  • Such cells may be positioned and electrically characterized using procedures substantially analogous to those described above for vesicles.
  • the positioning and measurement methods may be modified as desired to accommodate differences in vesicles and cells, including, among others, the cytoskeleton, the varied lipid and protein content of cell membranes, and the cell wall in plants and certain algae, bacteria, and fungi.
  • the cell may be made more flexible by disrupting the cytoskeleton, for example, using cytochalasin and/or colchicine.
  • the cell wall may be removed to expose a relatively smooth membrane surface capable of forming a tighter electrical seal.
  • the extracellular matrix may be removed or digested, for example, using one or more proteases, lipases, and/or glycosidases, among others.
  • the methods may be used for a variety of patch clamp experiments, in a variety of formats or configurations.
  • the cell as initially bound and sealed, is in a “cell-attached configuration.” If the membrane patch over the aperture then is ruptured or destroyed, for example, by applying a pulse of voltage or suction, electrical measurements can be performed over the entire cell membrane in a “whole-cell configuration.” Alternatively, if the membrane patch over the aperture is permeabilized, for example, by the addition of pore formers such as amphotericin B or nystatin to the reference compartment, electrical measurements again may be performed over the entire cell membrane in a “perforated-patch configuration.” Alternatively, if the cell (instead of the membrane patch over the aperture) is lysed, electrical properties of the patch may be measured in an “inside-out configuration.” In the lattermost approach, the cytosolic side of the membrane is exposed to the measurement solution, and the relatively small area of membrane being analyzed potentially makes possible the study of individual channel events.
  • FIGS. 16 - 18 show exemplary results of positioning and voltage clamp experiments performed using Jurkat cells. These cells, a human mature leukemic cell line, phenotypically resemble resting human T lymphocytes and are widely used to study T cell physiology. Similar results (not shown) were obtained using TE 671 cells and CHO cells.
  • FIG. 16 shows the time course of positioning, binding, and subsequent development of a tight electrical seal for a Jurkat cell.
  • the cell was positioned at ⁇ 60 mV. Seal formation occurred about 15 seconds after cell addition, quickly rising to about 1000 G ⁇ .
  • the aperture size was about 3 ⁇ m, and the chip resistance was about 250 k ⁇ .
  • FIG. 17 shows a series of plots of current versus time showing the current flowing through the membrane of a Jurkat cell at the indicated positive and negative clamp voltages in a cell-attached configuration.
  • the curves appear quantized, switching largely between just two values, one low and one high, particularly at higher voltages. This characteristic suggests that single-channel events are being observed, corresponding to the opening and closing of the channel.
  • FIG. 18 shows an analysis of the current flowing through the membrane of a Jurkat cell for a +60 mV clamp voltage.
  • Panel A shows a representative plot of current versus time. This plot again has a quantized character, like FIG. 17.
  • Panel B shows a histogram plotting the relative occurrence of a given current versus the current. The histogram is bimodal, with peak values of about 1.3 pA (the relatively smaller peak at left) and about 4.8 pA (the relatively larger peak at right), corresponding to an average of about 3.5 pA.
  • the positioning and measurement systems provided by the invention may be used for a variety of purposes and a variety of assays. Exemplary miscellaneous applications are described below.
  • the system may be used to screen libraries according to any suitable criterion, such as the identification of candidate drugs, modulators, and the like.
  • Suitable libraries include compound libraries, combinatorial chemistry libraries, gene libraries, phage libraries, and the like.
  • the system is exceptionally well suited to probing libraries whose members are present only in small amounts, such as (1) the large number of potential ligands that can be produced using combinatorial chemistry, and (2) many receptor proteins, above all ligand-controlled and G-protein-coupled receptors (GPCRs).
  • the automation and outstanding mechanical stability of the measurement system according to the invention permits its use in biosensors.
  • sensors By using suitable transformed cells, receptors reconstituted in vesicles, or channel-forming proteins, sensors can be set up that are sensitive to very different substrates or metabolites.
  • measurement sensitivity will in principle only be dependent on the binding constant of the receptor. This sensitivity may lie under one nanomole for G-protein-coupled receptors, and in the nanomolar range for ionotropic receptors (e.g., 5 HT3, nAChR, GABA A R, glycine R, and GluR).
  • ionotropic receptors e.g., 5 HT3, nAChR, GABA A R, glycine R, and GluR.

Abstract

Systems for positioning and/or analyzing samples such as cells, vesicles, cellular organelles, and fragments, derivatives, and mixtures thereof, for electrical and/or optical analysis, especially relating to the presence and/or activity of ion channels.

Description

    CROSS-REFERENCES
  • This application is a continuation-in-part of the following U.S. patent applications, which are incorporated herein by reference: Ser. No. 09/581,837, filed Jun. 16, 2000; and Ser. No. ______ , filed Sep. 14, 2000, titled EFFICIENT METHODS FOR THE ANALYSIS OF ION CHANNEL PROTEINS, and naming Christian Schmidt as inventor. U.S. patent application Ser. No. 09/581,837, in turn, claims priority from PCT Patent Application Serial No. PCT/IB98/01150, filed Jul. 28, 1998, which claims priority from Swiss Patent Application Serial No. 2903/97, filed Dec. 17, 1997. Each of these patent applications is incorporated herein by reference. U.S. patent application Ser. No. ______ , filed Sep. 14, 2000, titled EFFICIENT METHODS FOR THE ANALYSIS OF ION CHANNEL PROTEINS, and naming Christian Schmidt as inventor, in turn, claims priority from Ser. No. 09/581,837, with priority claims as listed above, U.S. Provisional Patent Application Serial No. 60/232,365, filed Sep. 14, 2000; Ser. No. 60/233,800, filed Sep. 19, 2000; and Ser. No. ______ , filed Sep. 13, 2001, titled HIGH-THROUGHPUT PATCH CLAMP SYSTEM, and naming Christian Schmidt as inventor. Each of these patent applications is incorporated herein by reference. [0001]
  • This application is based upon and claims the benefit under 35 U.S.C. § 119 of the following U.S. provisional patent applications, which are incorporated herein by reference: Ser. No. 60/233,800, filed Sep. 19, 2000, titled DESIGN OF HIGHLY INTEGRATED PHARMACEUTICAL SCREENING CHIPS, and naming Christian Schmidt as inventor; and Ser. No. ______ , filed Sep. 13, 2001, titled HIGH-THROUGHPUT PATCH CLAMP SYSTEM, and naming Christian Schmidt as inventor. [0002]
  • This application incorporates by reference in their entirety for all purposes the following U.S. Pat. Nos. 5,355,215, issued Oct. 11, 1994; and No. 6,097,025, issued Aug. 1, 2000. [0003]
  • This application incorporates by reference in their entirety for all purposes the following patent applications: U.S. patent application Ser. No. 90/708,905, filed Nov. 8, 2000; PCT Patent Application Serial No. PCT/IB00/00095, filed Jan. 26, 2001; and PCT Patent Application Serial No. PCT/IB00/00097, filed Jan. 26, 2001. [0004]
  • This application incorporates by reference in their entirety for all purposes the following U.S. patent applications: Ser. No. 09/337,623, filed Jun. 21, 1999; Ser. No. 09/349,733, filed Jul. 8, 1999; Ser. No. 09/478,819, filed Jan. 5, 2000; Ser. No. 09/596,444, filed Jun. 19, 2000; Ser. No. 09/710,061, filed Nov. 10, 2000; Ser. No. 09/722,247, filed Nov. 24, 2000; Ser. No. 09/759,711, filed Jan. 12, 2001; Ser. No. 09/765,869, filed Jan. 19, 2001; Ser. No. 09/765,874, filed Jan. 19, 2001; Ser. No. 09/766,131, filed Jan. 19, 2001; Ser. No. 09/767,434, filed Jan. 22, 2001; Ser. No. 09/767,579, filed Jan. 22, 2001; Ser. No. 09/767,583, filed Jan. 22, 2001; Ser. No. 09/768,661, filed Jan. 23, 2001; Ser. No. 09/768,765, filed Jan. 23, 2001; Ser. No. 09/770,720, filed Jan. 25, 2001; Ser. No. 09/770,724, filed Jan. 25, 2001; Ser. No. 09/777,343, filed Feb. 5, 2001; Ser. No. 09/813,107, filed Mar. 19, 2001; Ser. No. 09/815,932, filed Mar. 23, 2001; and Ser. No. 09/836,575, filed Apr. 16, 2001; and Ser. No. ______ , filed Aug. 20, 2001, titled APPARATUS AND METHODS FOR THE GENERATION OF ELECTRIC FIELDS WITHIN MICROPLATES, and naming James M. Hamilton as inventor. [0005]
  • This application incorporates by reference in their entirety for all purposes the following U.S. Provisional Patent Applications: Serial No. 60/223,642, filed Aug. 8, 2000; Ser. No. 60/244,012, filed Oct. 27, 2000; Ser. No. 60/267,639, filed Feb. 10, 2001; Ser. No. 60/287,697, filed Apr. 30, 2001; Ser. No., filed Aug. 2, 2001, titled pH PROBES FOR CELL-BASED FLUORESCENCE ASSAYS, and naming Zhenjun Diwu, Jesse J. Twu, Guoliang Yi, Luke D. Lavis, and Yen-Wen Chen as inventors; and Serial No. ______ , filed Aug. 31, 2001, titled KINETIC ASSAY FOR DETERMINING CALCEIN RETENTION IN CELLS, and naming Kelly J. Cassutt, Jesse J. Twu, and Anne T. Ferguson as inventors. [0006]
  • This application incorporates by reference in its entirety for all purposes the following publications: Richard P. Haugland, Handbook of Fluorescent Probes and Research Chemicals (6[0007] th ed. 1996); and Joseph R. Lakowicz, PRINCIPLES OF FLUORESCENCE SPECTROSCOPY (2nd Ed. 1999).
  • FIELD OF THE INVENTION
  • The invention relates to systems for positioning and/or analyzing samples. More particularly, the invention relates to systems for positioning and/or analyzing samples such as cells, vesicles, cellular organelles, and fragments, derivatives, and mixtures thereof, for electrical and/or optical analysis, especially relating to the presence and/or activity of ion channels. [0008]
  • BACKGROUND OF THE INVENTION
  • A variety of important biological processes occur at or within cell membranes. It therefore is not surprising that the biological function of membrane proteins has become an area of active research. Signal transduction processes in general, including nerve conduction, and neuroreceptors in particular have been shown to be influenced by pharmacologically active ingredients, making them obvious targets for drug development.[0009] i Ion channels and ion transporters also have been shown to be an important class of therapeutic targets. In fact, interactions with ion channels have become a major potential source of adverse effects when administering a therapeutic agent, leading the Food and Drug Administration (FDA) and other government regulatory agencies to require safety profiling of potential therapeutics against certain ion channels.
  • This understanding of the interactions between potential drugs and cell membrane components is beginning to play a crucial role in modern drug development. In view of the increasing number of known receptors and the rapidly growing libraries of potential pharmaceutical ingredients, there clearly is a need for highly sensitive screening methods that permit the analysis of a large number of different substances with high assay throughput per unit time, otherwise known as “high throughput screening” (or “HTS”). In particular, there is a need for automated and/or high throughput screening methods that are relevant to cell membrane components. [0010]
  • At present, relatively traditional methods are used for the screening of pharmaceutical ingredients. Such methods include ligand binding assays and receptor function tests that are performed separately.[0011] ii Although binding assays are relatively inexpensive, and amenable to high throughput, they require labeled high-affinity ligands, and generally are limited to assays for ligands that can compete effectively for labeled ligand. Fluorescent or fluorogenic reagents generally are compatible with high throughput assays, including the analysis of ion channels using fluorescent calcium indicators, and the evaluation of membrane potential effects with potential-sensitive dyes. However, such reagents typically are not sensitive enough for single cell measurements, and generally can provide only indirect measurements of the membrane component of interest.
  • The patch clamp was introduced by Neher and Sakmann in the early 1980s as a powerful technique for the direct study of drug effects on single receptors. In recognition of the strength of the method, Neher and Sakmann were awarded the Nobel prize in 1991. Classical patch-clamp methods often are used in conjunction with functional membrane receptor assays, including receptors coupled to G-proteins and ion channel-forming receptors.[0012] iii This method is highly specific and extremely sensitive: it can, in principle, be used to measure the channel activity of individual receptor molecules. In doing so, glass micropipettes with an opening diameter of typically 1-0.1 μm are pressed on the surface of a biological cell. The membrane surface that is covered by the micropipette is called a “patch.” If the contact between the glass electrode and the cell membrane surface is sufficiently electrically isolating, the ion flow over the membrane patch can be measured electrically with the aid of microelectrodes, one placed in the glass pipette and the other placed in the milieu opposite the membrane.iv A key advantage of this electrophysiological method is that it makes directly accessible the function of the corresponding channel-forming proteins or receptors coupled to channel-forming proteins via the measured electrical characteristics of the channel-forming proteins.
  • Unfortunately, several major limitations have prevented patch-clamp technology from revolutionizing receptor science and pharmaceutical drug development. For example, to produce high quality results, the patch-clamp method requires a tremendous effort in technical installation and highly qualified operators. Moreover, in addition to being expensive, a standard patch-clamp setup may require a long set-up time and have a high failure rate. [0013]
  • Thus, there is a need for a system for positioning and/or analyzing cells that is rapid, facile, and suitable for multiarray analysis, such as the system provided by the invention. [0014]
  • SUMMARY OF THE INVENTION
  • The invention provides systems for positioning and/or analyzing samples such as cells, vesicles, cellular organelles, and fragments, derivatives, and mixtures thereof, for electrical and/or optical analysis, especially relating to the presence and/or activity of ion channels.[0015]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a schematic view of a system for positioning and/or analyzing samples in accordance with aspects of the invention. [0016]
  • FIG. 2 is a cross-sectional side view of a substrate chip prepared from Si/SiO[0017] 2 in accordance with aspects of the invention.
  • FIG. 3 is a cross-sectional side view of a measurement system having planar electrodes in accordance with aspects of the invention. [0018]
  • FIG. 4 is a cross-sectional side view of a measurement system having point or wire electrodes in accordance with aspects of the invention. [0019]
  • FIG. 5 is a cross-sectional side view of a measurement system having open fluid compartments in accordance with aspects of the invention. [0020]
  • FIG. 6 is a top view of a measurement system having multiple measurement sites in accordance with aspects of the invention. [0021]
  • FIG. 7 is a cross-sectional side view of the measurement system of FIG. 6, taken generally along line [0022] 7-7 in FIG. 6.
  • FIG. 8 is a cross-sectional side view of a measurement system having optical measurement aids in accordance with aspects of the invention. [0023]
  • FIG. 9 is a partially cross-sectional partially schematic side view of a measurement system for combined electrical/optical detection. [0024]
  • FIG. 10 is a contour plot of the electric potential adjacent an aperture in a substrate in accordance with aspects of the invention, computed by finite element method (FEM) simulation. [0025]
  • FIG. 11 is a plot of current versus time showing a decrease in current upon addition of Ca[0026] 2+ to a final concentration of 4 mM following the docking of vesicles at a 7-μm aperture in the unmodified surface of a suitable substrate.
  • FIG. 12AB is a pair of plots of current versus time showing the time course of vesicle binding and the subsequent development of membranes with very high electrical insulation resistance for (A) a 4-μm aperture and (B) a 7-μm aperture in a poly-L-lysine-coated SiO[0027] 2 substrate.
  • FIG. 13 is a plot of current versus time showing the passage of individual vesicles through a 7-μm aperture, as reflected in fluctuations in the plot recorded at a constant clamp voltage, V[0028] c, of −80 mV.
  • FIG. 14 is a plot of current versus time showing the time- and voltage-dependent switching of alamethicin pores in a membrane produced on the substrate (C[0029] alamethicin=0.1 μg/mL in 85 mM KCl) at negative potentials.
  • FIG. 15AB is a pair of plots of current versus time showing the changes in measured membrane resistance of a membrane produced on a Si/SiO[0030] 2 carrier chip after fusion with vesicles containing nAChR (nicotinic acetylcholine receptor). FIG. 15A shows the membrane resistance during accidental receptor openings in the absence of ligands at 400 mM KCl and positive potentials. FIG. 15B shows the membrane resistance 150 seconds after the addition of the nAChR agonist carbamylcholine (20 μm final concentration), where no receptor openings are observed due to desensitization of the receptors.
  • FIG. 16 is a plot of current versus time showing the time course of positioning, binding, and subsequent development of a tight electrical seal for a Jurkat cell. [0031]
  • FIG. 17 is a series of plots of current versus time showing the current flowing through the membrane of a Jurkat cell for the indicated positive and negative clamp voltages. [0032]
  • FIG. 18 is an analysis of the current flowing through the membrane of a Jurkat cell for a +60 mV clamp voltage showing (A) a representative plot of current versus time, and (B) a histogram showing the relative likelihood of the measured currents.[0033]
  • DETAILED DESCRIPTION
  • The invention provides systems such as single and multiaperture biochips for positioning and/or analyzing membrane-bound samples, such as cells, vesicles, cellular organelles, and/or portions thereof. Positioning a sample, as used here, generally comprises locating or placing the sample at a preselected position, within the system, typically for subsequent analysis. Analyzing the sample generally comprises detecting a presence or activity within the sample, while it is positioned at the preselected position, typically relating at least in part to electrical properties of the sample. [0034]
  • FIG. 1 shows a [0035] representative system 30 for positioning and/or analyzing samples in accordance with aspects of the invention. The system includes a substrate 32, at least two fluid compartments 34 a,b, and at least two electrodes 36 a,b. (In some cases, for example, where only optical measurements are to be performed, the system may have only a single fluid compartment and no electrodes.) The substrate comprises a separating wall of electrically isolating material, and may include an aperture and/or window 38 and an associated adhesion surface 40 adjacent the aperture to which samples 42 may be bind or be fixed using any suitable mechanism. The fluid compartments generally comprise any region or volume adapted to support a fluid adjacent the aperture. The electrodes generally comprise any mechanism for applying and/or measuring an electric potential and associated electric field across the aperture. In most embodiments, a first side of the substrate is used as a sample or measurement side, and a second side of the substrate is used as a reference side, although these roles may be interchangeable. The measurement side is used to hold samples during positioning and/or analysis, and typically includes adhesion surface 40, a measurement fluid compartment 34 a and a measurement electrode 36 a. The reference side is used to complete the electric circuit, and typically includes a reference fluid compartment 34 b and a reference electrode 36 b. Generally, despite their different names, the measurement electrode and the reference electrode independently may be set to any suitable voltage, including ground.
  • The system may include or be interfaced with one or more auxiliary systems, including (1) a [0036] sample handling system 44 for introducing, removing, and/or otherwise manipulating fluids and/or samples, (2) an analysis system 46 for analyzing samples, particularly by mechanisms other than direct electrical measurement, and/or (3) an incubation system for storing samples before and/or during assays, and/or (4) a cleaning system for cleaning substrates and/or other system components.
  • The system may be used for a variety of applications. These applications may include automated and/or high-throughput patch-clamp analysis (e.g., for drug screening), portable biosensor analysis (e.g., for environmental analytes), and so on. These applications also may include the separation of cells or vesicles, the analysis of the sizes of cells or vesicles, the direct functional analysis of ionotropic membrane proteins, for example, in ligand binding studies, and/or the positioning of cells or vesicles for any suitable purpose, including purely optical investigations and/or microinjections, among others. Typically, a sample such as a cell or vesicle is introduced into the measurement compartment and then is directed toward the aperture, for example, using an electric force created by the two electrodes. The sample contacts the adhesion surface, binds across the aperture, and forms an electrical seal with the aperture sufficient for performing an assay of interest. The effects of an applied voltage created by the electrodes then may be studied, typically before and/or after exposure to a suitable assay condition The studies may be performed by measuring changes in electrical properties across the aperture, such as current, resistance, or the like, and/or by measuring other changes in the sample, such as ion levels or the like. [0037]
  • The assay condition generally comprises any change of condition, optionally including a change in environmental condition, such as sample temperature, but more typically including the addition of one or more reagents such as candidate drug compounds to the sample. The reagent may be a chemical reagent, such as an acid, a base, a metal ion, an organic solvent, or other substance intended to effect a chemical change in the sample. Alternatively, the reagent may have or be suspected to have a biological activity or type of interaction with a given biomolecule. Selected assay components may include membrane-active substances, such as pore promoters, proteoliposomes, and/or membrane proteins. Selected assay reagents also may include oligonucleotides, nucleic acid polymers, peptides, proteins, drugs, and other biologically active molecules. [0038]
  • The system may have one or more advantages over prior systems for measuring electrical properties of cells and vesicles. First, the system is relatively simple, both in the production of electrically insulating patch membranes and in the associated measurements. Thus, the system, alone or in combination with modern microtechnological methods, is suitable for use in automated and/or “high throughput screening” (HTS) applications. Second, the positioning and measuring capabilities of the system are well suited to the combination of electrical and optical measurements, through which, on these planar membranes, obtained by means of the positioning process according to the invention, new, important information concerning membrane channels and receptors may be obtained. [0039]
  • The following sections describe various components and functionalities of the system, including (A) the substrate, (B) the apertures and windows, (C) the adhesion surfaces, including mechanisms for achieving binding, (D) the fluid compartments, (E) the electrodes, (F) multiaperture systems, (G) the analysis system, (H) the sample handling system, (I) the samples, (J) the sample positioning process, and (K) the measurement process, among others. [0040]
  • A. Substrates [0041]
  • The substrate generally comprises any surface or set of surfaces capable of separating two fluid compartments. The substrate typically includes an aperture that passes through the substrate to connect the two fluid compartments and at least one adhesion surface adjacent the aperture for binding a sample such as a cell or vesicle for analysis. The substrate preferably is nonconductive (e.g., electrically insulating), thus reducing or eliminating electrical contact between the two fluid compartments, except through the aperture. [0042]
  • The substrate may be formed of any suitable material. Preferably, the substrate is nonconductive, inert (in the system), and no more than slightly modifiable chemically. Exemplary materials include silicon (including silicon (Si) and silicon derivatives, such as silicon oxide (SO[0043] 2; silica) and silicon oxinitride (SiOxNy)), glass, quartz, plastic, and so on. Among these, the silicon-based substrates have several advantages. First, they are commercially available. Second, they are easily processed, for example, so that they may be provided with an aperture and/or window, as described below in Example 1. Third, they readily may be coated or otherwise partially or completely covered with insulating and/or adhesion-promoting materials. Such surface layers include layers of quartz, glass, and solid and/or gelatinous polymers, among others. Such surface layers also include plastomers and elastomers, such as polyimides, polymethylmethacrylates, polycarbonates, and silica gels (e.g. Sylgard). Such surface layers also may be homogeneous or inhomogeneous, where, for example, in the latter case, they may be applied as droplets.
  • The substrate may include two or more pieces or components, for example, being constructed of a holder on which the material actually relevant to membrane positioning and membrane binding is fastened or into which this material is admitted, where this material for the positioning, or alternatively the binding, of the membranes has at least one aperture. [0044]
  • The substrate may be formed with any suitable geometry, subject to the above limitations. However, preferably, the substrate is at least substantially planar, and more preferably, the substrate is microscopically flat and molecularly relatively planar, particularly at the adhesion surface. [0045]
  • Examples 1-7 below, among others, describe exemplary substrates, including materials, geometries, and relationships with other components of the system. [0046]
  • B. Apertures and Windows [0047]
  • The aperture and window(s) are the portions of the substrate most immediately involved in the positioning and/or analysis of samples. [0048]
  • The aperture generally comprises any opening or other passage through the substrate. This opening may include a hole, a gap, and/or a slit, among others, and may allow fluid contact between fluid compartments positioned at opposite sides of the aperture. The aperture may be capable of forming an electrical seal with a sample such as a cell or vesicle that is sufficiently “tight” to use in a patch clamp experiment. Exemplary seals (depending on sample type and condition) have included >10 kΩ, >100 kΩ, >1 MΩ, >10 MΩ, >100 MΩ, >1 GΩ, >10 GΩ, >100 GΩ, and even >1TΩ. Alternatively, or in addition, the aperture may be capable of focusing an electric field with sufficient strength to position a sample such as a cell or vesicle about the aperture. The aperture may include a hole, a gap, and/or a slit, among others. [0049]
  • The aperture is characterized by a length L[0050] ap and a diameter daperture The length is determined by the thickness of the substrate adjacent the aperture, generally ranging between about 3 μm and about 1000 μm, and preferably ranging between about 100 nm and about 20 μm. The diameter of the aperture, as measured immediately adjacent the binding surface, is influenced by a variety of different factors, which may urge toward either smaller or larger apertures. First, smaller apertures generally increase the quality of the electrical seal between the aperture and the sample, up to a limit. In particular, to form a tight electrical seal, the aperture should be smaller, preferably significantly smaller, than the size of the sample (i.e., daperture<<dcell, dvesicle), but larger, preferably significantly larger, than the lipids and other molecules present in the sample. Second, smaller apertures generally increase the mechanical stability of the membrane across the aperture. In particular, the force required to deflect a portion of membrane is inversely proportional to the square of the radius of the portion being deflected (i.e., proportional to the value of rM −2; see, e.g., Example 12), so that the selection of small (e.g., daperture<5 μm) apertures may significantly increase membrane stability, particularly relative to the typical (e.g., daperture>100 μm) apertures used in conventional black lipid membrane (BLM) systems. Third, smaller apertures generally increase the strength and focus of the electric field passing through the aperture, which is especially useful when positioning samples. Fourth, larger apertures generally reduce the access resistance, improving the quality of the voltage (or current) clamp, probably by easing the physical access of the conduction ions. Based on these factors, the diameter of the aperture generally is less than about 15 to 20 μm, usually is less than about 10 μm, preferably is less than about 7 μm, and more preferably is less than about 5 μm. In particular, sizes between about 0.3 μm and about 7 μm may yield an outstanding probability and quality of sealing. Stated alternatively, the aperture preferably should have a diameter of no more than a few tens of percent, and more preferably no more than about 30 percent, of the sample diameter. Thus, for cellular samples, which typically have a diameter of greater than about 20 μm, the aperture preferably should have a diameter of no more than about 5-7 μm.
  • The window generally comprises a portion of the fluid compartment adjacent and providing access to the aperture. The preferred size of the window is determined by factors analogous to those described above for determining the preferred size of the aperture. In brief, the diameter of the window preferably is less than about 1000 μm, and more preferably is significantly smaller, being not more than about 100 μm. [0051]
  • Examples 1-7 below, among others, describe exemplary apertures and windows, including geometries and relationships with other components of the system. [0052]
  • C. Binding and Adhesion Surfaces [0053]
  • The adhesion surface generally comprises any surface or set of surfaces adjacent the aperture to which samples such as cells and vesicles may bind for analysis. The adhesion surface typically is at least substantially planar over an area exceeding that of the bound portion of the sample but in some cases may be at least slightly concave in the direction of the sample. Thus, the adhesion surface may have an area of at least about 25 μM[0054] 2 for a cell that is about 5 μm in (bound) diameter, at least about 100 μm2 for a cell that is about 10 μm in (bound) diameter, and so on.
  • Binding, as used here, generally comprises any stable or semi-stable association between a sample and an adhesion surface that results in an electrical seal between the sample and one or more apertures that is sufficiently “tight” to allow the desired measurement. Binding may be mediated by any suitable mechanism, direct or indirect, including electrostatic interactions, covalent bonding, ionic bonding, hydrogen bonding, van der Waals interactions, and/or hydrophobic-hydrophilic[0055] v interactions, among others. In general, binding may be facilitated by the appropriate selection, treatment, and/or modification of the substrate, the sample, the measurement medium, or a suitable combination thereof.
  • Binding may be facilitated by appropriate selection of the substrate. Thus, preferred substrates typically include a relatively flat or gently contoured binding surface adjacent the aperture of interest, so that cells or vesicles may bind to form an acceptable seal with the aperture without unwanted or unnecessary deformation. Moreover, preferred substrates also typically include a modifiable binding surface, so that the surface may be treated as desired to promote binding. [0056]
  • Binding also may be facilitated by appropriate treatment of the substrate, as suggested above. Thus, in some applications, the surface may be treated or otherwise modified so that electrostatic or, in given cases, hydrophobic, van der Waals or covalent binding of vesicles or cells, or -the corresponding membranes or membrane fragments, is promoted. For example, the binding surface may be coated with an adhesion promoter, such as poly-L-lysine, poly-D-lysine, gelatin, collagen, laminin, fibronectin, proteoglycans, polyethylenimine, albumen, BIOMATRIX EHS (Nunc Nalge International), BIOBOND (Electron Microscopy Services, Inc.), and/or MATRIGEL (Becton-Dickinson), among others. Alternatively, or in addition, the binding surface is modified in a way that promotes molecule-specific binding, such as with avidin and/or biotin, or by modification with immobilized lectins. Alternatively, or in addition the binding surface (especially a silicon binding surface) may be coated with an oxide or oxynitride layer. Alternatively, or in addition, the binding surface may be coated with largely hydrophobic compounds such as Tocopherol. In some embodiments, an electrically charged surface may be generated by modification, in particular, by means of polycations and/or silanes, for example, aminosilanes, or the substrate may have a coating or other surface layer with an electrically charged surface. Microstructured silicon/silicon oxide or silicon/silicon nitride substrates are especially suitable for providing a good electrostatic attraction, after being coated with a substance lending the desired surface charge.[0057] vi Finally, to improve the quality and consistency of the surface characteristics, the substrate may be subjected to oxygen plasma cleaned and/or partially or completely hydrophylized before the modification of its surface and/or before its immediate use, in addition to or in lieu of the above modifications. In some aspects of the invention, unwanted hydrophylization/modification of the hydrophobic surface can be avoided by using silicon nitride for the surface layer.
  • Binding also may be facilitated by appropriate selection and/or treatment of the sample itself. Thus, the sample may include unsaturated lipids or other compositions that increase the fluidity of its membrane, potentially enhancing membrane flexibility during binding and seal formation. Alternatively, or in addition, the sample may include charged lipids or other compositions that increase the charge on the sample, potentially enhancing the ability of the sample to bind electrostatically to substrate surfaces bearing an opposite charge. For example, for a positively charged substrate surface, the vesicle might include negatively charged palmitoyl-oleoyl-phosphatidylglycerol (POPG). [0058]
  • In some cases, binding may be facilitated by interactions between specific binding pairs (SBPs), where one member of the pair is associated with the sample and the other member of the pair is associated with the substrate. The interactions between members of a specific binding pair typically are noncovalent, and the interactions may be readily reversible or essentially irreversible. An exemplary list of suitable specific binding pairs is shown in Table 1. [0059]
    TABLE 1
    Representative Specific Binding Pairs
    First SBP Member Second SBP Member
    antigen antibody
    biotin avidin or streptavidin
    carbohydrate lectin or carbohydrate receptor
    DNA antisense DNA
    enzyme substrate enzyme
    histidine NTA (nitrilotriacetic acid)
    IgG protein A or protein G
    RNA antisense RNA
  • Binding also may be facilitated by appropriate selection and/or treatment of the measurement medium. For example, the medium may include binding mediators that participate in or otherwise promote interactions between the sample and substrate, for example, by forming cross-bridges between the sample and substrate and/or by counteracting the effects of binding inhibitors associated with the sample, substrate, or medium. The binding mediators may act specifically, for example, by binding to specific groups or molecules on the sample or substrate. Thus, biotin might act as a specific binding mediator by binding to and cross-linking avidin or streptavidin on the sample and substrate. The binding mediators also may act less specifically, or nonspecifically, for example, by binding to classes or categories of groups or molecules on the sample or substrate. Thus, Ca[0060] 2+ ions might act as a relatively nonspecific binding mediator by binding to and cross-linking negative charges on the sample and substrate. Ca2+ ions are particularly appropriate for mediating the binding of cells or vesicles containing negative lipids and substrates containing negative surface charges, such as SiO2 substrates.
  • After binding, samples such as cells or vesicles may be broken up, for example, by treatment with a hypotonic medium, such as pure water. [0061]
  • Examples 1-7, 10, and 11 below, among others, describe exemplary adhesion surfaces, including materials, treatments, modifications, geometries, and the kinetics and efficacy of sample binding. [0062]
  • D. Fluid Compartments [0063]
  • The fluid compartments generally comprise any region or volume adapted to support a fluid adjacent the aperture. The compartments may perform several functions, including covering the sample, providing a medium through which the cell may be moved during positioning, and/or providing a medium for establishing electrical contact between the electrodes, among others. The compartments generally may have any suitable volumes, but they typically have volumes between about 0.1 to 40-100 μL. Thus, assays typically require only a limited amount of sample, facilitating the analysis of effects of precious compounds. [0064]
  • The fluid compartments may be closed or open. A closed compartment comprises a compartment that is at least substantially bounded or delimited on all sides by a wall or other separating layer, exclusive of an input and/or output port. In contrast, an open compartment comprises a compartment that is not bounded on at least one side (i.e., over at least some solid angle) by a wall. [0065]
  • Closed compartments typically are physically confined, i.e., bounded by some combination of the substrate, an electrode, and one or more spacers, being established within voids and channels therein. The spacers are used in many embodiments, particularly those involving planar electrodes, to establish and maintain the relative positions of the substrate and electrodes. Such spacers typically are formed of an electrically isolating material, like the substrate. The spacers may include channels disposed between the aperture and the electrode. These channels, typically filled with a conductive solution, can serve as a sample or reference chamber. It is beneficial if the reference chamber has such small dimensions that the reference buffer solution may be fixed therein by capillary forces, and/or forced therein by surface tension (e.g., at the fluid/air interface in an open compartment). [0066]
  • Open compartments typically are free standing, i.e., not bounded in at least one, typically lateral, direction. Instead, the fluid may be fixed between the substrate and electrode without other physical boundaries by capillary forces and/or surface tension. [0067]
  • Examples 2-7 below, among others, describe exemplary fluid compartments, including geometries, boundaries, and relationships with other components of the system. [0068]
  • E. Electrodes [0069]
  • The electrodes generally comprise any mechanism for creating and/or modulating an electric potential across an aperture, particularly for use in positioning and/or analyzing samples. [0070]
  • The electrodes may be formed of any material capable of inducing current flow through an aperture upon application of a physiological potential. Suitable electrodes include silver, gold, and/or platinum, among others. Preferred electrodes include silver/silver chloride (Ag/AgCl) and/or platinum (Pt) redox electrodes. [0071]
  • The electrodes may be formed with any suitable geometry and be disposed in any suitable arrangement, consistent with their performing their intended function(s). Preferred electrodes have planar, cylindrical, or point geometries. Preferred electrode arrangements are symmetrical, with similar electrodes positioned at similar distances and orientations from each aperture on each side. Symmetrical electrode arrangements generally will create symmetrical electric fields. Typically, the electrodes are located opposite one another across a single aperture, with each electrode reaching into at least one compartment, or at least contacting a surface of it. The electrodes customarily are located at a distance of about 0.5 to 3 mm, and usually about 0.5 to 1 mm, from the substrate, although they can be closer or farther in some embodiments. Depending on embodiment, the electrodes may be attached directly to a recording carrier, or to a cartridge in which this carrier is packaged, and/or to a holder that is not in direct contact to the substrate. [0072]
  • The electrodes should be capable of creating an electric potential sufficient to perform their function, for example, positioning and/or analyzing samples, without unduly disrupting the samples. Preferred electric potentials give rise to electric field intensities of greater than about 100 V/m, particularly adjacent the aperture. In the following materials, one electrode is referred to as a measurement electrode, p Examples 2-7 below, among others, describe exemplary electrodes, including geometries (e.g., planar, cylindrical, and point), materials (e.g., silver and/or platinum), and relationships with other components of the system. [0073]
  • F. Multiaperture Systems [0074]
  • The invention provides multiaperture systems for positioning and/or analyzing samples. These systems include two or more apertures, which may be disposed at the same and/or separate sites. Apertures disposed at the same site may be used to study single samples at two or more positions on the sample. In contrast, apertures disposed at separate sites may be used to study two or more samples, sequentially and/or simultaneously, at one or more positions on each sample. The production of multiaperture systems generally is straightforward, especially using silicon substrates and Ag/AgCl electrodes, both of which are easily microstructurable. In particular, multiaperture systems may be produced from a single continuous substrate having two or more apertures or by joining together two or more smaller substrates each having one or more apertures. The latter approach may be less expensive for substrates such as silicon with costs that increase faster than area. [0075]
  • Exemplary multiaperture systems employ a multiarray layout having a plurality of separate measurement sites. In these systems, each site includes at least one aperture and fluid and electrical contact with at least one fluid compartment and at least one electrode, respectively, on each side of the aperture. The fluid compartments and electrodes on one side of the substrate (the measurement side) generally are separated to allow independent recordings. However, the fluid compartments and electrodes on the other side (the reference side) may be partially or totally combined, because these components typically function merely to provide a common electrical potential (e.g., ground). The sample generally may be positioned on either the measurement or the reference side, although typically it is positioned on the measurement side so that each fluid compartment independently can contain the same or different types of samples. Thus, in these exemplary systems, several apertures may be used on one substrate, and the measurements may be performed over at least two apertures sequentially and/or in parallel and/or in such a manner that all or several electrodes on one side of the substrate have a common electrical potential, or, alternatively, are combined to form one electrode. Similarly, more than two electrodes and more than one aperture can be present in such a way that at least one electrode, for example, a reference electrode, serves the measurement via more than one aperture, or the measurement arrangement can have a substrate with more than one aperture and twice as many electrodes as apertures in such a way that one aperture always is located between two electrodes. [0076]
  • Measurement sites may be separated using any suitable mechanism, including hydrophilic/hydrophobic surface patterning, as described below, and/or dividing the carrier surface into small compartment wells (e.g., by laminating a thin polydimethylsiloxane (PDMS) layer containing small holes to the carrier surface adjacent the aperture). [0077]
  • The multiaperture system generally may include any number of measurement sites, positioned in any suitable arrangement, with any suitable size or footprint, all consistent with forming electric fields within each site to position and/or analyze samples. Preferred configurations may be selected based on utility and/or convenience. Thus, preferred systems may include features selected from standard microplates, so that the system may be used with standard microplate equipment, including handlers, washers, and/or readers, among others. These features may include a rectangular frame, with a major dimension of about 125-130 mm, a minor dimension of about 80-90 mm, and a height of about 5-15 mm, although other dimensions are possible. The frame may include a base configured to facilitate handling and/or stacking, and/or a notch configured to facilitate receiving a cover. These features also may include 96, 384, 864, 1536, 3456, or 9600 measurement sites, among others, positioned on a rectangular or hexagonal array. Three exemplary configurations that will fit as rectangular arrays within a microplate-sized frame are listed in the following table: [0078]
    Arrangement of Pitch (mm) Density (/mm2)
    Number of Sites Sites Between Sites of Sites
    96  8 × 12 9 1/81
    384 16 × 24 4.5 4/81
    1536 32 × 48 2.25 16/81 
  • Here, pitch is the center-to-center site-to-site spacing, and density is the number of sites per unit area. These features also may include the color of system components, particularly components in the optical path in optical assays. For example, in fluorescence applications, system components preferably are made of opaque black plastic to reduce background photoluminescence and/or “crosstalk,” where crosstalk is the transmission of light emitted in one site to adjacent sites where it may be detected. In contrast, in chemiluminescence applications, system components preferably are made of opaque white plastic to increase reflection of emitted light out of the site by the white surfaces while still reducing crosstalk. [0079]
  • Examples 5 and 6 below, among others, describe exemplary multiaperture positioning and/or analysis systems, including additional features such as reference fiducials not described above. [0080]
  • G. Analysis System [0081]
  • The positioning and measurement system of the present invention optionally may be coupled to or integrated with an analysis system for analyzing samples and sample components. The analysis system generally comprises any mechanism for analyzing or otherwise characterizing samples, qualitatively or quantitatively, other than by direct electrical measurement as used by the positioning and measurement system. The analysis system may require that the sample be separated from the measurement system and/or from other sample components, as described above. Alternatively, or in addition, the analysis system may allow the sample to be studied in situ, without such separation. Generally, measurements made by the positioning and measurement system and measurements made by the analysis system may be performed simultaneously or sequentially, in any order or in any combination, in association with or independent of one another. [0082]
  • The analysis system may be based on any suitable analytical technique, including spectroscopic, hydrodynamic, and imaging methods, among others, particularly those adaptable to high-throughput analysis of multiple samples. Preferred analysis systems are based on the optical analysis of samples, particularly luminescence-based optical analysis, but also absorption, scattering, circular dichroism, optical rotation, and imaging, among others. In luminescence analysis, light transmitted from the sample is detected and analyzed, and properties of the detected light are used to infer properties of the sample, including the presence, size, shape, mobility, quantity, activity, and/or association state of selected components of the sample. In photoluminescence, including fluorescence and phosphorescence, the emission of light from the sample is induced by illuminating the sample with appropriate excitation light. In chemiluminescence, the emission of light from the sample is induced by chemical reactions occurring within the sample. The analysis may involve measuring various properties of the detected light, including its intensity, lifetime, polarization, quantum yield, and Stokes' shift, among others. The analysis also may involve using one or more of these properties in techniques such as fluorescence intensity (FLINT), fluorescence polarization (FP), fluorescence resonance energy transfer (FRET), fluorescence lifetime (FLT), total internal reflection fluorescence (TIRF), fluorescence correlation spectroscopy (FCS), fluorescence recovery after photobleaching (FRAP), and fluorescence imaging, including confocal CCD observation, among others. [0083]
  • In luminescence assays, light typically is detected from a luminophore, i.e., a molecule or other species that emits luminescence. The luminophore may be endogenous or exogenous. Moreover, the luminophore may be the material of interest in the assay but more commonly is simply a reporter that provides information about another material that is the true material of interest. In particular, the luminophore may be an exogenous molecule that reports on (1) membrane potential, (2) the presence or concentration of a target metal, such as Ca[0084] 2+, Mg2+, and Zn2+, (3) the presence or concentration of an inorganic ion, such as Na+, K+, and Cl, (4) pH, (5) reactive oxygen species, including nitric oxide, (6) ion channels, including Ca2+ channels, Na+ channels, K+ channels, and Cl channels, (7) signal transduction, (8) cell viability, and (9) endocytosis and exocytosis, among others. Suitable luminophores for reporting on this and other information are described in Richard P. Haugland, Handbook of Fluorescent Probes and Research Chemicals (6th ed. 1996), which is incorporated herein by reference.
  • The combination of optical technologies with the patch-clamp technologies presented here permits, for the first time, the distinction or resolution of ligand binding events and channel activities, among others. In this way, for example, important information regarding the stabilization of changes in receptor conformation through ligand binding and/or the functional variation in ligand binding sites in receptors may be obtained.[0085] vii Such information is potentially important for understanding the particular mode of action of individual agonists and antagonists, and thus exhibits great promise for future drug development.
  • The optical analysis system typically will include a light source, a detector, and one or more optical relay structures for directing excitation light from the light source to the sample and for directing emission light from the sample to the detector. However, the light source and excitation optical relay structure are optional during analysis utilizing chemiluminescence methods. The optical analysis system may use epi- and/or trans-detection schemes, involving illuminating off of and/or through the sample, respectively. [0086]
  • Exemplary optical analysis systems, and components thereof, are described below under Examples and in the various patents, patent applications, and other materials listed above under Cross-References and incorporated herein by reference. Preferred optical analysis systems are described in the following materials, which are incorporated herein by reference: U.S. Pat. No. 5,355,215, issued Oct. 11, 1994; U.S. Pat. No. 6,097,025, issued Aug. 1, 2000; U.S. Provisional Patent Application Serial No. 60/267,639, filed Feb. 10, 2001; and Joseph R. Lakowicz, [0087] Principles of Fluorescence Spectroscopy (2nd ed. 1999).
  • The combined system is suitable for simultaneous and/or sequential electrical and optical (e.g., photoluminescence) measurements. Suitable apparatus may include a planar, and vertically easily realizable, optically transparent structure, for example, with the use of planar pointed electrodes, or alternatively point electrodes disposed outside of the vertical lines going through the aperture. This allows not only fluorescence or electrical analysis of single cells (or membranes) but also the combined optical-electrical observation of cells (or membranes), particularly in response to exposure to externally applied substances, such as potential medical drugs. This revolutionary approach allows significantly more efficient selection of new drugs and the elucidation of their molecular action. [0088]
  • Example 7 below, among others, describes an exemplary analysis system. Additional examples are described in the various patents and patent applications listed above under Cross-References and incorporated herein by reference. [0089]
  • H. Sample-handling System [0090]
  • The positioning and measurement system according to the invention optionally may be coupled to or integrated with a sample-handling system for adding, manipulating, exchanging, and/or removing samples and sample components, including cells and vesicles, sample media, and compounds and reagents, such as candidate modulators and/or other analytes. The sample-handling system may add samples such as cells or vesicles to arbitrary compartments, convey liquid into and/or out of arbitrary compartments, and/or exchange samples and/or liquid between arbitrary compartments, among others. The sample-handling system also may separate samples, or sample components, in particular using capillary electrophoresis (CE) and/or high-pressure liquid chromatography (HPLC), and serve the analysis of the separated substances, or it can be provided with means that serve the continuous or regular testing of the state of the liquid in the compartments as well as with means for retroactive regulation according to preset filling parameters. Because it is reasonable, according to the analysis strived for, to bring the membrane into contact with measurement solution on both sides, the addition of a substance to be investigated obviously can be done on the side customarily serving as the reference side. The sample-handling system may be multiplexed to interact with several substrates and/or with a multiaperture substrate, among others. [0091]
  • The sample-handling system may be based on any suitable mechanism, including tubes, pumps, hydrostatic pressure differentials, electro-osmotic processes, piezo drop-on-demand processes, ink-jet processes, contact transfer processes, temperature-controlled processes, and/or mechanical displacement, among others. In some embodiments, fluids such as reference buffers may be introduced into a pasty gel, whereby an exchange of the liquid lying outside the gel is possible without changing the composition of the reference buffer stored in the gel. Suitable gels include agarose and polyacrylamide. [0092]
  • Example 2 below, among others, describes an exemplary sample handling system. Additional examples are described in the various patents and patent applications listed above under Cross-References and incorporated herein by reference, including U.S. patent application Ser. No. 09/777,343, filed Feb. 5, 2001; and U.S. Provisional Patent Application Serial No. 60/267,639, filed Feb. 10, 2001. [0093]
  • I. Samples [0094]
  • The sample generally comprises any species having a membrane or other surface capable of forming a seal with an aperture sufficient for performing electrical measurements such as patch clamp experiments. The sample may include cells, vesicles, cellular organelles, membrane-bound viruses, and fragments, derivatives, and mixtures thereof. [0095]
  • Biological samples may include or be derived from (1) eukaryotic cells, i.e., cells with a nucleus, including cells from plants, animals, fungi, yeast, and protozoans, or enucleated derivatives thereof; (2) prokaryotic organisms, including bacteria and archaebacteria; (3) viruses; (4) organelles or extracts, such as nuclei, mitochondria, endosomes, the Golgi apparatus, peroxisomes, lysosomes, endoplasmic reticulum, chloroplasts, axons, and dendritic processes, among others; and (5) gametes, including eggs and sperm. These cells and other materials may be obtained from any suitable source, including cell cultures, patient samples, and tissues, among others. These cells also may be subjected to any suitable treatments to alter membrane properties, for example, to introduce a novel or modified ion channel, among others. These treatments may include genetic modification by any suitable method, including chemical treatment, irradiation, transfection, infection, and/or injection, among others. [0096]
  • Vesicles and other synthetic samples may include or be derived from (1) unilamellar vesicles, (2) multilamellar vesicles, (3) small vesicles (having diameters less than about 1000 nm), (4) large vesicles (having diameters greater than about 1000 nm), (5) monodisperse vesicles, and (6) polydisperse vesicles. These vesicles may be formed from any suitable lipid(s) and/or protein(s) using any suitable technique. Exemplary lipids include DLPC, DMPC, DPPC, DSPC, DOPC, DMPE, DPPE, DOPE, DMPA, DPPA, DOPA, DMPG, DPPG, DOPG, DMPS, DPPS, and DOPS, among others. [0097]
  • Examples 8 and 15-17 below, among others, describe exemplary samples, including vesicle and cell samples. [0098]
  • J. Sample Positioning [0099]
  • The electrical, optical, and/or other analysis of samples generally is preceded by a positioning step, in which the sample is directed to or otherwise located at the adhesion surface. Sample positioning generally occurs in two sequential substeps: (1) a first (prepositioning) substep, in which the sample is introduced to the measurement compartment, and (2) a second (micropositioning) substep, in which the sample is brought into proximity or actual contact with the adhesion surface. These steps may be performed robotically, at least substantially without direct human involvement or intervention. [0100]
  • The prepositioning substep generally involves introducing the sample to the measurement compartment, preferably in a manner that facilitates subsequent binding of the sample to the adhesion surface. Thus, the sample may be introduced generally above the adhesion surface (or associated aperture), so that it is directly between the electrodes, if they are symmetrically arranged, and so that gravity will tend to pull it straight down toward the aperture. Alternatively, or in addition, the sample may be introduced relatively close to the adhesion surface, and/or with an initial velocity toward the adhesion surface, among others. [0101]
  • The micropositioning step generally involves bringing the sample into proximity or actual contact with the adhesion surface, once the sample is in the measurement compartment. Generally, samples may be micropositioned using any suitable force or other mechanism, including sedimentation (e.g., “1g-sedimentation” under the influence of gravity), electromagnetic forces (e.g., electrophoresis, electro-osmosis, and the like), optical forces (e.g., optical tweezers), fluid-mediated forces (e.g., pressure, vacuum, flow, diffusion, and the like), and/or manual forces. Alternatively, or in addition, the cells may be positioned by fluid flow from the sample compartment to the reference compartment by a hydrostatic pressure difference or by a difference in surface tension between the two compartments. Preferably, samples are micropositioned using electromagnetic forces, specifically, field focusing of an electric field created by applying a potential across the two electrodes. In brief, this technique exploits the field focusing that occurs adjacent the aperture, creating an electric force that, at least adjacent the aperture, points in all positions toward the aperture, with a strength that increases with proximity to the aperture. [0102]
  • Examples 2 and 9 below, among others, describe exemplary methods for prepositioning and micropositioning samples, respectively. [0103]
  • K. Measurement Process [0104]
  • The measurement process provided by aspects of the invention allows in particular the measurement of ion channel flows in a reliable and reproducible manner, often with a high signal-to-noise ratio. These abilities reflect the precise positioning and electrically tight binding of cells, vesicles, cellular organelles, and/or membranes of corresponding origin, at microstructured apertures in a planar substrate. This electrically tight binding may be achieved at least in part by strong interactions between the surface of the substrate and the surface of the bound membrane, such as strong electrostatic attractions. [0105]
  • The electrical characteristics of transmembrane ion channels or ionotropic receptors may be characterized using “voltage-clamp technologies,” such as classical voltage-clamp, patch-clamp, and oocyte voltage-clamp, among others.[0106] viii Specifically, an electrical potential difference is applied across the membrane containing the relevant ion channel(s), and, simultaneously, the current necessary to maintain this difference is analyzed. The relationship between the voltage and current may be expressed mathematically using Ohm's Law, which states that V=IR, or equivalently, I=V/R, where V=voltage, I=current, and R=resistance. The current provides insight into membrane electrical properties, such as its conductivity, and therefore insight into the conformation state of the channel-forming protein (e.g., open (passing ions) or closed (blocking ions)). Thus, the current may be used to analyze voltage dependencies, ligand binding events, and so on.
  • The ability of current measurements to yield meaningful data in a patch clamp or other electrophysiology experiment is dependent on ensuring that the measured current reflects ion flow through the sample (e.g., through ion channels in the membrane) and not through other components of the system. In particular, to obtain acceptable or better signal-to-noise ratios, it typically is desirable to ensure that the measured current includes no more than a ten or twenty percent contribution from unintended sources (e.g., that sources of noise lie under the signals to be measure by approximately the factor of five or ten). Unfortunately, the ion flow through ionotropic membrane proteins with 0.1 to 50 pA at a −60-mV membrane potential is in general very small, so that leakage currents occurring essentially between the membrane and its fastening quickly may become significant, representing a principal problem in all voltage-clamp technologies. [0107]
  • The problem of leakage currents can be solved in a variety of ways. For example, enlarging the aperture and thereby the patch of membrane to be analyzed may reduce the contribution of leakage currents to the total signal, because the area of the membrane patch and so the intended signal will grow as the radius of the aperture squared, while the circumference of the membrane and so the leakage current will grow merely as the radius. Unfortunately, increasing the size of the membrane may lead to a loss in specificity, particularly in biological systems, because more channels and more types of channels will be in the membrane area analyzed. Then, in general, an unambiguous or completely artifact-free statement, for example, in the case of the addition of ligands, may no longer be possible. [0108]
  • Establishing and maintaining a very high seal between the membrane and aperture also may reduce the contribution of leakage currents. This invention uses this principle, at least in part. To implement the seal, a planar substrate chip having a surface that is strongly adhesive for cells and vesicles is used. This chip separates the two compartments clamped at different potentials during the measurement, where a (sub)micrometer-sized aperture is located in its middle. This aperture is filled with reference buffer solution and electrically tightly sealed during current measurements by strong binding of cells and vesicles to the surface. This electrically tight binding may permit the measurement of very small ion flows (e.g., down to at least about 0.1 pA) and, concomitantly, the plotting of membrane resistance with a good or better signal-to-noise ratio. [0109]
  • Further (mechanical) stability may be derived from using capillary forces to fill and store the reference and/or measurement buffers. In particular, unbounded or open fluid compartments may experience fewer disturbances (e.g., due to temperature differentials) of the membrane due to hydrostatic pressure than closed systems. [0110]
  • The measurement systems described here may be used for a variety of applications, some of which are described below in Example 16, including “perforated-patch,” “whole-cell,” and “inside-out” patch clamp techniques. For example, measurement systems of the planar type are particularly well suited, due to the short diffusion times associated therewith, to the use of “perforated-patch” techniques.[0111] IX In these techniques, an electrical connection to the interior of the cells (cytosol) is achieved by permeabilization of the area of the membrane suspended across the aperture with pore-forming antibiotics. An advantage of this technique is that it does not require washing out the cytosol with measurement buffer solution for simultaneous electrical access. In particular, a pore former such as, for example, amphotericin B or nystatin can be added to the reference compartment, after a biological cell, or, under special circumstances, a vesicle (if its mechanical stability is sufficiently high) is bound to the upper side of the aperture. In doing so, the rate of perforation of the membrane patch over the aperture is significantly greater than in comparable standard patch-clamp techniques.
  • For example, measurement systems of the planar type also are particularly well suited to the use of “whole-cell” techniques. In these techniques, an electrical connection to the cytosol is achieved by destroying the membrane patch, for example, using a voltage pulse. This destruction, in turn, may facilitate the simple addition of larger proteins into the cytoplasm, via the reference solution, again because the planar layout of the measurement system allows significantly faster diffusion of large macromolecules into the cytosol or the interior of a vesicle than comparable standard whole-cell techniques.[0112] x
  • The system facilitates the addition and/or exchange of various system components, including solutions and/or substances, as suggested above. For example, in some applications, the measurement solution, the reference solution, or both solutions may be replaced by another solution. Alternatively, or in addition, a substance to be analyzed may be added to the solution on the measurement and/or reference side. The substance may include a pore former that can be added to one or both compartments with the aim of increasing the electrical conductivity, or, alternatively, the permeability of the membrane with respect to certain ions. The substance also may include detergent-solubilized proteins or proteoliposomes of arbitrary size, with the aim of fusing them to the membrane over the aperture and thereby making arbitrary membrane proteins contained therein accessible to electrical or optical measurements. The fusion of proteoliposomes is described in detail in U.S. patent application Ser. No. ______ , filed Sep. 14, 2001, titled EFFICIENT METHODS FOR THE ANALYSIS OF ION CHANNEL PROTEINS, and naming Christian Schmidt as inventor. [0113]
  • Examples 12-16 below, among others, describe exemplary results obtained from various electrical measurements on vesicle and cell-derived membranes. [0114]
  • EXAMPLES
  • The following examples describe selected aspects and embodiments of the invention. These examples are included for illustration and should not be interpreted as restricting, limiting, or defining the entire scope of the invention. Additional examples are described in the following patent applications, which are incorporated herein by reference: U.S. Provisional Patent Application Serial No. ______ , filed Sep. 13, 2001, titled HIGH-THROUGHPUT PATCH CLAMP SYSTEM, and naming Christian Schmidt as inventor; and U.S. patent application Ser. No. ______ , filed Sep. 14, 2001, titled EFFICIENT METHODS FOR THE ANALYSIS OF ION CHANNEL PROTEINS, and naming Christian Schmidt as inventor. [0115]
  • Example 1
  • Substrate Chip [0116]
  • This example, illustrated in FIG. 2, describes an exemplary Si/SiO[0117] 2 chip substrate 50 for use in positioning and/or studying cells, vesicles, and the like, in accordance with aspects of the invention.
  • The substrate includes a [0118] body 52, a surface layer 54, a window 56, and an aperture 58. The body comprises an at least substantially planar, commercially available silicon wafer. The surface layer comprises a silicon oxide or silicon oxynitride layer formed adjacent one or more sides of the body. In this embodiment, the surface layer has a thickness of at least about 50 to 200 nm and provides at least one adhesion surface 60 a,b capable of binding cells, vesicles, and/or other samples. The window and aperture comprise openings through the body and surface layer, respectively. These openings are at least substantially concentrically aligned, with dimensions sufficient to allow fluid contact between opposite sides of the substrate.
  • The substrate may be produced using any suitable method, including photolithography or, for apertures having diameters of less than about 1.5 μm, electron beam lithography. These methods may involve anisotropic etching of the silicon in a medium containing KOH, as well as reactive ion etching of the silica layer. [0119]
  • In alternative embodiments, the substrate may include a body and/or a surface layer having a different geometry and/or formed of different materials. In addition, the window may be absent, or the window and the aperture both may be openings in the body, particularly in embodiments lacking a surface layer. [0120]
  • Example 2
  • Measurement System with Planar Electrodes [0121]
  • This example, illustrated in FIG. 3, describes an [0122] exemplary measurement system 70 having planar electrodes, in accordance with aspects of the invention.
  • The measurement system includes a [0123] substrate 72, at least two fluid compartments 74 a,b, at least two redox electrodes 76 a,b, and optionally at least four spacers 78 a-d. In this embodiment, all of these components are at least substantially planar; however, in other embodiments, one or more of these components may have a different geometry. Generally, samples may be introduced into either compartment, and measurements may be performed with the system in any orientation. However, to simplify the description, the top fluid compartment 74 a and top electrode 76 a (as drawn) are referred to here as the measurement compartment and measurement electrode, and the bottom fluid compartment 74 b and the bottom electrode 76 b (as drawn) are referred to as the reference compartment and the reference electrode.
  • The substrate is used to support cells, vesicles, and other samples for electrical analysis. The substrate includes a [0124] body 80, a window 82, and an aperture 84 connecting the two fluid compartments. The substrate further includes at least one adhesion surface 86 a,b positioned adjacent one or both ends of the aperture for binding cells, vesicles, and/or other samples. An exemplary substrate is described in more detail in Example 1.
  • The fluid compartments are used to support fluids such as electrolyte solutions or growth media in apposition to the substrate and aperture. The compartments are formed by apertures or voids in the substrate, spacers, and/or electrodes. [0125]
  • The electrodes are used to apply and/or measure an electric potential and associated electric field across the aperture. [0126] Measurement electrode 76 a comprises a 0.8-mm thick chlorinated square (e.g., 4×4 mm2) or annular (e.g., d=2 mm) silver (Ag) plate, preferably having a frustoconical or funnel-shaped opening 88 (e.g., dmin=0.4 to 1 mm). The measurement electrode is positioned at least substantially parallel to the surface of the substrate, preferably at a distance of up to about 1 mm from the surface of the substrate. The measurement electrode further is positioned so that opening 88 is at least substantially concentrically positioned above aperture 84. Reference electrode 76 b comprises a 2-mm thick square silver plate (e.g., 20×20 mm2), which preferably has a purity greater than about 99.98% silver. The preferred silver/silver chloride (Ag/AgCI) reference electrode may be produced during manufacture of the system, for example, (1) by exposing the reference compartment to a molecular Cl2 gas, typically while applying a potential to the electrode, or (2) by filling the reference compartment with 1 M HCl, and then chlorinating the exposed silver for 90 seconds under a 0.8-V potential. The substrate is mounted, after its underside is wetted with buffer solution, over the reference compartment filled with reference buffer solution. In this embodiment, the reference electrode functions to support and maintain other components of the system.
  • The spacers may be used for several functions, including (1) separating the substrate and electrodes, (2) forming the fluid compartments, and (3) contributing to the structure of a [0127] feed opening 90 used to introduce samples to the sample compartment. Specifically, first and second spacers 78 a,b are positioned about the measurement electrode. These spacers include openings 92 a,b that may be aligned concentrically with opening 88 in the measurement electrode and aperture 84 in the substrate to form a “feed opening” for introducing samples into the system. The feed opening may be of arbitrary form; typically, however, it is elliptical, in particular circular, with a preferred diameter of about 0.2 to 2 mm, and a more preferred diameter of about 0.5 to 1 mm, to facilitate its concentric alignment with the aperture. A third spacer 78 c is positioned between the measurement electrode and the substrate to form an insulating barrier between these two elements. This spacer, preferably formed from silicone (e.g., Sylgard 184, Dow Coming, USA), includes a ring-like opening 92 c that again may be mounted concentrically about aperture 84, for example, with a radius r of about 1 mm. The ring-like opening forms, together with the meniscus that forms between the chip and measurement electrode, the sample chamber (sample compartment) for the addition of cells, vesicles, and/or measurement solution. Finally, a fourth spacer 78 d is positioned between the reference electrode and the substrate to forming an insulating barrier between these two elements. This spacer, preferably formed as a 0.5 to 2 mm-thick silicon rubber seal (e.g., Sylgard), includes a channel or chamber 92 d having dimensions of about 1 mm in width and less than about 6 mm in length. The spacer may be imprinted and, if filled with buffer solution, produce contact between the aperture, or alternatively the membrane, and the reference electrode.
  • The measurement system may be configured or adapted to facilitate the addition, positioning, and/or analysis of samples. Thus, the setup preferably has means on one or both sides of the substrate that make possible an addition of liquid, a storage of liquid, and, in given cases, an exchange of liquid, as well as the addition of cells, vesicles, or other cellular organelles, or parts of the same, between the substrate and the electrode(s). For example, during measurement, or membrane production, a small (e.g., 5 to 10 μL) volume of measurement or vesicle solution (e.g., a cell suspension) may be added (e.g., by pipette) directly to the feed opening, the window, and/or the aperture, on the measurement side of the substrate or on the upper side of the measurement electrode. The aperture preferably has a diameter such that, when a voltage differential exists over the chip, an inhomogeneous electrical field, mediated by the electrodes, is set up around the aperture. This field may increase in magnitude near the aperture, such that samples can be moved electrophoretically toward the aperture. Furthermore, the substrate preferably includes at least one surface [0128] 94 a,b, on one or both sides of the aperture, that is attractive for biological membranes, permitting the molecule-specific and/or multivalent ion-mediated binding of cells, vesicles, membrane fragments, and/or cellular organelles. The surface of the substrate further may be structured to create hydrophilic and hydrophobic areas, with the hydrophilic area preferably positioned around the aperture.
  • Example 3
  • Measurement System with Point or Wire Electrodes [0129]
  • This example, illustrated in FIG. 4, describes an [0130] exemplary measurement system 110 having point or wire electrodes, in accordance with aspects of the invention.
  • The measurement system includes a [0131] substrate 112, two fluid compartments 114 a,b, and two point or wire electrodes 116 a,b. The substrate and fluid compartments are used to support samples and fluids, respectively, as described above. The substrate includes a body 118, a window 120, and an aperture 122 connecting the two fluid compartments. The substrate further may be surface modified and/or fastened to a holder, including a glass or Teflon holder. The electrodes are used to apply an electric potential and associated electric field across the aperture, also as described above. Here, the electrodes comprise the chlorinated end surfaces 124 a,b of two silver wires 126 a,b, or, alternatively, two silver electrodes, disposed above and below the substrate. The electrodes preferably have diameters between about 0.1 and 2 mm and a relative separation of about 4 mm. In some embodiments, the electrodes may be provided with a protective outer layer 128 a,b that covers and protects the outside surface of the electrodes, except at the end surfaces.
  • The measurement system may be used for positioning and/or analyzing samples. In an exemplary approach, sample medium is added to both sides of the substrate, and held between the substrate and electrode by capillary forces. Next, the offset is calibrated, and a suitable voltage is applied (typically, V=−60 to −100 mV). Then, cells or vesicles are added to an appropriate (e.g., modified) side of the substrate, and cell binding and/or membrane formation are pursued with the aid of a change in the electrical parameters. Finally, the properties of ion channels or other membrane components are studied using suitable electrophysiology methods. Throughout, the addition or exchange of samples and/or sample media may be performed using a sample handling system, as described above, such as a pipette or tube mounted near the aperture. [0132]
  • Example 4
  • Measurement System Having Open Fluid Compartments [0133]
  • This example, illustrated in FIG. 5, describes an [0134] exemplary measurement system 150 having open fluid compartments, in accordance with aspects of the invention.
  • The measurement system includes a [0135] substrate 152, at least two fluid compartments 154 a,b, and at least two electrodes 156 a,b. These components perform at least substantially the same functions as their namesakes in Examples 2 and 3.
  • The substrate comprises an insulating [0136] silicon chip 158. The substrate may include a groove that is closed by a thin silicon nitride (Si3N4) 160/silicon oxide (SiO2) 162 diaphragm containing a small aperture 164 having a diameter that usually is less than about 20 μm. The substrate further may include a surrounding insulating layer 166, for example, thermally grown silicon oxide, to reduce system capacitance. The surface of the substrate may be treated to promote the tight adhesion of cell or vesicle-associated lipid bilayers, for example, by (1) physisorption of poly-L-lysine (with a typical molecular weight greater than about 15,000 daltons), (2) chemical modification with 4-aminobutyl-dimethyl-methoxysilane, and/or (3) attachment of molecules that bind (specifically or nonspecifically) to the cell surface (e.g., lectins), among others.
  • The fluid compartments comprise open regions of the substrate surface adjacent the aperture to which fluid is confined. Here, fluid is confined by a combination of hydrophilic and hydrophobic interactions. Specifically, fluid is attracted to the region adjacent the aperture by hydrophilic interactions and excluded from regions away from the aperture by surrounding layers of [0137] hydrophobic material 168 a,b attached or bound to the surface. Consequently, the buffer compartments are delineated by the surface of the substrate on one side and by surface tension on the opposing side, creating dome-shaped compartments, as shown.
  • The electrodes comprise conductive elements such as Ag/AgCl for generating an electric potential across the aperture. The electrodes, which may be used for positioning and/or recording, are immersed in the fluid compartments. The electrodes may be directly attached to the substrate (e.g., by sputtering or printing) or to a container that contains the substrate. Here, a first (measurement or recording) electrode is used to apply a measurement voltage, and a second (reference) electrode is used to apply a ground. [0138]
  • The measurement system may be used for positioning and/or analyzing samples, at least substantially as described above. In particular, upon application of a voltage between the two fluid compartments, mediated by the redox electrodes immersed in the two compartments, a strongly inhomogeneous field is created around the aperture that attracts cells, vesicles, and other charged objects towards the aperture. After these samples bind and/or form membranes, they may be analyzed electrically and/or optically, among others. [0139]
  • Example 5
  • Measurement System Having Multiple Measurement Sites [0140]
  • This example, illustrated in FIGS. 6 and 7, describes an [0141] exemplary measurement system 190 having multiple measurement sites, in accordance with aspects of the invention. The drawings show two alternative embodiments, separated by break lines, that include different carrier/electrode configurations.
  • The measurement system includes a plurality of measurement sites, each capable of positioning and/or analyzing a sample, as described above. More specifically, the measurement system includes a [0142] substrate 192, a plurality of fluid compartments 194 a,b, and a plurality of electrodes 196 a,b. The measurement sites are formed from portions of the substrate and combinations (e.g., pairs) of fluid compartments and electrodes. The substrate preferably comprises (1) a silicon body 198, (2) a silicon nitride diaphragm 200 having a plurality of apertures 202, at least one per measurement site, and (3) a hydrophobic and/or insulating surface coat 204. The fluid compartments preferably comprise (1) a plurality of measurement compartments 194 a, and (2) at least one reference compartment 194 b. The electrodes preferably comprise (1) a plurality of measurement electrodes 196 a, at least one per aperture or measurement site, and (2) at least one reference (ground) electrode 196 b. The measurement system further may include additional features, such as (1) a support or carrier plate 206 to simplify the design and/or to increase the reliability of the system, and/or (2) one or more reference fiducials 207 for reference and/or alignment purposes, as described below.
  • The components of the measurement system are described in more detail in subsequent subsections. Briefly, on one side, the substrate contains a patterned surface that physically separates the measurement compartments, allowing independent measurements. The patterned surface may be created by the patterned attachment of hydrophilic materials at measurement sites and hydrophobic materials at intervening positions. The measurement compartments may be accessed independently using a separate measurement electrode for each compartment, where each electrode is connected independently to one or more voltage sources, such as a voltage clamp circuit. On the other side, the substrate contains a reference compartment that can be separated but that preferably is unified to form a single compartment in contact with a single (usually ground) electrode. In some embodiments, the substrate includes a silicon chip containing grooves that are closed by a silicon nitride/silicon oxide diaphragm. The diaphragm includes a small aperture having a diameter of less than about 20 μm. The substrate otherwise may be surrounded by an insulating layer, for example, a thermally grown silicon oxide layer, to reduce the system capacitance. [0143]
  • Substrate [0144]
  • The substrate generally comprises any structure adapted to provide two or more sites for positioning and/or analyzing samples electrically, as described above. The substrate may be formed from any suitable material, including silicon, plastic, and/or glass. The substrate generally may include any number of sample sites arranged in any suitable format, as described above. Preferred formats include 8×12 (96) rectangular arrays and 16×24 (384) rectangular arrays, with standard microplate footprints. Some embodiments may include additional sites, including additional rows or columns of sites. For example, in one such embodiment, the system includes an additional row of sites, configured as an 8×13 (104) rectangular array. [0145]
  • Fluid Compartments [0146]
  • The fluid compartments generally comprise any region adapted to support fluid for bathing the sample and for providing electrical contact between the measurement and reference compartments. [0147]
  • The measurement compartments are used for positioning and/or analyzing samples. These compartments are defined by hydrophilic spots on the chip surface, surrounded by a hydrophobic surface coating, for localizing fluid. The measurement compartments include an aperture positioned within the hydrophilic spot and a measurement electrode positioned for electrical contact with the associated measurement fluid. The hydrophilic spot typically includes an at least substantially planar or concave adhesion surface, which may be selected and/or treated as described above to promote sample binding and/or membrane formation. [0148]
  • The reference compartments are used for completing the electric circuit, typically to electric ground. These “backside” compartments may be combined to form one or more large compartments (corresponding to two or more measurement compartments), since the separate compartments typically would contain the same buffer solution and each be connected to ground. In particular, a single large backside compartment and a single backside electrode are sufficient for spatial resolution of individual recordings, if the measurement compartments are addressed individually. In some embodiments, the backside electrode may be deposited directly on the recording chip or on an embedding cartridge. [0149]
  • Electrodes [0150]
  • The electrodes generally comprise any mechanism adapted to apply and/or measure an electric potential across the aperture, with each measurement site in contact with at least one measurement electrode and at least one reference electrode, as described above. [0151]
  • The composition of the electrodes is selected to allow current flow at physiological potentials. Preferred electrodes include silver/silver chloride (Ag/AgCl) and/or platinum (Pt) redox electrodes for both the sample and reference compartments. Particularly preferred electrodes include silver (Ag) as the electrode material, chlorinated within a chlorine (Cl[0152] 2) atmosphere.
  • The number of electrodes may vary. The upper side of the substrate (associated with the measurement compartments) preferably includes enough separate electrodes independently to address each corresponding recording site, e.g., 8×13 electrodes on a 2.25 mm grid. In contrast, the lower side of the substrate (associated with the reference compartment) preferably includes a single electrode. [0153]
  • The electrodes may be insulated outside the measurement compartment. Preferred insulation material preferably has a high electrical resistance and a low dielectric constant and loss. Particularly preferred insulation material is produced from Teflon, silicon nitride (Si[0154] 3N4), and/or Sylgard by spin coating or chemical vapor deposition (CVD). These materials are sufficiently hydrophobic (even after short oxygen-plasma treatment) to confine the measurement and reference compartments. Moreover, these materials may include or be formed to include grooves or holes, potentially improving fluid support and/or reducing evaporation.
  • The electrodes at the various measurement sites may be connected electrically to [0155] corresponding contacts 208 for clean and/or easy access to appropriate electronic components, such as amplifiers, recording devices, and the like. In a preferred embodiment, the contacts are positioned near the edge or border of the substrate, and a bonding wire 210 joins the electrodes and contacts, although more generally any mechanism capable of establishing an electrical connection may be employed. In particular, the electrodes can be bonded to contacts placed on a plastic (e.g., polypropylene) carrier that embeds the entire recording chip.
  • Support Element [0156]
  • The support element generally comprises any mechanism for independently and portably supporting the substrate and associated system components, potentially simplifying design and/or increasing reliability. The support element may support the substrate at its edges and/or in its interior, with the interior support potentially reducing or preventing sagging and/or stress of the substrate. In an exemplary embodiment, the support element includes a [0157] carrier plate 206 and a spacer 212 sandwiched between the substrate and the carrier plate near the edges of the substrate. The carrier plate may be formed from glass (e.g., PYREX) and/or any other suitable material. The substrate, spacer, and carrier plate may be joined using any suitable mechanism, such as anodic bonding. The separation between the substrate and the carrier plate (i.e., the spacer thickness) preferably is chosen to be less than about 1 mm, to allow filling of the backside (i.e., reference) compartment by capillary forces. By extending the glass plate over the borders of the chip, in some embodiments, it may be possible to bond the upper electrodes to contacts placed on the glass plate.
  • Reference fiducials [0158]
  • The reference fiducials generally comprise any feature or characteristic of the measurement system adapted to provide information that facilitates sample handling and/or analysis, for example, as described in U.S. Pat. No. 6,258,326, issued Jul. 10, 2001, which is incorporated herein by reference. [0159]
  • The reference fiducials, or a subset thereof, may be used to encode information and/or to provide reference positions. For example, the reference fiducials may encode information relating to the identity of the manufacturer of the system and/or one or more properties of the system and/or the associated samples. Alternatively, or in addition, the reference fiducials may provide reference positions useful to correct for cross-system drift (due to dimensional irregularities in the system) and/or to align the system with ancillary devices, such as an electrical device for electrical analysis and/or an optical device for optical analysis. [0160]
  • The reference fiducials may encode information using any suitable mechanism, including electrical and/or optical mechanisms. For example, the reference fiducials may encode information electrically, based on the resistance, capacitance, and/or inductance, among others, of a particular portion or portions of the system. Alternatively, or in addition, the reference fiducials may encode information optically, based on the size, shape, position, color, absorptivity, reflectivity, and/or transmissivity of a particular portion or portions of the system. [0161]
  • The reference fiducials may be identified and read using any suitable mechanism, including the electrical device and/or optical device used in sample analysis. [0162]
  • Example 6
  • Measurement System Having Optical Measurement Aids [0163]
  • This example, illustrated in FIG. 8, describes an [0164] exemplary measurement system 230 having optical measurement aids, in accordance with aspects of the invention.
  • The measurement system includes a [0165] substrate 232, a plurality of fluid compartments 234 a,b, a plurality of electrodes 236 a,b, and a carrier plate 238, at least substantially as described above in Example 5. However, the system further includes an optical measurement aid for use in conjunction with a suitable optical analysis system, as described above. The optical measurement aid generally comprises any element or mechanism adapted to facilitate and/or enable optical analysis of samples such as cells or vesicles positioned on or near the substrate. The optical measurement aid may comprise a modification of one or more of the elements listed above and/or a new element in addition to and/or in lieu of one or more of the elements listed above.
  • The optical measurement aid may comprise a support element that includes a short spacer and/or a thin, optically transparent carrier plate, as described above. A short spacer and/or a thin carrier plate may shorten the optical path length between the optical device and sample, by reducing the separation between the substrate and carrier plate. A thin carrier plate also may better match the optical requirements of the optical analysis system. To this end, the thickness of the carrier plate may be selected to correspond to the thickness of a standard microscope cover slip, for example, 0.08 to 0.13 mm thick (No. 0), 0.13 to 0.17 mm thick (No. 1), 0.16 to 0.19 mm thick (No. 1½), or 0.17 to 0.25 mm thick (No. 2), among others. To related ends, the carrier plate may be selected to improve overall optical transmission, for example, by using crystal-clear, pure water-white glass or super clarity, clear-white borosilicate glass. Alternatively, or in addition, the carrier plate may be selected to improve transmission of polarized light, for example, by using strain-free glass or fused silica. Alternatively, or in addition, the carrier plate may be selected to have uniform surface quality, exceptional flatness, and/or precise dimensions, among others. [0166]
  • The optical measurement aid also may comprise a carrier plate or other interface having an array of [0167] lenses 240 such as microlenses that correspond in number and spacing to the array of measurement sites. These lenses may be formed from any suitable material (such as glass or plastic) using any suitable technique (such as etching or molding). The lenses may be used for high-magnification and/or high numerical aperture analysis of samples, including the analysis of single cells positioned on single apertures. To assist such analysis, the x-y resolution of the recording apertures and microlenses preferably is less than a few (e.g., about 1-4) μm, which may be facilitated using a high-precision bonding process. Moreover, the z resolution of these components preferably is less than a few (e.g., about 1-4) μm, which may be facilitated using lenses having high numerical apertures.
  • The lenses in the array generally may have any shape capable of collecting light from the sample and/or focusing light onto the sample. For example, the lenses may be plano-convex, meaning that they have a flat (plano) surface and an opposed outwardly bulging (convex) surface. The plano-convex lenses may have two orientations. In the first orientation, exemplified by [0168] lens 240, the convex surface 242 faces toward the sample site, and the planar surface 244 faces away from the sample site. In the second orientation, exemplified in FIG. 8 by lens 240′, the convex surface 242′ faces away from the sample site, and the planar surface 244′ faces toward the sample site. In either orientation, the lens will collect light transmitted from the sample and direct the collected light toward a detector, such as an imaging detector (e.g., a charge-coupled device (CCD)) or a point detector (e.g., a photomultiplier tube (PMT)), among others.
  • The optical measurement aid also may include a window [0169] 246 in the substrate having a shape configured to match an optical sensed volume, including the frustoconical shape through which excitation light is directed onto the sample and/or from which emission light is detected from the sample, for example, as described in U.S. patent application Ser. No. 09/478,819, filed Jan. 5, 2000, which is incorporated herein by reference. The matching may be used in optical analysis to increase sensitivity (for example, by avoiding detection from walls of the sample well) and/or to decrease sample volume, among others.
  • Example 7
  • Analysis System [0170]
  • This example, illustrated in FIG. 9, describes an [0171] exemplary measurement system 270 for combined electrical/optical detection, in accordance with aspects of the invention.
  • The combined measurement system includes an [0172] electrical analysis system 272 and an optical analysis system 274.
  • The electrical analysis system generally comprises any system for performing electrical measurements such as patch clamp measurements on a sample such as a cell, vesicle, or biological organelle. The electrical analysis system may include any suitable combination of [0173] apertures 275, substrates 276, fluid compartments 278 a,b, and electrodes (not visible in this view), among other elements, as described above. Exemplary systems are described above in Examples 2-6.
  • The optical analysis system generally comprises any system for detecting light transmitted from the sample, particularly photoluminescence and chemiluminescence light. The optical analysis system may include a [0174] light source 280, a detector 282, and an optical relay structure 284 for transmitting excitation light from the light source to the sample and emission light from the sample to the detector. The system further may include additional components for performing additional and/or duplicative functions, including (1) filters 286 positioned in the excitation and/or emission optical paths for altering the intensity, wavelength, and/or polarization of the excitation and emission light, respectively, (2) confocal optics elements 288 such as an aperture positioned in an image plane for reducing detection of out-of-focus light, and (3) a reference monitor 290 positioned to detect a portion of the excitation light for correcting for variations (e.g., fluctuations and/or inhomogeneities) in the excitation light.
  • The light source generally comprises any mechanism for producing light suitable for use in an optical assay, such as a photoluminescence, scattering, and/or absorbance assay, among others. Suitable light sources include lasers, arc lamps, incandescent lamps, fluorescent lamps, electroluminescent devices, laser diodes, and light-emitting diodes (LEDs), among others. The light source may be capable of use in one or more illumination modes, including continuous and time-varying modes, among others. [0175]
  • The detector generally comprises any mechanism for detecting light transmitted from a sample in an optical assay. Suitable detectors include charge-coupled devices (CCDs), intensified charge-coupled devices (ICCDs), videcon tubes, photomultiplier tubes (PMTs), photodiodes, and avalanche photodiodes, among others. The detector may be capable of use in one or more detection modes, including (a) imaging and point-reading modes, (b) discrete (e.g., photon-counting) and analog (e.g., current-integration) modes, and (c) steady-state and time-resolved modes, among others. [0176]
  • The optical relay structure generally comprises any mechanism for transmitting light between the light source, sample, and detector (or simply the sample and detector in a chemiluminescence assay). Suitable optical relay structures may include mirrors, lenses, and/or fiber optics, among others. Here, the optical relay structure includes a beamsplitter that generally transmits excitation light toward the sample and generally reflects emission light toward the detector. [0177]
  • FIG. 9 shows an exemplary embodiment of a combined electrical/optical measurement system, including components as described above. Here, a parallel read-out system is used for confocal-optical recordings, for example, using the chip substrate system of FIG. 8. In either order, the chip substrate is placed in an appropriate light beam that is able to excite fluorescent probes of interest, and the sample membranes or cells are positioned at the individual apertures of the chip. The samples are excited using one parallel light beam, for example, using a 45-degree mirrored beamsplitter. The fluorescent light coming from the biological sample or any associated fluorescent probes is transmitted to an optional filter and confocal optics element to increase the signal-to-noise ratio before being projected onto the light sensitive chip of a CCD camera. The confocal optics element reduces or eliminates out-of-focus light not originating from the sample. The spatial resolution of the CCD chip allows detection of fluorescence from all apertures (and consequently all biological samples) simultaneously, if desired. [0178]
  • More generally, the system may be configured to allow top and/or bottom illumination and/or detection of the sample(s), permitting the following combinations: (1) top illumination and top detection, or (2) top illumination and bottom detection, or (3) bottom illumination and top detection, or (4) bottom illumination and bottom detection. Same-side illumination and detection, (1) and (4), is referred to as “epi” and is preferred for photoluminescence and scattering assays. Opposite-side illumination and detection, (2) and (3), is referred to as “trans” and is preferred for absorbance assays. [0179]
  • Alternatively, or in addition, the system may be configured to allow illumination and/or detection at oblique angles. For example, illumination light may impinge on the bottom of a sample holder at an acute angle (e.g., about 45 degrees) relative to detection. In comparison with a straight-on epi system (light source and detector directed at about 90 degrees to sample holder) or a straight-through trans system (light source directed through sample holder directly at detector), an oblique system may reduce the amount of excitation light reaching the detector. [0180]
  • Suitable systems, and components thereof, for top/bottom and/or oblique illumination are described in the following materials, which are incorporated herein by reference: U.S. Pat. No. 5,355,215, issued Oct. 11, 1994; U.S. Pat. No. 6,097,025, issued Aug. 1, 2000; and U.S. Provisional Patent Application Serial No. 60/267,639, filed Aug. Feb. 10, 2001. [0181]
  • Example 8
  • Producing, Sizing, and Binding of Vesicles [0182]
  • This example describes exemplary methods for producing, sizing, and binding lipid vesicles. [0183]
  • A mixture of 100 μL asolectin (Fluka) or egg lecithin (EPC), 50 μL palmitoyloleylphosphatidylglycerol (POPG), and 3 μL dipalmitoyl phosphatidyl-ethanolamine-rhodamine (DPPE-rhodamine) (Molecular Probes, USA) (all 10 mg/mL in chloroform, Avanti Polar Lipids), and 70 μL methanol is dried in a rotary vaporizer (Büchi Rotavapor R-114) at low (400 mm Hg) pressure in a 10 mL round flask to form a film. After a 1-hour incubation under vacuum, to the flask is added either 10 mL H[0184] 2O or 10 mL of a buffer solution having a concentration of less than 150 mM of KCl and/or less than 600 mM of sucrose or preferably of sorbitol. After a subsequent 16-hour incubation at 37° C., the resulting lipid vesicles appear as an almost transparent cloud. The lipid vesicles are aspirated and removed using a 1 mL pipette and stored at 4° C. until further use. Storage of the vesicle solution may be improved by the addition of sodium azide (NaN3) to a concentration of 0.2% by weight. This vesicle preparation procedure yields mostly (>90%) unilamellar vesicles, with sizes up to 250 μm. However, some of the vesicles may contain additional smaller vesicles, which are not relevant for membrane formation.
  • The ability of the resulting vesicles to establish electrically tight seals against a surface aperture is enhanced by purification of the initial vesicle mixture to remove vesicles and lipid impurities that are smaller than about 10 μm in size. Without such purification, the binding of such smaller vesicles in the vicinity of the aperture may prevent electrically tight sealing of the aperture by large (e.g., larger than 10 μm) vesicles. The vesicles may be sized by dialysis, for example, using a nylon mesh with a 20-μm pore size for at least about 20 hours. If necessary, the membrane fluidity of the resulting vesicles may be lowered, for example, by adjusting the lipid composition so that it includes a higher fraction of low-fluidity lipids and/or by lowering the temperature so that it is closer to the phase-transition temperature of the vesicles (e.g., less than or equal to about 4° C., or more preferably less than or equal to about 1° C., for some lipids). The unilamellarity of the resulting vesicle membranes may be demonstrated and/or verified using any suitable analytical technique, such as microscopic analysis using a confocal microscope.[0185] xi
  • More generally, vesicles may be produced, sized, and bound using any suitable methods. For example, large unilamellar vesicles (giant unilamellar vesicles, GUVs) may be produced using the hydration method.[0186] xii Similarly, proteoliposomes may be produced using an appropriately modified hydration method.xiii Additional vesicles may be produced using the methods described in U.S. patent application Ser. No. ______ , filed Sep. 14, 2001, titled EFFICIENT METHODS FOR THE ANALYSIS OF ION CHANNEL PROTEINS, and naming Christian Schmidt as inventor.
  • Example 9
  • Electrophoretic Positioning of Vesicles [0187]
  • This example, illustrated in FIG. 10, describes exemplary methods for electrophoretically positioning samples such as cells and lipid vesicles. The positioning attainable using these methods may exceed that attainable using gravity sedimentation, in at least the following ways: (1) a decrease in the necessary number of vesicles or cells, (2) an increase in the total rate of membrane formation, and (3) an increase in the probability of a successful membrane setup or cell binding. Vesicles and cells also may be prepositioned prior to electrophoretic positioning to improve performance, for example, by introducing the vesicles or cells to the sample so that they are initially positioned above the aperture. [0188]
  • The electrophoretic positioning methods make use of inhomogeneities in the electric potential and associated electric field surrounding the aperture. FIG. 10 shows results of a finite element method (FEM) simulation of the electric potential distribution around a substrate in accordance with aspects of the invention. The substrate includes a 4-μm aperture positioned between parallel electrodes. The field distribution is shown as a series of equipotential lines (corresponding a cross-section through the three-dimensional equipotential surfaces), with a spacing of 4 mV, where the potential difference between the electrodes is 80 mV. The field-line curve is distorted in this simulation from its normal circular form to an elliptical form to reflect leak currents in the edge region of the carrier chips. The following parameters were used in the simulation: C[0189] buffer=10 mM KCl, V=80 mV, daperture=4 μm, and spacing between the aperture and each electrode=1 mm.
  • The electric field associated with an electric potential is minus the spatial rate of change of the potential, i.e., E=−∇∇. Thus, the electric field is perpendicular to the equipotential surfaces at all positions, pointing in the direction of decreasing potential. Moreover, the electric field is stronger where the equipotential surfaces are closer together, and weaker where these surfaces are farther apart. Consequently, from FIG. 10, the electric field points toward the aperture (on one side of the aperture), with a strength that increases with proximity to the aperture. [0190]
  • These electrophoretic positioning methods generally may be used in any system capable of creating and focusing an electric field through an aperture. In preferred systems, the electrodes used to create the field are positioned relatively close together, for example, within about 5-10 mm, reducing the voltage required to create an acceptable electric field. Specifically, the measurement and reference electrodes are located, one above and one below the substrate, at a distance of about 0.2 to 3 mm, preferably about 0.5-2 mm, and more preferably about 0.5 to 1 mm. The clamp voltage generated by these electrodes is not critical; however, it customarily lies in the range V[0191] c=−300 to -300 mV, preferably lies in the range−60 to -100 mV, and more preferably lies in the range−60 to −80 mV. The associated electrophoretic-driving force directs vesicles and cells, following the electric field, toward the aperture. In particular, because the electric field is strongly inhomogeneous, increasing sharply in magnitude with proximity to the aperture, vesicles and cells move automatically toward the aperture. In particular, the fields are most effective near the aperture (e.g., within about 200 μm of the aperture), so that samples preferably are brought into this range by prepositioning or reach it convectively. For this purpose, a hole (for example, d<1 mm) may be located in the measurement electrode with respect to the aperture.
  • The following subsections describe two alternative methods of electrophoretic positioning. [0192]
  • [0193] Variation 1
  • The offset voltage V[0194] offset between the electrodes may be corrected before each measurement. To do so, 5 μL of buffer solution is added directly to the aperture, and the measurement electrode is brought to within about 1 mm from the substrate surface. After a liquid meniscus forms between the surface of the substrate and the electrode, the offset voltage and the capacitance of the system are adjusted to compensate.
  • A 10-μL dispersion of lipid vesicles subsequently is added to the upper side of the measurement electrode, where the vesicles can sediment through the circular opening located in the measurement electrode. Vesicles that move through the measurement electrode opening may be accelerated directly to the aperture opening under the influence of an electric field generated by the applied electrode voltage, V[0195] M=−50 to −80 mV. In doing so, the focusing achieved, measured in the number of vesicles passing through the aperture opening with unmodified surfaces, is a function of the size of the window (that is, the portion of the SiO2 layer laid open by etching). Smaller SiO2 windows (e.g., less than about 45×45 μm2) clearly increase vesicle throughput.
  • Variation 2: [0196]
  • The offset voltage V[0197] offset between the electrodes may be corrected before each measurement. To do so, 5 μL of buffer solution is added between the substrate and the measurement electrode, or alternatively between the substrate and the reference electrode, after which the voltage is determined at which the current flow vanishes, satisfying the expression I(Voffset)=0.
  • A 3-μL dispersion of lipid vesicles subsequently is added to the measurement compartment near the aperture, where, in the case of a plane parallel electrode arrangement, the vesicles can sediment through the circular opening located in the measurement electrode. Vesicles that come into the vicinity (e.g., less than about 200 μm) of the aperture experience a very high field intensity (generally but not necessarily between about 100 kV/m and several kV/m) and are accelerated according to the electric field curve directly to the aperture. After the vesicles bind to the substrate and form an electrically tight seal, they are analyzed electrically. [0198]
  • Example 10
  • Sealing of Vesicles with Unmodified Surfaces [0199]
  • The example, illustrated in FIG. 11, describes the sealing of vesicles, as described above, with unmodified surfaces. In particular, FIG. 11 shows a plot of current versus time after the docking or binding of vesicles to a 7-μm aperture in the unmodified surface of a suitable substrate. The plot shows that the addition of Ca[0200] 2+ to a final concentration of 4 mM leads quickly to a tight electrical seal between the vesicle membrane and the substrate surface. Specifically, the addition of Ca2+ causes a rapid, significant drop in current, indicating that the membrane has at least substantially blocked ion pathways through the aperture.
  • Example 11
  • Binding and Adsorption of Vesicles on Modified SiO[0201] 2 Surfaces
  • The example, illustrated in FIG. 12AB, describes the binding and/or other interactions of vesicles as described above with polylysine-modified SiO[0202] 2 surfaces.
  • The binding between these vesicles and surfaces may be strong and rapid, manifesting itself in less than about 0.5 seconds after an appropriate proximity is reached. The probability of successfully positioning a vesicle and subsequently forming an electrically tight membrane seal is strongly dependent on the size of the aperture, the size of the SiO[0203] 2 window, and the number, size, and size distribution of the vesicles in the vesicle solution. If substrates having aperture diameters less than about 2 μm and window sizes greater than about 40 μm are used in conjunction with suspensions of vesicles having a vesicle diameter greater than about 40 μm, the probability of binding and forming an electrically tight seal may exceed 90% (n>15, where n is the number of trials). In general, a decrease in the width of the aperture and an increase in the purity of the vesicle suspensions lead to greater reproducibility in the formation of tight aperture seals, both substrate to substrate and vesicle preparation to vesicle preparation.
  • Vesicles that bind to the surface subsequently may be drawn out to form substantially flat, defect-free membranes. Fluorescence microscopy studies performed using vesicles labeled with both rhodamine (to label vesicle membranes) and carboxyfluorescein (to label vesicle interiors) show that vesicles flatten and may burst upon binding, forming unilamellar structures, since bound vesicles appear flat and red, suggesting that carboxyfluorescein has been released. These studies were conducted using polylysine-coated glass and a confocal microscope (LSM 510, Zeiss Jena, Germany). Electrical studies of membrane resistance, R[0204] M, demonstrate that the bound vesicles may form substantially defect-free lipid membranes, since very high membrane resistances (e.g., RM>6.4 GΩ (n=26)) are measured on the substrates in symmetric 85 mM KCl. An analogous series of measurements in symmetric 10 mM KCl demonstrates binding of the vesicles, after appropriate proximity, in less than about 0.2 seconds, with a probability greater than about 70% (n>15) and a membrane resistance greater than about 10 GΩ.
  • To promote strong adhesion of the vesicles, the surface of the substrate, in given cases, is coated with an adhesion promoter, for example, polycations.[0205] xiv For physisorption, for example, an aqueous solution of polycations (e.g., 0.1% poly-1-lysine bromide, MW 100,000, Sigma) may be added to the substrate for about 2-5 minutes directly before the measurement and subsequently rinsed off with measurement buffer solution. The covalent binding of peptide polycations preferably is done using previously activated hydroxyl groups of the quartz surface, for example by means of tosyl chloride (triphenylchloromethane).xv Through the modification of the substrate surface, an attraction of vesicles with negative surface charge is achieved, which is completely sufficient for electrically tight seals between the membrane and the substrate surface. Alternatively, the surface also may be modified by other compounds having cation characteristics in the desired pH range, such as, for example, 4-aminobutyl-dimethyl-methoxysilane. Finally, treating the substrates in O2 plasma for several minutes before surface modification leads to more consistent surface characteristics.
  • FIG. 12AB shows the time course of vesicle binding and the subsequent development of membranes with very high electrical insulation resistance for a 4-μm aperture (FIG. 12A) and a 7-μm aperture (FIG. 12B) in a poly-L-lysine-coated SiO[0206] 2 substrate. The measurements were performed in the presence of 10 μM KCl, using a clamp voltage of −80 mV.
  • Example 12
  • Membrane Electrical Properties [0207]
  • This example describes electrical factors relating to preferred aperture sizes, including characteristic electrical properties. [0208]
  • The thermal noise σ of a circular lipid membrane is proportional to R[0209] M −½:xvi σ = 4 kTf c R M
    Figure US20020144905A1-20021010-M00001
  • where R[0210] M=Rspec/(πrM 2). It follows therefrom that σ = r M 4 π kTf c R spec
    Figure US20020144905A1-20021010-M00002
  • In these formulae, σ is the effective noise flow, r is the radius, f is the frequency, k is the Boltzmann constant, R is the resistance, and T is the temperature. [0211]
  • Thus, to be a usable membrane for measurement purposes, r[0212] M/{square root}{square root over (Rspec)} should be very small. The minimization of this product can be pursued according to the invention in two ways: (1) by minimizing the membrane radius rM, and/or (2) by the electrically tight sealing of the membranes used.
  • Example 13
  • Electrical Parameters of Lipid Membranes [0213]
  • This example describes the effects of vesicle fusion on electrical parameters of the measurement system, as described above. [0214]
  • The resistance across the sample substrate changed significantly following vesicle fusion. Before fusion, the resistance is up to 1 MΩ (usually <450 kΩ) in 85 mM KCl, and similarly usually up to 1 MΩ in 1 mM KCl, depending in both cases on the size of the aperture. Greater resistances are interpreted as artifacts, possibly reflecting, for example, the inclusion of air bubbles under the aperture opening. After fusion, the resistance is greater than about 6.4 GΩ in 85 mM KCl, greater than about 10 GΩ in 10 mM KCl, and greater than about 40 GΩ in 1 mM KCl, corresponding to four order-of-magnitude increases in resistance. Here, the resistance R is at least approximately related to the applied voltage V and the current I according to Ohm's law, i.e., R=V/I. [0215]
  • The capacitance of the sample substrate changed only insignificantly following fusion, by several pF in 85 mM KCl, and by 160 to 280 pF in 1-10 mM KCl. [0216]
  • Example 14
  • Vesicle Passage through Micrometer Pores [0217]
  • This example, illustrated in FIG. 13, describes the passage of vesicles through apertures in the substrate. [0218]
  • The passage of vesicles through an aperture in the presence of negatively charged surfaces, such as unmodified SiO[0219] 2 layers, can be observed by monitoring changes in current (or, equivalently, resistance) across the aperture. Specifically, the passage of vesicles will lead to a decrease in current and an associated increase in resistance. To monitor for artifacts in the observed values, the polarity of the voltage is reversed, whereupon no modulation of current or resistance is observed.
  • The duration of observed changes in the amplitude of resistance can be correlated with size of the vesicles passing through the aperture being monitored. For example, modulations in the amplitude of resistance lasting up to 18 seconds suggest the passage of very large vesicles with sufficiently fluid membranes. Where vesicle populations with diameters greater than about 50 μm (n=4) are used in conjunction with aperture openings with diameters of about 7 μm, an almost exclusive variation of the time of passage for fixed changes in amplitude as a function of vesicle size is observed. It is presumed that vesicles undergoing passage through the aperture opening are drawn out during their passage to form tubular structures with definite diameters and closed surfaces. [0220]
  • By analyzing the typical time of passage for large vesicles (d[0221] vesicle>>daperture) and the typical change in the amplitude of resistance for small vesicles (dvesicle˜daperture), the composition of the vesicles with respect to size can be determined for a given vesicle solution. The method of the invention therefore possesses utility for analyzing size distributions in selected populations of vesicles and cells.
  • Example 15
  • Observation of Alamethicin Pores and Nicotinic Acetylcholine Receptors [0222]
  • This example, illustrated in FIGS. 14 and 15AB, describes observation of electrical activity of alamethicin pores and nicotinic acetylcholine receptors (nAChR) in fused vesicles. These observations confirm the biological utility of the invention. [0223]
  • FIG. 14 shows a plot of current versus time for membranes containing alamethicin. In these experiments, a membrane is formed over an aperture in 85 mM KCl. Next, alamethicin is added to the measurement compartment, to a final concentration of 0.1 μg/mL.[0224] xvii Finally, a potential is applied, and a plot of current versus time is generated. The amplitude and dwell times of the current fluctuations observed in this plot, corresponding to 600 pS conductivities of the alamethicin pores, prove the functionality and high sensitivity of the system.
  • FIG. 15AB shows an analogous plot of current versus time for membranes containing the membrane protein nAChR. In these experiments, a membrane is formed as above. Next, nAChR is introduced into the membrane via Ca[0225] 2+-mediated fusion. Specifically, nAChR is purified from an appropriate source, and then reconstituted into small unilamellar vesicles.xviii Next, these vesicles are added to the measurement compartment, and then fused to the membrane by increasing the Ca2+ concentration of the sample chamber to greater than about 1 mM. In given cases, the fusion is supported by the subsequent temporary setup of an osmotic gradient.xix Finally, a potential is applied, and a plot of current versus time is generated. In the absence of agonists, typical receptor opening events are observed (FIG. 15A), whereas, in the presence of agonists, such as carbamylcholine (20 μM final concentration), such receptor opening events are substantially extinguished within a short time (t<100 seconds) (FIG. 15B).
  • Example 16
  • Analysis of Cells [0226]
  • This example, illustrated in FIGS. [0227] 16-18AB, describes use of the above-described systems in the study of cells.
  • The methods of the invention are generally applicable to the investigation and analysis of cells. Such cells may be positioned and electrically characterized using procedures substantially analogous to those described above for vesicles. However, in some cases, the positioning and measurement methods may be modified as desired to accommodate differences in vesicles and cells, including, among others, the cytoskeleton, the varied lipid and protein content of cell membranes, and the cell wall in plants and certain algae, bacteria, and fungi. For example, the cell may be made more flexible by disrupting the cytoskeleton, for example, using cytochalasin and/or colchicine. Similarly, in measurements using plant cells, the cell wall may be removed to expose a relatively smooth membrane surface capable of forming a tighter electrical seal. Similarly, in measurements using animal cells derived from tissues, the extracellular matrix may be removed or digested, for example, using one or more proteases, lipases, and/or glycosidases, among others. [0228]
  • The methods may be used for a variety of patch clamp experiments, in a variety of formats or configurations. The cell, as initially bound and sealed, is in a “cell-attached configuration.” If the membrane patch over the aperture then is ruptured or destroyed, for example, by applying a pulse of voltage or suction, electrical measurements can be performed over the entire cell membrane in a “whole-cell configuration.” Alternatively, if the membrane patch over the aperture is permeabilized, for example, by the addition of pore formers such as amphotericin B or nystatin to the reference compartment, electrical measurements again may be performed over the entire cell membrane in a “perforated-patch configuration.” Alternatively, if the cell (instead of the membrane patch over the aperture) is lysed, electrical properties of the patch may be measured in an “inside-out configuration.” In the lattermost approach, the cytosolic side of the membrane is exposed to the measurement solution, and the relatively small area of membrane being analyzed potentially makes possible the study of individual channel events. [0229]
  • FIGS. [0230] 16-18 show exemplary results of positioning and voltage clamp experiments performed using Jurkat cells. These cells, a human mature leukemic cell line, phenotypically resemble resting human T lymphocytes and are widely used to study T cell physiology. Similar results (not shown) were obtained using TE 671 cells and CHO cells.
  • The cells were cultured and prepared using standard cell culture techniques. These cells were maintained for 2-5 days at 37° C. in 5% CO2 in RPMI with Glutamax, supplemented with 10% FCS and P/S (100 U/100 μg/mL). Before use, cells were resuspended in a physiological buffer (PB=NaCl, 140 mM; HEPES, 10 mM; KCl, 5 mM; CaCl[0231] 2, 2 mM; MgCl2, 1.2 mM; pH 7.3, osmolarity 290 mOsm) at a density of 107 cells/mL. Lower and upper fluid compartments were filled with 20 μL and 15 μL of PB, respectively. Five μL of the cell suspension was added to the upper compartment. Positioning was made at Vm=−60 or −90 mV. All experiments were performed at room temperature.
  • FIG. 16 shows the time course of positioning, binding, and subsequent development of a tight electrical seal for a Jurkat cell. The cell was positioned at −60 mV. Seal formation occurred about 15 seconds after cell addition, quickly rising to about 1000 GΩ. The aperture size was about 3 μm, and the chip resistance was about 250 kΩ. [0232]
  • FIG. 17 shows a series of plots of current versus time showing the current flowing through the membrane of a Jurkat cell at the indicated positive and negative clamp voltages in a cell-attached configuration. The curves appear quantized, switching largely between just two values, one low and one high, particularly at higher voltages. This characteristic suggests that single-channel events are being observed, corresponding to the opening and closing of the channel. [0233]
  • FIG. 18 shows an analysis of the current flowing through the membrane of a Jurkat cell for a +60 mV clamp voltage. Panel A shows a representative plot of current versus time. This plot again has a quantized character, like FIG. 17. Panel B shows a histogram plotting the relative occurrence of a given current versus the current. The histogram is bimodal, with peak values of about 1.3 pA (the relatively smaller peak at left) and about 4.8 pA (the relatively larger peak at right), corresponding to an average of about 3.5 pA. [0234]
  • Example 17
  • Miscellaneous Applications [0235]
  • The positioning and measurement systems provided by the invention may be used for a variety of purposes and a variety of assays. Exemplary miscellaneous applications are described below. [0236]
  • Screening of Ingredients The system may be used to screen libraries according to any suitable criterion, such as the identification of candidate drugs, modulators, and the like. Suitable libraries include compound libraries, combinatorial chemistry libraries, gene libraries, phage libraries, and the like. The system is exceptionally well suited to probing libraries whose members are present only in small amounts, such as (1) the large number of potential ligands that can be produced using combinatorial chemistry, and (2) many receptor proteins, above all ligand-controlled and G-protein-coupled receptors (GPCRs). Owing to the process according to the invention, or alternatively the measurement arrangement/measurement apparatus according to the invention, it is possible to work with very few cells, either directly or after previous isolation and reconstitution of the receptor proteins in vesicles or lipid membranes. By the uncomplicated arrangements of the sensor elements in arrays, different substances or receptors can be selected simultaneously. There is moreover the possibility of receptor cleaning and reconstitution in lipid vesicles microchromatographically in on-chip containers that optionally may be integrated into the apparatus according to the invention. [0237]
  • Replacement of Conventional Patch-clamp Technologies [0238]
  • Conventional patch-clamp technologies form the foundation of the investigation of the functionality of membrane receptors as well as the modification of membrane characteristics as a response to signal and metabolic processes in cells. If isolated cells of a homogeneous cell population serve as the object of the investigation, as is, for example, often the case in transformed cells, the process according to the invention serves as an at least comparable replacement for the patch-clamp technologies. As objects of investigation for this process, for example, dissociated neurons and cultivated mammalian cells as well as plant protoplasts are suitable. [0239]
  • Portable Biosensors/Environmental Analytics [0240]
  • The automation and outstanding mechanical stability of the measurement system according to the invention permits its use in biosensors. By using suitable transformed cells, receptors reconstituted in vesicles, or channel-forming proteins, sensors can be set up that are sensitive to very different substrates or metabolites. Moreover, if sufficiently tight electric seals are formed, which is possible using the apparatus according to the invention, then measurement sensitivity will in principle only be dependent on the binding constant of the receptor. This sensitivity may lie under one nanomole for G-protein-coupled receptors, and in the nanomolar range for ionotropic receptors (e.g., 5 HT3, nAChR, GABA[0241] AR, glycine R, and GluR).xx
  • The disclosure set forth above may encompass multiple distinct inventions with independent utility. Although each of these inventions has been disclosed in its preferred form(s), the specific embodiments thereof as disclosed and illustrated herein are not to be considered in a limiting sense, because numerous variations are possible. The subject matter of the inventions includes all novel and nonobvious combinations and subcombinations of the various elements, features, functions, and/or properties disclosed herein. The following claims particularly point out certain combinations and subcombinations regarded as novel and nonobvious. Inventions embodied in other combinations and subcombinations of features, functions, elements, and/or properties may be claimed in applications claiming priority from this or a related application. Such claims, whether directed to a different invention or to the same invention, and whether broader, narrower, equal, or different in scope to the original claims, also are regarded as included within the subject matter of the inventions of the present disclosure. [0242]
  • [0243] i J. P. Changeux (1993), “Chemical Signaling in the Brain,” Sci. Am. Nov. Pages 30 ff; A. G. Gilman (1995), Angew. Chem. Int. Ed. Engl. 34:1406-1428; M. Rodbell (1995), Angew. Chem. Int. Ed. Engl. 34: 1420-1428.
  • [0244] ii J. Hodgson (1992), Bio/Technology 9:973.
  • [0245] iii J. Knowles (1997), “Medicines for the New Millennium Hunting Down Deseases [sic: Diseases].” Odyssey Vol. 3(1).
  • [0246] iv O. P. Hamill, A. Marty, et al. (1981), “Improved Patch-clamp Techniques for High-resolution Current Recording from Cells and Cell-free Membrane Patches”. Pflugers Arch 391(2):85-100.
  • [0247] v (Radler, J., H. Strey, et al. (1995), “Phenomenology and Kinetics of Lipid Bilayer Spreading on Hydrophilic Surfaces.” Langmuir 11(11):4539-4548.
  • [0248] vi For example, polycations, such as described by Mazia, Schatten, et al. (see D. Mazia, G. Schatten et al. (1975), “Adhesion of Cells to Surfaces Coated with Polylysine.” J. Cell Biol. 66:198-200).
  • [0249] vii J. Edelstein, O. Schaad, J. -P. Changeux (1997), “Single Binding versus Single Channel Recordings: A New Approach to Study Ionotropic Receptors.” Biochemistry 36:13755-13760.
  • [0250] viii See Hamill, Marty, et al. (1981), loc. cit.; J. G. Nicholls, A. R. Martin, et al. (1992), From Neuron to Brain: A Cellular and Molecular Approach to the Function of the Nervous System. Sunderland, Ma., Sinauer Associates, Inc.
  • [0251] ix R. Horn, A. Marty (1988), “Muscarinic Activation of Ionic Currents Measured by a New Whole-cell Recording Method,” J. Gen. Physiol. 92(2):145-59; J. Rae, K. Cooper, et al. (1991), “Low Access Resistance Perforated Patch Recordings Using Amphotericin B.” J. Neurosci. Methods 37(1): 15-26.
  • [0252] x Z. M. Pei, J. M. Ward, et al. (1996), “A Novel Chloride Channel in Vicia Faba Guard Cell Vacuoles Activated by the Serine/Theonine Kinase, CDPK.” EMBO J. 15(23):6564-74.
  • [0253] xi See, e.g., R. B. Gennis (1989), Biomembranes: Molecular Structure and Function. New York, Springer Verlag.
  • [0254] xii H. H. Hub, U. Zimmerman, et al. (1982), “Preparation of Large Unilamellar Vesicles.” FEBS Lett. 140(2):254-256; P. Mueller, T. F. Chien, et al.(1983), “Formation and Properties of Cell-like Lipid Bilayer Vesicles.” Biophys. J. 44(3):375-81, K. Akashi, H. Miyata, et al. (1996), “Preparation of Giant Liposomes in Physiological Conditions and their Characterization under an Optical Microscope.” Biophys. J. 71(6):3242-50
  • [0255] xiii M. Criado and B. U. Keller (1987), “A Membrane Fusion Strategy for Single-channel Recordings of Membranes Usually Non-accessible to Patch-clamp Pipette Electrodes.” FEBS Lett. 224(1):172-6; B. U. Keller, R. Hedrich, et al. (1988), “Single-channel Recordings of Reconstituted Ion Channel Proteins: An Improved Technique.” Pflugers Arch 411(l):94-100.
  • [0256] xiv See Mazia, Schatten, et al. loc. cit., 1975.
  • [0257] xv M. L. Williamson, D. H. Atha, et al. (1989), “Anti-T2 Monoclonal Antibody Immobilization on Quartz Fibers: Stability and Recognition of T2 Mycotoxin.” Analytical Letters 22(4):803-816.
  • [0258] xvi B. Sakmann and E. Neher (1983), Single-channel Recording, New York, Plenum Press.
  • [0259] xvii R. B. Gennis (1989), Biomembranes: Molecular Structure and Function, New York, Springer Verlag.
  • [0260] xviii T. Schürholz, J. Kehne, et al. (1992), “Functional Reconstitution of the Nicotinic Acetylcholine Receptor by CHAPS Dialysis Depends on the Concentration of Salt, Lipid, and Protein,” Biochemistry 31(21):5067-77; Schürholz, T. (1996), “Critical Dependence of the Solubilization of Lipid Vesicles by the Detergent CHAPS on the Lipid Composition. Functional Reconstitution of the Nicotinic Acetylcholine Receptor into Preformed Vesicles above the Critical Micellization Concentration,” Biophys. Chem. 58(1-2):87-96).
  • [0261] xix See Eray, Dogan, et al. (1995) loc. cit.
  • [0262] xx R. A. North (1994), Ligand- and Voltage-gated Ion Channels, CRC Press; S. J. Peroutka, (1991), Serotonin Receptor Subtypes-Basic and Clinical Aspects, New York, John Wiley; Peroutka, S. J. (1994), G-protein-coupled Receptors, CRC Press; E. C. Conley, (1996), The Ion Channel Facts Book, Academic Press.

Claims (13)

I claim:
1. A system for positioning and/or analyzing samples such as cells, vesicles, and cellular organelles, and fragments, derivatives, and mixtures thereof, comprising:
a substrate having a plurality of apertures;
at least one recording fluid compartment and at least one reference fluid compartment, arranged on opposites side of the substrate, and in contact via the apertures; and
at least one recording electrode and at least one reference electrode, each in contact with at least one of the fluid compartments, and adapted to apply and/or measure an electrical potential across the apertures.
2. The system of claim 1, further comprising a support element for independently supporting the substrate and associated system components.
3. The system of claim 2, where the support element includes a carrier plate and at least one spacer sandwiched between the substrate and the carrier plate.
4. The system of claim 3, where the space defined between the substrate and the carrier plate includes at least one of the compartments.
5. The system of claim 3, where the carrier plate is made of a transparent material, such as glass, and includes a plurality of microlenses arranged in such a way that they allow the parallel optical observation of the samples that are positioned near the apertures.
6. The system of claim 2, where each recording electrode contacts the substrate or the support element at least substantially at its border.
7. The system of claim 1, where at least two fluid compartments are arranged on one side of the substrate, each of those compartments being in contact, via the apertures, with a single fluid compartment arranged on the other side of the substrate.
8. The system of claim 1, where at least one electrode is arranged adjacent the substrate.
9. The system of claim 1, where the recording fluid compartment is arranged above or below the substrate.
10. The system of claim 1, where the substrate includes at least one material selected from the group consisting of silicon, silicon derivatives, glass, and plastic.
11. The system of claim 1, where the diameter of the aperture is less than about 15 nm.
12. The system of claim 11, where the diameter of the aperture is between about 0.3 μm and about 7 μm.
13. The system of claim 1, where the number of recording fluid compartments is selected from the group consisting of 96, 384, 1536, and 9600.
US09/957,116 1997-12-17 2001-09-19 Sample positioning and analysis system Abandoned US20020144905A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US09/957,116 US20020144905A1 (en) 1997-12-17 2001-09-19 Sample positioning and analysis system
US10/093,680 US7201836B2 (en) 1997-12-17 2002-03-07 Multiaperture sample positioning and analysis system
US10/229,863 US7244349B2 (en) 1997-12-17 2002-08-27 Multiaperture sample positioning and analysis system
US10/334,815 US7387715B2 (en) 1997-12-17 2002-12-31 Sample positioning and analysis system
US11/535,064 US20070209935A1 (en) 1997-12-17 2006-09-25 Multiaperture Sample Positioning and Analysis System

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
CH290397 1997-12-17
CH2903/97 1997-12-17
PCT/IB1998/001150 WO1999031503A1 (en) 1997-12-17 1998-07-28 Positioning and electrophysiological characterization of individual cells and reconstituted membrane systems on microstructured carriers
IBPCT/IB98/01150 1998-07-28
US09/581,837 US6758961B1 (en) 1997-12-17 1998-07-28 Positioning and electrophysiological characterization of individual cells and reconstituted membrane systems on microstructured carriers
US23236500P 2000-09-14 2000-09-14
US23380000P 2000-09-19 2000-09-19
US32217801P 2001-09-13 2001-09-13
US09/957,116 US20020144905A1 (en) 1997-12-17 2001-09-19 Sample positioning and analysis system

Related Parent Applications (7)

Application Number Title Priority Date Filing Date
US09581837 Continuation-In-Part 1998-07-28
US09/581,837 Continuation-In-Part US6758961B1 (en) 1997-12-17 1998-07-28 Positioning and electrophysiological characterization of individual cells and reconstituted membrane systems on microstructured carriers
US09/581,837 Continuation US6758961B1 (en) 1997-12-17 1998-07-28 Positioning and electrophysiological characterization of individual cells and reconstituted membrane systems on microstructured carriers
PCT/IB1998/001150 Continuation WO1999031503A1 (en) 1997-12-17 1998-07-28 Positioning and electrophysiological characterization of individual cells and reconstituted membrane systems on microstructured carriers
PCT/IB1998/001150 Continuation-In-Part WO1999031503A1 (en) 1997-12-17 1998-07-28 Positioning and electrophysiological characterization of individual cells and reconstituted membrane systems on microstructured carriers
US09/952,461 Continuation-In-Part US20020104757A1 (en) 1997-12-17 2001-09-14 Efficient methods for the analysis of ion channel proteins
US10/093,680 Continuation-In-Part US7201836B2 (en) 1997-12-17 2002-03-07 Multiaperture sample positioning and analysis system

Related Child Applications (4)

Application Number Title Priority Date Filing Date
US09/952,461 Continuation-In-Part US20020104757A1 (en) 1997-12-17 2001-09-14 Efficient methods for the analysis of ion channel proteins
US10/093,680 Continuation US7201836B2 (en) 1997-12-17 2002-03-07 Multiaperture sample positioning and analysis system
US10/093,680 Continuation-In-Part US7201836B2 (en) 1997-12-17 2002-03-07 Multiaperture sample positioning and analysis system
US10/229,863 Continuation-In-Part US7244349B2 (en) 1997-12-17 2002-08-27 Multiaperture sample positioning and analysis system

Publications (1)

Publication Number Publication Date
US20020144905A1 true US20020144905A1 (en) 2002-10-10

Family

ID=27509097

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/957,116 Abandoned US20020144905A1 (en) 1997-12-17 2001-09-19 Sample positioning and analysis system
US10/093,680 Expired - Lifetime US7201836B2 (en) 1997-12-17 2002-03-07 Multiaperture sample positioning and analysis system
US11/535,064 Abandoned US20070209935A1 (en) 1997-12-17 2006-09-25 Multiaperture Sample Positioning and Analysis System

Family Applications After (2)

Application Number Title Priority Date Filing Date
US10/093,680 Expired - Lifetime US7201836B2 (en) 1997-12-17 2002-03-07 Multiaperture sample positioning and analysis system
US11/535,064 Abandoned US20070209935A1 (en) 1997-12-17 2006-09-25 Multiaperture Sample Positioning and Analysis System

Country Status (1)

Country Link
US (3) US20020144905A1 (en)

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020104757A1 (en) * 1997-12-17 2002-08-08 Christian Schmidt Efficient methods for the analysis of ion channel proteins
US20020182627A1 (en) * 2001-03-24 2002-12-05 Xiaobo Wang Biochips including ion transport detecting strucutres and methods of use
US20030008412A1 (en) * 1997-10-10 2003-01-09 Ciphergen Biosystems, Inc. Plate alignment and sample transfer indicia for a multiwell multiplate stack and method for processing biological/chemical samples using the same
US20030052002A1 (en) * 1997-12-17 2003-03-20 Horst Vogel Multiaperture sample positioning and analysis system
US20030078483A1 (en) * 1999-12-14 2003-04-24 Thierry Herve Microelectrode supporting cell with excitable membrane
WO2003048786A2 (en) * 2001-11-30 2003-06-12 Bristol-Myers Squibb Company Pipette configurations and arrays thereof for measuring cellular electrical properties
WO2003093494A2 (en) * 2002-05-04 2003-11-13 Aviva Biosciences Corporation Apparatus including ion transport detecting structures and methods of use
US20030215941A1 (en) * 2002-03-12 2003-11-20 Stewart Campbell Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound
US6682649B1 (en) * 1999-10-01 2004-01-27 Sophion Bioscience A/S Substrate and a method for determining and/or monitoring electrophysiological properties of ion channels
US20040146849A1 (en) * 2002-01-24 2004-07-29 Mingxian Huang Biochips including ion transport detecting structures and methods of use
WO2004074829A1 (en) * 2003-02-21 2004-09-02 Sophion Bioscience A/S Capillary stop
US20050009004A1 (en) * 2002-05-04 2005-01-13 Jia Xu Apparatus including ion transport detecting structures and methods of use
US20050058990A1 (en) * 2001-03-24 2005-03-17 Antonio Guia Biochip devices for ion transport measurement, methods of manufacture, and methods of use
US20050176133A1 (en) * 2003-02-21 2005-08-11 Matsushita Electric Industrial Co., Ltd. Measuring instrument for biosensor and measuring method using same
US20050196746A1 (en) * 2001-03-24 2005-09-08 Jia Xu High-density ion transport measurement biochip devices and methods
WO2005098396A2 (en) * 2004-01-10 2005-10-20 Jia Xu High-density ion transport measurement biochip devices and methods
US20060029955A1 (en) * 2001-03-24 2006-02-09 Antonio Guia High-density ion transport measurement biochip devices and methods
US7056430B1 (en) 2002-01-09 2006-06-06 Axon Instruments, Inc. Detachable cell-delivery system for patch-clamp unit
US20070218471A1 (en) * 2005-10-17 2007-09-20 Samsung Electronics Co., Ltd Method and device for detecting dna using surface-treated nanopore
US20070296847A1 (en) * 2006-06-21 2007-12-27 Chao-Chi Chang Method of making image capture unit
US20080049313A1 (en) * 2006-08-25 2008-02-28 Carl Zeiss Microlmaging Gmbh Illumination optics for an optical observation device
US20080121784A1 (en) * 2006-11-15 2008-05-29 Ether Precision, Inc. Image capture unit and methods
US20090047731A1 (en) * 2005-06-07 2009-02-19 Matsushita Electric Industrial Co., Ltd. Cellular electrophysiological measurement device and method for manufacturing the same
US20090239033A1 (en) * 2002-06-05 2009-09-24 Panaconic Corporation Diaphragm and device for measuring cellular potential using the same, manufacturing method of the diaphragm
US20100039713A1 (en) * 2008-08-15 2010-02-18 Ether Precision, Inc. Lens assembly and method of manufacture
US20100322610A1 (en) * 2009-06-23 2010-12-23 Ether Precision, Inc. Imaging device with focus offset compensation
US20110039165A1 (en) * 2008-03-12 2011-02-17 Sony Corporation Fuel cell and method for manufacturing the same, enzyme-immobilized electrode and method for manufacturing the same, and electronic apparatus
US20110240471A1 (en) * 2008-10-01 2011-10-06 Tecan Trading Ag Exchangeable carriers pre-loaded with reagent depots for digital microfluidics
US20120152765A1 (en) * 2010-12-14 2012-06-21 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Potentiometric sensor and method for the start-up of a potentiometric sensor
WO2012095298A1 (en) * 2011-01-10 2012-07-19 Albert-Ludwigs-Universität Freiburg Microstructure device for measuring molecular membranes and a method for producing said microstructure device
US20130249530A1 (en) * 2009-11-06 2013-09-26 Wisconsin Alumni Research Foundation Piezoelectric substrate for the study of biomolecules
US9322820B2 (en) 2013-03-14 2016-04-26 Wisconsin Alumni Research Foundation System and apparatus for nanopore sequencing
EP3338084A4 (en) * 2015-08-21 2019-04-03 Deakin University A microfluidic device and methods for manufacturing same
CN110187088A (en) * 2019-05-05 2019-08-30 浙江大学 Cell microsphere array chip apparatus and its method for electric potential signal measurement
US11255814B2 (en) * 2008-05-05 2022-02-22 The Regents Of The University Of California Functionalized nanopipette biosensor
US11561216B2 (en) 2012-02-13 2023-01-24 Oxford Nanopore Technologies Plc Apparatus for supporting an array of layers of amphiphilic molecules and method of forming an array of layers of amphiphilic molecules
US11596940B2 (en) 2016-07-06 2023-03-07 Oxford Nanopore Technologies Plc Microfluidic device
US11789006B2 (en) 2019-03-12 2023-10-17 Oxford Nanopore Technologies Plc Nanopore sensing device, components and method of operation
US11955207B2 (en) 2015-06-30 2024-04-09 Emerald Cloud Lab, Inc. Laboratory experiment data exploration and visualization

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244349B2 (en) * 1997-12-17 2007-07-17 Molecular Devices Corporation Multiaperture sample positioning and analysis system
US7067046B2 (en) * 2000-08-04 2006-06-27 Essen Instruments, Inc. System for rapid chemical activation in high-throughput electrophysiological measurements
US7678539B2 (en) * 2000-08-10 2010-03-16 Corning Incorporated Arrays of biological membranes and methods and use thereof
US7429316B1 (en) * 2001-10-09 2008-09-30 Yuri Osipchuk Planar patch-clamp cartridge with integrated electrode
US7201831B2 (en) * 2002-02-22 2007-04-10 Water Security And Technology, Inc. Impurity detection device
WO2005007866A2 (en) * 2003-05-31 2005-01-27 Aviva Biosciences Corporation Biochip devices for ion transport measurement, methods of manufacture, and methods of use
JP4394916B2 (en) * 2003-09-19 2010-01-06 独立行政法人科学技術振興機構 Artificial lipid bilayer membrane formation apparatus, artificial lipid bilayer membrane formation method, and use thereof
JP4394917B2 (en) * 2003-09-19 2010-01-06 独立行政法人科学技術振興機構 Current measuring device with artificial lipid bilayer membrane
US20060157684A1 (en) * 2004-12-15 2006-07-20 The Regents Of The University Of California Thin film multilayer with nanolayers addressable from the macroscale
US7473533B2 (en) * 2004-12-30 2009-01-06 Corning Incorporated Membrane arrays and methods of manufacture
US7807042B2 (en) * 2005-01-27 2010-10-05 Auburn University System for and method of patch clamp analysis
US7846396B2 (en) * 2005-05-31 2010-12-07 Sierra Sensors Gmbh Sample holder for surface plasmon resonance measuring instruments
US9233846B2 (en) * 2005-10-14 2016-01-12 The Regents Of The University Of California Formation and encapsulation of molecular bilayer and monolayer membranes
US7777505B2 (en) * 2006-05-05 2010-08-17 University Of Utah Research Foundation Nanopore platforms for ion channel recordings and single molecule detection and analysis
US7849581B2 (en) * 2006-05-05 2010-12-14 University Of Utah Research Foundation Nanopore electrode, nanopore membrane, methods of preparation and surface modification, and use thereof
US20100025263A1 (en) * 2006-05-05 2010-02-04 University Of Utah Research Foundation Nanopore particle analyzer, method of preparation and use thereof
WO2008036614A1 (en) 2006-09-18 2008-03-27 California Institute Of Technology Apparatus for detecting target molecules and related methods
TW200844437A (en) * 2007-05-02 2008-11-16 Nat Univ Tsing Hua Portable optical detection chip and its manufacturing method thereof
US9121843B2 (en) 2007-05-08 2015-09-01 Trustees Of Boston University Chemical functionalization of solid-state nanopores and nanopore arrays and applications thereof
WO2009094786A1 (en) * 2008-01-31 2009-08-06 Acadia University Device and method for collecting a sample from a wet environment
WO2011040996A1 (en) 2009-09-30 2011-04-07 Quantapore, Inc. Ultrafast sequencing of biological polymers using a labeled nanopore
WO2011085047A1 (en) 2010-01-05 2011-07-14 The Regents Of The University Of California Droplet bilayer formation using throughput liquid handling techniques
KR101747297B1 (en) 2010-08-04 2017-06-27 삼성전자주식회사 Backlight unit and 2D and 3D image display system
US10598609B2 (en) 2011-03-14 2020-03-24 Battelle Memorial Institute Universal liquid sample device and process for high resolution transmission electron microscope imaging and multimodal analyses of liquid sample materials
US10505234B2 (en) 2011-03-14 2019-12-10 Battelle Memorial Institute Battery cell and n situ battery electrode analysis method
US9274059B2 (en) * 2011-03-14 2016-03-01 Battelle Memorial Institute Microfluidic electrochemical device and process for chemical imaging and electrochemical analysis at the electrode-liquid interface in-situ
US9150598B2 (en) 2011-10-05 2015-10-06 The Regents Of The University Of California Masking apertures enabling automation and solution exchange in sessile bilayers
US9649630B2 (en) * 2012-01-09 2017-05-16 Sophion Bioscience A/S Patch area cell adhesion
WO2013130808A1 (en) 2012-02-29 2013-09-06 D.E. Shaw Research, Llc Methods for screening voltage gated proteins
US9651539B2 (en) 2012-10-28 2017-05-16 Quantapore, Inc. Reducing background fluorescence in MEMS materials by low energy ion beam treatment
US20150346144A1 (en) * 2012-12-27 2015-12-03 Senova Systems, Inc. Ph meter
EP2781591B1 (en) * 2013-03-19 2017-05-03 Unisense Fertilitech A/S A tray, a system and a method for monitoring and culturing of a cell culture
US9753009B2 (en) 2013-04-17 2017-09-05 Revalesio Corporation Methods and apparatus for trapping and size resolution of nanoparticles and nanobubbles
CA2909297A1 (en) * 2013-04-17 2014-10-23 Revalesio Corporation Controlling nanobubble and nanoparticle dynamics in conical nanopores
CN105283560B (en) 2013-05-24 2018-11-30 昆塔波尔公司 The foranalysis of nucleic acids detected by mixed FRET based on nano-pore
CA2963604C (en) 2014-10-10 2023-02-14 Quantapore, Inc. Nanopore-based polymer analysis with mutually-quenching fluorescent labels
CA2964790C (en) 2014-10-24 2023-02-21 Quantapore, Inc. Efficient optical analysis of polymers using arrays of nanostructures
WO2018009346A1 (en) 2016-07-05 2018-01-11 Quantapore, Inc. Optically based nanopore sequencing
EP3493908B1 (en) * 2016-08-05 2023-11-29 Vital Signs Solutions Limited Device and method for liquid analysis to detect biomarkers
US20180313787A1 (en) * 2017-04-28 2018-11-01 BioForce Medical, Inc. Isolation of Circulating Tumor Cells Using Electric Fields

Family Cites Families (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856633A (en) 1971-01-07 1974-12-24 Foxboro Co Concentration measurements utilizing coulometric generation of reagents
US4062750A (en) 1974-12-18 1977-12-13 James Francis Butler Thin film electrochemical electrode and cell
DE2502621C3 (en) 1975-01-23 1978-09-14 Kernforschungsanlage Juelich Gmbh, 5170 Juelich Measurement of elastic and dielectric properties of the membrane of living cells
FR2353856A1 (en) 1976-06-02 1977-12-30 Chateau Guy TAPE INTENDED TO BE USED AS A SUPPORT FOR A REACTION FOR EXAMPLE CHEMICAL OR BIOCHEMICAL, AND ANALYSIS PROCESS IMPLEMENTING IT
DE2741638C3 (en) 1977-09-15 1980-03-27 Ernst Dipl.-Phys. Dr. 8000 Muenchen Remy Specimen carrier with electrode arrangement for cell examination, as well as its manufacture
US4128456A (en) 1977-10-11 1978-12-05 Lee Kai S Suction electrode for intracellular potential measurement
US4225410A (en) 1978-12-04 1980-09-30 Technicon Instruments Corporation Integrated array of electrochemical sensors
US4456522A (en) 1981-09-23 1984-06-26 Critikon, Inc. Support and anchoring mechanism for membranes in selectively responsive field effect devices
DE3144003C2 (en) 1981-11-04 1984-11-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Measuring arrangement for extremely small currents
US4441507A (en) 1981-11-30 1984-04-10 Morris Steffin High speed single electrode membrane voltage clamp
US5310674A (en) 1982-05-10 1994-05-10 Bar-Ilan University Apertured cell carrier
US4490216A (en) 1983-02-03 1984-12-25 Molecular Devices Corporation Lipid membrane electroanalytical elements and method of analysis therewith
US4661451A (en) 1984-02-06 1987-04-28 Ortho Diagnostic Systems, Inc. Methods for immobilizing and translocating biological cells
US4661321A (en) 1984-05-30 1987-04-28 Halliburton Company Continuous reactor design
US4952518A (en) 1984-10-01 1990-08-28 Cetus Corporation Automated assay machine and assay tray
JPS61247965A (en) 1985-04-25 1986-11-05 Susumu Kogyo Kk Enzyme immunological measurement method
EP0213825A3 (en) 1985-08-22 1989-04-26 Molecular Devices Corporation Multiple chemically modulated capacitance
JP2662215B2 (en) 1986-11-19 1997-10-08 株式会社日立製作所 Cell holding device
US4911806A (en) 1987-02-27 1990-03-27 Biotronics Method and apparatus for separating particles in liquid suspension utilizing oscillating electric and magnetic fields
US5079600A (en) 1987-03-06 1992-01-07 Schnur Joel M High resolution patterning on solid substrates
US5169600A (en) 1987-07-15 1992-12-08 Fuji Photo Film Co., Ltd. Biochemical analysis apparatus for incubating and analyzing test sites on a long tape test film
US5055263A (en) 1988-01-14 1991-10-08 Cyberlab, Inc. Automated pipetting system
US5111221A (en) 1988-05-13 1992-05-05 United States Of America As Represented By The Secretary Of The Navy Receptor-based sensor
US5225374A (en) 1988-05-13 1993-07-06 The United States Of America As Represented By The Secretary Of The Navy Method of fabricating a receptor-based sensor
WO1990002327A1 (en) 1988-08-18 1990-03-08 AUSTRALIAN MEMBRANE AND BIOTECHNOLOGY RESEARCH INSTITUTE LTD., Commonwealth Scientific and Industrial Research Organization Improvements in sensitivity and selectivity of ion channel membrane biosensors
FR2637687B1 (en) 1988-10-11 1991-01-11 Inst Textile De France SINGLE USE DEVICE FOR BIOLOGICAL TESTS
US5443955A (en) 1989-01-27 1995-08-22 Australian Membrane And Biotechnology Research Institute Receptor membranes and ionophore gating
US4912060A (en) 1989-02-17 1990-03-27 World Precision Instruments, Inc. Method and apparatus for electrical testing of membranes
US5262128A (en) 1989-10-23 1993-11-16 The United States Of America As Represented By The Department Of Health And Human Services Array-type multiple cell injector
GB8927377D0 (en) 1989-12-04 1990-01-31 Univ Edinburgh Improvements in and relating to amperometric assays
US5229163A (en) 1989-12-21 1993-07-20 Hoffmann-La Roche Inc. Process for preparing a microtiter tray for immunometric determinations
US5041266A (en) 1989-12-21 1991-08-20 Hoffmann-La Roche Inc. Tray for immunometric determinations
IL93020A (en) 1990-01-09 1995-06-29 Yeda Res & Dev Biosensors comprising a lipid bilayer doped with ion channels anchored to a recording electrode by bridging molecules
US5750015A (en) 1990-02-28 1998-05-12 Soane Biosciences Method and device for moving molecules by the application of a plurality of electrical fields
DE4115414C2 (en) 1991-05-10 1995-07-06 Meinhard Prof Dr Knoll Process for the production of miniaturized chemo- and biosensor elements with an ion-selective membrane as well as carriers for these elements
US5187096A (en) * 1991-08-08 1993-02-16 Rensselaer Polytechnic Institute Cell substrate electrical impedance sensor with multiple electrode array
US5632957A (en) 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US5605662A (en) 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
IL103674A0 (en) 1991-11-19 1993-04-04 Houston Advanced Res Center Method and apparatus for molecule detection
US5310469A (en) 1991-12-31 1994-05-10 Abbott Laboratories Biosensor with a membrane containing biologically active material
JP2869246B2 (en) 1992-03-26 1999-03-10 三洋電機株式会社 Neural model element
US5508200A (en) 1992-10-19 1996-04-16 Tiffany; Thomas Method and apparatus for conducting multiple chemical assays
US5810725A (en) 1993-04-16 1998-09-22 Matsushita Electric Industrial Co., Ltd. Planar electrode
US6225059B1 (en) 1993-11-01 2001-05-01 Nanogen, Inc. Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics
US6287517B1 (en) 1993-11-01 2001-09-11 Nanogen, Inc. Laminated assembly for active bioelectronic devices
US6099803A (en) 1994-07-07 2000-08-08 Nanogen, Inc. Advanced active electronic devices for molecular biological analysis and diagnostics
US6068818A (en) 1993-11-01 2000-05-30 Nanogen, Inc. Multicomponent devices for molecular biological analysis and diagnostics
DE4400955C2 (en) 1993-12-23 1999-04-01 Fraunhofer Ges Forschung Adhesion-controllable surface structure
US5563067A (en) 1994-06-13 1996-10-08 Matsushita Electric Industrial Co., Ltd. Cell potential measurement apparatus having a plurality of microelectrodes
US6071394A (en) * 1996-09-06 2000-06-06 Nanogen, Inc. Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis
US6403367B1 (en) * 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
CA2203886C (en) 1994-10-28 2003-09-02 Soren-Peter Olesen Patch clamp apparatus and technique having high throughput and low fluid volume requirements
US5585069A (en) 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US5955352A (en) 1994-12-22 1999-09-21 Showa Yakuhin Kako Co., Ltd. Instruments for chemical and microbiological tests
US6043037A (en) 1995-02-06 2000-03-28 The Regents Of The University Of California Rapid method for measuring clastogenic fingerprints using fluorescence in situ hybridization
US5795782A (en) 1995-03-17 1998-08-18 President & Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
SE9502258D0 (en) 1995-06-21 1995-06-21 Pharmacia Biotech Ab Method for the manufacture of a membrane-containing microstructure
JP3643863B2 (en) 1995-08-09 2005-04-27 アークレイ株式会社 Liquid holder and manufacturing method thereof
DE19529371C3 (en) 1995-08-10 2003-05-28 Nmi Univ Tuebingen Microelectrode array
US6762036B2 (en) * 1995-11-08 2004-07-13 Trustees Of Boston University Cellular physiology workstations for automated data acquisition and perfusion control
WO1997017426A1 (en) 1995-11-08 1997-05-15 Trustees Of Boston University Cellular physiology workstations for automated data acquisition and perfusion control
DE19544127C1 (en) 1995-11-27 1997-03-20 Gimsa Jan Dr Suspended particle micro-manipulation
DE19601054C1 (en) 1996-01-05 1997-04-10 Inst Bioprozess Analysenmesst Biological particle parameter measuring method
DE19601488C1 (en) 1996-01-17 1997-05-28 Itt Ind Gmbh Deutsche Measuring device manufacturing method for measuring or testing physiological parameter at biocomponent
US5885470A (en) 1997-04-14 1999-03-23 Caliper Technologies Corporation Controlled fluid transport in microfabricated polymeric substrates
US6103479A (en) 1996-05-30 2000-08-15 Cellomics, Inc. Miniaturized cell array methods and apparatus for cell-based screening
AU3508197A (en) 1996-06-27 1998-01-14 Cellstat Technologies, Inc High-throughput screening method and apparatus
US6008010A (en) 1996-11-01 1999-12-28 University Of Pittsburgh Method and apparatus for holding cells
DE19646505A1 (en) 1996-11-12 1998-05-14 Itt Ind Gmbh Deutsche Device for carrying out tests on cell samples and the like
WO1998022819A1 (en) 1996-11-16 1998-05-28 Nmi Naturwissenschaftliches Und Medizinisches Institut An Der Universität Tübingen In Reutlingen Stiftung Bürgerlichen Rechts Array of microelements, method of contacting cells in a liquid environment and method for the production of an array of microelements
US6228326B1 (en) 1996-11-29 2001-05-08 The Board Of Trustees Of The Leland Stanford Junior University Arrays of independently-addressable supported fluid bilayer membranes
CA2271717A1 (en) * 1996-12-12 1998-06-18 Prolume, Ltd. Apparatus and method for detecting and identifying infectious agents
US5904824A (en) 1997-03-07 1999-05-18 Beckman Instruments, Inc. Microfluidic electrophoresis device
US5958345A (en) 1997-03-14 1999-09-28 Moxtek, Inc. Thin film sample support
US6143496A (en) 1997-04-17 2000-11-07 Cytonix Corporation Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
WO1998050791A1 (en) 1997-05-01 1998-11-12 Neurosearch A/S An automatic electrode positioning apparatus
US5981268A (en) 1997-05-30 1999-11-09 Board Of Trustees, Leland Stanford, Jr. University Hybrid biosensors
GB9712386D0 (en) 1997-06-14 1997-08-13 Univ Coventry Biosensor
US6163719A (en) 1997-09-09 2000-12-19 Sherman; Adam Jacob Biological membrane voltage estimator
WO1999014368A2 (en) 1997-09-15 1999-03-25 Whitehead Institute For Biomedical Research Methods and apparatus for processing a sample of biomolecular analyte using a microfabricated device
CA2301557A1 (en) 1997-09-19 1999-04-01 Aclara Biosciences, Inc. Apparatus and method for transferring liquids
US6106784A (en) 1997-09-26 2000-08-22 Applied Chemical & Engineering Systems, Inc. Thawing station
DE19744649C2 (en) 1997-10-09 2003-03-27 Fraunhofer Ges Forschung Method for measuring bioelectric signals from cells according to the patch clamp method and use of a device for this
DE19753598C1 (en) 1997-12-03 1999-07-01 Micronas Intermetall Gmbh Device for measuring physiological parameters
DE59801410D1 (en) * 1997-12-17 2001-10-11 Ecole Polytech POSITIONING AND ELECTROPHYSIOLOGICAL CHARACTERIZATION OF INDIVIDUAL CELLS AND RECONSTRUCTED MEMBRANE SYSTEMS ON MICROSTRUCTURED CARRIERS
US7244349B2 (en) * 1997-12-17 2007-07-17 Molecular Devices Corporation Multiaperture sample positioning and analysis system
US20020144905A1 (en) * 1997-12-17 2002-10-10 Christian Schmidt Sample positioning and analysis system
US6027695A (en) 1998-04-01 2000-02-22 Dupont Pharmaceuticals Company Apparatus for holding small volumes of liquids
EP0962524B1 (en) 1998-05-27 2004-11-03 Micronas GmbH Apparatus and process for the intracellular manipulation of a biological cell
DE19841337C1 (en) * 1998-05-27 1999-09-23 Micronas Intermetall Gmbh Intracellular manipulation of biological cell contents, assisting injection or removal of substances or cell components
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6132582A (en) 1998-09-14 2000-10-17 The Perkin-Elmer Corporation Sample handling system for a multi-channel capillary electrophoresis device
US6267872B1 (en) 1998-11-06 2001-07-31 The Regents Of The University Of California Miniature support for thin films containing single channels or nanopores and methods for using same
JP2002532717A (en) * 1998-12-11 2002-10-02 サイミックス テクノロジーズ、インク Sensor array based system and method for rapid material characterization
JP4454155B2 (en) * 1999-01-08 2010-04-21 アプライド バイオシステムズ, エルエルシー Fiber arrays for contacting chemical species and methods of using and making fiber arrays
US6377057B1 (en) 1999-02-18 2002-04-23 The Board Of Trustees Of The Leland Stanford Junior University Classification of biological agents according to the spectral density signature of evoked changes in cellular electric potential
CN1185492C (en) 1999-03-15 2005-01-19 清华大学 Single-point strobed micro electromagnetic units array chip or electromagnetic biologic chip and application thereof
US6927049B2 (en) * 1999-07-21 2005-08-09 The Regents Of The University Of California Cell viability detection using electrical measurements
US6365129B1 (en) 1999-08-04 2002-04-02 Tosk, Inc. Invivo high throughput toxicology screening method
US6488829B1 (en) 1999-08-05 2002-12-03 Essen Instruments Inc High-throughput electrophysiological measurement apparatus
US6682649B1 (en) * 1999-10-01 2004-01-27 Sophion Bioscience A/S Substrate and a method for determining and/or monitoring electrophysiological properties of ion channels
DE19948473A1 (en) * 1999-10-08 2001-04-12 Nmi Univ Tuebingen Method and device for measuring cells in a liquid environment
AU1591301A (en) 1999-11-09 2001-06-06 Sri International Workstation, apparatus, and methods for the high-throughput synthesis, screeningand characterization of combinatorial libraries
WO2001038873A2 (en) * 1999-11-24 2001-05-31 Biotronic Technologies, Inc. Devices and methods for detecting analytes using electrosensor having capture reagent
GB9930719D0 (en) * 1999-12-24 2000-02-16 Central Research Lab Ltd Apparatus for and method of making electrical measurements on an object in a m edium
AU2001234996A1 (en) * 2000-02-11 2001-08-20 Yale University Planar patch clamp electrodes
EP1266218A2 (en) * 2000-03-15 2002-12-18 Aviva Biosciences Corporation Apparatus and method for high throughput electrorotation analysis
CN1319761A (en) 2000-03-15 2001-10-31 清华大学 Apparatus and method for high-flux electric rotation detection
US20030139336A1 (en) * 2000-03-21 2003-07-24 Norwood James Henry Interface patch clamping
US20030129581A1 (en) * 2000-06-06 2003-07-10 Owen David Geraint Patch-clamping method and apparatus
DE10032568A1 (en) * 2000-07-05 2002-01-24 Nmi Univ Tuebingen Device and method for electrically contacting biological cells suspended in a liquid
EP1178315A1 (en) * 2000-07-31 2002-02-06 Albrecht Dr.med. Priv.Doz. Lepple-Wienhues Method and apparatus for examining cells using the patch clamp method
US7270730B2 (en) * 2000-08-04 2007-09-18 Essen Instruments, Inc. High-throughput electrophysiological measurement system
US6613285B1 (en) * 2000-09-25 2003-09-02 General Electric Company Reactor plate and method
CN1325909C (en) 2000-09-27 2007-07-11 清华大学 Apparatus for particle operation and guide and use method thereof
CA2424941A1 (en) * 2000-10-10 2002-04-18 Aviva Biosciences Corporation An integrated biochip system for sample preparation and analysis
US6461860B2 (en) 2001-01-25 2002-10-08 Axon Instruments, Inc. Alignment mechanism for two-electrode voltage-clamp perfusion chamber for electrophysiological testing of oocytes
US20020108869A1 (en) * 2001-02-09 2002-08-15 Alex Savtchenko Device and technique for multiple channel patch clamp recordings
US6899800B2 (en) * 2001-06-20 2005-05-31 Axon Instruments, Inc. Polymeric electrode for electrophysiological testing
US6949355B2 (en) * 2001-10-11 2005-09-27 Aviva Biosciences Methods, compositions, and automated systems for separating rare cells from fluid samples
AU2002352988A1 (en) * 2001-11-30 2003-06-17 Bristol-Myers Squibb Company Pipette configurations and arrays thereof for measuring cellular electrical properties
US20030104512A1 (en) * 2001-11-30 2003-06-05 Freeman Alex R. Biosensors for single cell and multi cell analysis
WO2003047738A2 (en) * 2001-11-30 2003-06-12 Bristol-Myers Squibb Company Liquid interface configurations for automated patch clamp recording
DE10203686A1 (en) * 2002-01-31 2003-08-07 Bayer Ag Method for performing electrical measurements on biological membrane bodies
US7201875B2 (en) * 2002-09-27 2007-04-10 Becton Dickinson And Company Fixed mounted sorting cuvette with user replaceable nozzle
US20040251145A1 (en) * 2003-02-21 2004-12-16 Robertson Janet Kay High throughput screening (HTS) method and apparatus for monitoring ion channels

Cited By (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030008412A1 (en) * 1997-10-10 2003-01-09 Ciphergen Biosystems, Inc. Plate alignment and sample transfer indicia for a multiwell multiplate stack and method for processing biological/chemical samples using the same
US20020104757A1 (en) * 1997-12-17 2002-08-08 Christian Schmidt Efficient methods for the analysis of ion channel proteins
US20030052002A1 (en) * 1997-12-17 2003-03-20 Horst Vogel Multiaperture sample positioning and analysis system
US6682649B1 (en) * 1999-10-01 2004-01-27 Sophion Bioscience A/S Substrate and a method for determining and/or monitoring electrophysiological properties of ion channels
US20030078483A1 (en) * 1999-12-14 2003-04-24 Thierry Herve Microelectrode supporting cell with excitable membrane
US20090209029A1 (en) * 2001-03-24 2009-08-20 Antonio Guia High-density ion transport measurement biochip devices and methods
US20050058990A1 (en) * 2001-03-24 2005-03-17 Antonio Guia Biochip devices for ion transport measurement, methods of manufacture, and methods of use
US20060029955A1 (en) * 2001-03-24 2006-02-09 Antonio Guia High-density ion transport measurement biochip devices and methods
US20020182627A1 (en) * 2001-03-24 2002-12-05 Xiaobo Wang Biochips including ion transport detecting strucutres and methods of use
US7968305B2 (en) 2001-03-24 2011-06-28 Aviva Biosciences Corporation Biochips including ion transport detecting structures and methods of use
US20050196746A1 (en) * 2001-03-24 2005-09-08 Jia Xu High-density ion transport measurement biochip devices and methods
US9146221B2 (en) * 2001-03-24 2015-09-29 Aviva Biosciences Corporation High-density ion transport measurement biochip devices and methods
US20130266490A1 (en) * 2001-03-24 2013-10-10 Aviva Biosciences Corporation High-density ion transport measurement biochip devices and methods
WO2003048786A2 (en) * 2001-11-30 2003-06-12 Bristol-Myers Squibb Company Pipette configurations and arrays thereof for measuring cellular electrical properties
WO2003048786A3 (en) * 2001-11-30 2005-03-24 Bristol Myers Squibb Co Pipette configurations and arrays thereof for measuring cellular electrical properties
US7182915B2 (en) 2001-11-30 2007-02-27 Bristol-Myers Squibb Company Pipette configurations and arrays thereof for measuring cellular electrical properties
US7056430B1 (en) 2002-01-09 2006-06-06 Axon Instruments, Inc. Detachable cell-delivery system for patch-clamp unit
US20040146849A1 (en) * 2002-01-24 2004-07-29 Mingxian Huang Biochips including ion transport detecting structures and methods of use
US20050266478A1 (en) * 2002-01-24 2005-12-01 Mingxian Huang Biochips including ion transport detecting structures and methods of use
US7723029B2 (en) 2002-01-24 2010-05-25 Aviva Biosciences Corporation Biochips including ion transport detecting structures and methods of use
US20070166816A1 (en) * 2002-03-12 2007-07-19 Surface Logix, Inc. Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound
US20030215941A1 (en) * 2002-03-12 2003-11-20 Stewart Campbell Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound
WO2003093494A2 (en) * 2002-05-04 2003-11-13 Aviva Biosciences Corporation Apparatus including ion transport detecting structures and methods of use
US20050009004A1 (en) * 2002-05-04 2005-01-13 Jia Xu Apparatus including ion transport detecting structures and methods of use
WO2003093494A3 (en) * 2002-05-04 2004-02-05 Aviva Biosciences Corp Apparatus including ion transport detecting structures and methods of use
US20080286750A1 (en) * 2002-05-04 2008-11-20 Aviva Biosciences Corporation Apparatus including ion transport detecting structures and methods of use
US20090239033A1 (en) * 2002-06-05 2009-09-24 Panaconic Corporation Diaphragm and device for measuring cellular potential using the same, manufacturing method of the diaphragm
US8202439B2 (en) 2002-06-05 2012-06-19 Panasonic Corporation Diaphragm and device for measuring cellular potential using the same, manufacturing method of the diaphragm
US20060251544A1 (en) * 2003-02-21 2006-11-09 Sophion Bioscience A/S Capillary stop
US8268260B2 (en) 2003-02-21 2012-09-18 Sophion Bioscience A/S Capillary stop
US20050176133A1 (en) * 2003-02-21 2005-08-11 Matsushita Electric Industrial Co., Ltd. Measuring instrument for biosensor and measuring method using same
JP2006518851A (en) * 2003-02-21 2006-08-17 ソフィオン・バイオサイエンス・アクティーゼルスカブ Capillary stop
WO2004074829A1 (en) * 2003-02-21 2004-09-02 Sophion Bioscience A/S Capillary stop
WO2005098396A2 (en) * 2004-01-10 2005-10-20 Jia Xu High-density ion transport measurement biochip devices and methods
WO2005098396A3 (en) * 2004-01-10 2008-10-09 Jia Xu High-density ion transport measurement biochip devices and methods
US20090047731A1 (en) * 2005-06-07 2009-02-19 Matsushita Electric Industrial Co., Ltd. Cellular electrophysiological measurement device and method for manufacturing the same
US8318477B2 (en) 2005-06-07 2012-11-27 Panasonic Corporation Cellular electrophysiological measurement device and method for manufacturing the same
US20070218471A1 (en) * 2005-10-17 2007-09-20 Samsung Electronics Co., Ltd Method and device for detecting dna using surface-treated nanopore
US20070296847A1 (en) * 2006-06-21 2007-12-27 Chao-Chi Chang Method of making image capture unit
US20080049313A1 (en) * 2006-08-25 2008-02-28 Carl Zeiss Microlmaging Gmbh Illumination optics for an optical observation device
US8013289B2 (en) 2006-11-15 2011-09-06 Ether Precision, Inc. Lens array block for image capturing unit and methods of fabrication
US8134118B2 (en) 2006-11-15 2012-03-13 Ether Precision, Inc. Image capture unit and methods of fabricating a lens array block utilizing electrolysis
US20080121784A1 (en) * 2006-11-15 2008-05-29 Ether Precision, Inc. Image capture unit and methods
US20110039165A1 (en) * 2008-03-12 2011-02-17 Sony Corporation Fuel cell and method for manufacturing the same, enzyme-immobilized electrode and method for manufacturing the same, and electronic apparatus
US11940410B2 (en) 2008-05-05 2024-03-26 The Regents Of The University Of California Functionalized nanopipette biosensor
US11255814B2 (en) * 2008-05-05 2022-02-22 The Regents Of The University Of California Functionalized nanopipette biosensor
US20100039713A1 (en) * 2008-08-15 2010-02-18 Ether Precision, Inc. Lens assembly and method of manufacture
US8203791B2 (en) 2008-08-15 2012-06-19 Ether Precision, Inc. Image capturing unit and lens assembly
US7813043B2 (en) 2008-08-15 2010-10-12 Ether Precision, Inc. Lens assembly and method of manufacture
US20110240471A1 (en) * 2008-10-01 2011-10-06 Tecan Trading Ag Exchangeable carriers pre-loaded with reagent depots for digital microfluidics
US8993348B2 (en) * 2008-10-01 2015-03-31 The Governing Council Of The University Of Toronto Exchangeable carriers pre-loaded with reagent depots for digital microfluidics
US8090250B2 (en) 2009-06-23 2012-01-03 Ether Precision, Inc. Imaging device with focus offset compensation
US20100322610A1 (en) * 2009-06-23 2010-12-23 Ether Precision, Inc. Imaging device with focus offset compensation
US20130249530A1 (en) * 2009-11-06 2013-09-26 Wisconsin Alumni Research Foundation Piezoelectric substrate for the study of biomolecules
US9575021B2 (en) * 2009-11-06 2017-02-21 Wisconsin Alumni Research Foundation Piezoelectric substrate for the study of biomolecules
CN102565165A (en) * 2010-12-14 2012-07-11 恩德莱斯和豪瑟尔测量及调节技术分析仪表两合公司 Potentiometric sensor and method for the start-up of a potentiometric sensor
US9217724B2 (en) * 2010-12-14 2015-12-22 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Potentiometric sensor and method for the start-up of a potentiometric sensor
CN102565165B (en) * 2010-12-14 2014-12-24 恩德莱斯和豪瑟尔测量及调节技术分析仪表两合公司 Potentiometric sensor and method for the start-up of a potentiometric sensor
US20120152765A1 (en) * 2010-12-14 2012-06-21 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Potentiometric sensor and method for the start-up of a potentiometric sensor
WO2012095298A1 (en) * 2011-01-10 2012-07-19 Albert-Ludwigs-Universität Freiburg Microstructure device for measuring molecular membranes and a method for producing said microstructure device
US11561216B2 (en) 2012-02-13 2023-01-24 Oxford Nanopore Technologies Plc Apparatus for supporting an array of layers of amphiphilic molecules and method of forming an array of layers of amphiphilic molecules
US11913936B2 (en) 2012-02-13 2024-02-27 Oxford Nanopore Technologies Plc Apparatus for supporting an array of layers of amphiphilic molecules and method of forming an array of layers of amphiphilic molecules
US9322820B2 (en) 2013-03-14 2016-04-26 Wisconsin Alumni Research Foundation System and apparatus for nanopore sequencing
US11955207B2 (en) 2015-06-30 2024-04-09 Emerald Cloud Lab, Inc. Laboratory experiment data exploration and visualization
EP3338084A4 (en) * 2015-08-21 2019-04-03 Deakin University A microfluidic device and methods for manufacturing same
US11596940B2 (en) 2016-07-06 2023-03-07 Oxford Nanopore Technologies Plc Microfluidic device
US11789006B2 (en) 2019-03-12 2023-10-17 Oxford Nanopore Technologies Plc Nanopore sensing device, components and method of operation
CN110187088A (en) * 2019-05-05 2019-08-30 浙江大学 Cell microsphere array chip apparatus and its method for electric potential signal measurement

Also Published As

Publication number Publication date
US7201836B2 (en) 2007-04-10
US20030052002A1 (en) 2003-03-20
US20070209935A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
US7201836B2 (en) Multiaperture sample positioning and analysis system
US7244349B2 (en) Multiaperture sample positioning and analysis system
US20090153153A1 (en) Multiaperture sample positioning and analysis system
US8232074B2 (en) Nanoelectrodes and nanotips for recording transmembrane currents in a plurality of cells
WO2002024862A2 (en) Sample positioning and analysis system
US8784929B2 (en) Bilayers
US20140249056A1 (en) Bilayers
US8372600B2 (en) Method and apparatus for measuring changes in cell volume
US7858030B2 (en) Artificial lipid bilayer membrane formation device, artificial lipid bilayer membrane formation method, and usage thereof
US7408359B2 (en) Current measuring device having artificial lipid bilayer membrane
JP2007529003A (en) Analytical chip and method of using the analytical chip for measuring molecular structure and function
JP2007527540A (en) Method and apparatus for measuring cell volume change
EP3164712B1 (en) Microfluidic array supporting a lipid bilayer assembly
US20120214708A1 (en) Device and Process for Measuring Cell Properties
Danelon et al. Micro-and nanostructured devices for the investigation of biomolecular interactions

Legal Events

Date Code Title Description
AS Assignment

Owner name: CYTION SA, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SCHMIDT, CHRISTIAN;REEL/FRAME:012793/0977

Effective date: 20020313

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION